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This thesis uses experience gained from a large implementation trial in two rural districts of 
the Western Cape, South Africa, to address the needs of patients with non-communicable 
diseases (NCDs) and depression, and to identify solutions to those needs.  
 
The Primary Care 101 intervention supports and expands nurses’ role in integrated care, in 
particular for NCDs. It comprises a comprehensive clinical management tool implemented in 
primary care services using educational outreach training. It was evaluated using a 
pragmatic cluster randomised controlled trial: 38 clinics in the Eden and Overberg districts 
of the Western Cape were randomised to receive the intervention or to continue with usual 
care. 4393 Patients were enrolled and four cohorts identified: hypertension, diabetes, 
chronic respiratory disease and depression. Patients were re-interviewed once, 14 months 
later. Primary outcomes for the trial were treatment intensification for the hypertension, 
diabetes and chronic respiratory disease cohorts, and case detection for the depression 
cohort. Multimorbidity, NCD care and their socioeconomic associations were assessed on 
the whole trial cohort (combining intervention and control arms) at baseline and follow-up.  
 
The results are presented in published papers. Baseline data revealed considerable 
multimorbidity and unmet treatment needs (Paper 1). Socioeconomic indicators such as 
education, and modifiable clinic-level factors such as adequate staffing and community-
based chronic medication collection services were associated with blood pressure control 
(Paper 2) and depression management (Paper 3). The intervention was shown to be feasible 




The thesis addresses the public health challenge of providing integrated chronic disease 
primary care in South Africa by: 
 
• Providing original evidence for high levels of NCD multimorbidity and unmet 
treatment needs.  
• Identifying modifiable factors that could improve care for these diseases.  
• Providing new evidence from South Africa to support the bidirectional relationship 
between poverty and depression.  
• Reporting evidence of the effectiveness of a novel intervention aimed at improving 
NCD care. 
 
The findings point to the need for improved strategies for NCD care, including equipping 














Non-communicable diseases (NCDs) are the leading causes of death globally. The burden of 
NCDs in South Africa has been estimated to be two to three times higher than that in 
developed countries. This thesis uses experience gained from a large (38 clinics; 4393 
patients) implementation trial in two rural districts of the Western Cape during 2011 -2013 
to address the needs and potential solutions to the needs of patients with NCDs, including 
depression, attending primary care services. It examines multimorbidity, control and 
treatment of NCDs and depression; socioeconomic predictors of hypertension control and 
treatment; socioeconomic predictors of depression symptoms and treatment; and the 
effectiveness of educational outreach in the use of a clinical management tool (Primary Care 
101) in improving NCD care. 
 
Methods 
The thesis is based on experimental evidence from the randomised trial and observational 
evidence from the trial cohort. The Primary Care 101 (PC101) programme was evaluated 
using a pragmatic cluster randomised controlled trial (RCT). Thirty-eight clinics in the Eden 
and Overberg districts of the Western Cape were randomised to receive the PC101 
programme, which provides an integrated platform for NCD management, or to continue 
with usual care for these diseases. 4393 Patients were enrolled between March 2011 and 
November 2011, and four cohorts of patients identified: hypertension, diabetes, chronic 
respiratory disease and depression. Patients were interviewed once more, 14 months after 
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enrolment. Primary outcomes for the RCT were treatment intensification for the 
hypertension, diabetes, and chronic respiratory disease cohorts, and case detection for the 
depression cohort.  
 
Multimorbidity, control and treatment of NCDs; socioeconomic associations with 
hypertension control and treatment; and socioeconomic associations with depression 
symptoms and treatment were assessed on the whole trial cohort at baseline and follow-up, 
combining the intervention and control arms of the trial. Multiple regression models were 
used to avoid confounding and to estimate independent effects of socioeconomic factors 
and clinic characteristics.  
 
Findings 
The first paper describes the baseline data and demonstrates considerable multimorbidity 
and unmet treatment needs. Among participants with hypertension, diabetes, respiratory 
disease and depression, 80%, 92%, 88% and 80% respectively, had at least one of the other 
three conditions. The data confirmed poor levels of disease control and unmet treatment 
needs. Fifty-nine percent of participants with hypertension had a blood pressure ≥140/90 
mmHg. Among participants with diabetes, the mean haemoglobin A1c (HbA1c) value was 
9%, 2% above target. Only 12% of participants with symptoms of depression had been 
prescribed an antidepressant at a therapeutic dose. Fewer than a half of participants with 
chronic respiratory disease (asthma or chronic obstructive pulmonary disease) had received 
a beta2-agonist and only 34% an inhaled corticosteroid. These findings of poor control and 
low treatment levels for NCDs are similar to those of previous studies in South Africa and 
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suggest little, if any, change in recent years. The high levels of multimorbidity indicate the 
need for primary health care services to provide better integrated NCD care.  
 
The second paper examines socioeconomic and modifiable predictors of blood pressure 
control and treatment intensification in patients with hypertension. The study confirms 
both patient and clinic-related factors that are associated, first, with the likelihood of blood 
pressure control (patient factors), and second, with treatment intensification during the 
study period (patient and clinic-related factors). Blood pressure control at baseline was 
more likely in patients with more education (p=0.001) and in English compared with 
Afrikaans speaking participants (p=0.033). Treatment intensification was more likely in 
participants with higher blood pressure at baseline (P<0.001), concurrent diabetes 
(p=0.013), more education (p=0.020), and who attended clinics offering community-based 
chronic medication collection services (community-based medication supply) (p=0.009), 
with a doctor every day (p=0.004), or with more nurses (p<0.001). Health services need to 
be sensitive to the impact of socioeconomic factors, in particular, lower levels of education. 
The study points to clinic factors that may be addressed to improve the care of hypertensive 
patients. Besides attempting to improve staffing of clinics, this includes providing 
community-based medication supply. 
 
The third paper examines socioeconomic predictors and consequences of depression and 
its treatment. Socioeconomic disadvantage was shown to be both a cause and consequence 
of depression, and may also be a barrier to treatment. Symptoms of depression (higher 
Center for Epidemiologic Studies Depression Scale (CESD-10) scores) at baseline were 
associated with less formal education (p=0.004) and lower personal income (p=0.003). 
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Higher CESD-10 scores at follow-up were associated with less education (p=0.010) or receipt 
of welfare grants (p=0.007). In addition, participants with CESD-10 scores of ≥10 at baseline 
had 25 % higher odds of being unemployed at follow-up (p=0.016). Prescription of 
antidepressant medication for participants with a CESD-10 score of ≥10 at baseline was 
significantly higher in participants with more education (p=0.002), higher income (p< 0.001), 
or who were unemployed (p=0.001). Antidepressant medication at follow up was more 
likely in participants with higher income (p=0.023), and in clinics with better access to 
pharmacists (p=0.053) and community-based medication supply (p=0.013). Primary care 
clinics should be adequately staffed and have pharmacists on site but also enable patients 
to collect their repeat medications at more convenient locations. Evidence in support of the 
bidirectional relationship between poverty and depression reinforces arguments for the 
expansion of mental health services and improving the prevention, detection and treatment 
of depression in primary health care settings, for clinical and economic reasons. 
 
The fourth paper presents the results of the RCT. The PC101 intervention was shown to be 
feasible and safe but none of the four primary outcome measures, treatment intensification 
for hypertension, diabetes and chronic respiratory diseases, or case detection for 
depression, showed significant improvement (hypertension: 44% in the intervention group 
versus 40% in the control group, risk ratio [RR] 1.08 [95% CI 0.94 to 1.24; p = 0.252]; 
diabetes: 57% versus 50%, RR 1.10 [0.97 to 1.24; p = 0.126]; chronic respiratory disease: 
14% versus 12%, RR 1.08 [0.75 to 1.55; p = 0.674]; depression: 18% versus 24%, RR 0.76 
[0.53 to 1.10; p = 0.142]). PC101 offers a practical and acceptable tool to help expand the 
scope of practice of non-physician clinicians to include NCD care. While no primary 
outcomes showed a significant benefit of the intervention, there was also no evidence of 
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harm. The study illustrates the limitations of trials designed to study the effects of complex 
system interventions in real life, where even small changes across many endpoints, as seen 
in our study, may be useful to decision-makers. 
 
Conclusion 
This thesis provides new and original evidence for high levels of multimorbidity and unmet 
treatment needs for NCDs in the South African public primary care sector. It confirms 
associations between socioeconomic and clinic characteristics, and hypertension control 
and treatment, and depression symptoms and treatment. It identifies potentially modifiable 
clinic-level factors that could improve care for these diseases. It provides new evidence from 
South Africa in support of the bidirectional relationship between poverty and depression. 
Finally, it reports evidence of the effectiveness of a novel programme aimed at improving 
NCD management by supporting and expanding nurses’ role in NCD care. 
 
The work points to the need for improved strategies for diagnosing and managing NCDs and 
for better integrated NCD care, including equipping primary health care providers to 
manage NCDs and the complexities of multimorbidity.  
 
Health services need to be sensitive to the impact of socioeconomic factors, in particular 
lower levels of education. Clinic factors that may be addressed to improve NCD care include 
adequate staffing of clinics, having pharmacists on site, and provision for community-based 
collection of chronic medications. The latter is likely to be relevant to the care of all chronic 
diseases, and points to the need for expansion of convenient medication delivery services in 
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South Africa. Together, these measures should be viewed as achievable opportunities for 
improving the management of NCDs in primary care in South Africa. 
 
PC101 offers a practical and acceptable tool to help expand the scope of practice of non-
physician clinicians to include NCD care. The programme, with several subsequent 
adjustments aimed at increasing its impact, has been rolled out nationally in South Africa 
and is included in the National Department of Health’s checklist criteria for the Ideal Clinic 
and Integrated Clinical Services Management (ICSM) compliant package of clinical 
guidelines.   
 
PC101 forms the basis for the Practical Approach to Care Kit (PACK) (pack.bmj.com) which 
now extends to children, adolescents and community health workers. In partnership with 
the British Medical Journal (BMJ), global templates of the ‘PACK Adult’ programme have 
been developed. Localisations of PACK Adult for Brazil and Nigeria have been completed, 
and a randomised controlled trial is underway to evaluate the programme in the city of 
Florianópolis, Brazil. Ongoing development and evaluation of these programmes is required 
to ensure continued improvements in the management of NCDs in primary care. 
 
In summary, this thesis, including the four publications, addresses the public health 
challenge of providing integrated chronic disease management in South African primary 
care. It identifies needs and potential solutions to the needs of patients with NCDs in the 
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Chapter 1: Introduction and Literature Review 
 
1.1 Introduction 
Non-communicable diseases (NCDs) are the leading causes of death globally. They are 
projected to overtake communicable, maternal, perinatal, and nutritional diseases as the 
most common cause of death in Africa by 2030 (WHO 2011a). The burden of NCDs in South 
Africa has been estimated to be two to three times higher than that in developed countries 
(Mayosi et al. 2009). Further, multimorbidity is becoming the norm rather than the 
exception, with most people with chronic conditions having more than one (Mercer et al. 
2012) (Barnett et al. 2012). 
 
Despite this burden, chronic diseases and risk factors are often undiagnosed and 
inadequately treated in South Africa, resulting in high levels of uncontrolled hypertension, 
diabetes and chronic respiratory diseases (Mayosi et al. 2009) (Steyn K, Fourie J, and Temple 
N 2006) (Steyn et al. 2008) (Rayner 2010).  
 
Primary Care 101 (PC101) expands on PALSA PLUS, a clinical management tool which 
focussed on HIV and respiratory diseases, to include NCDs and mental health. PC101 is 
designed to strengthen health services by supporting and expanding nurses’ role in NCD 
care, alongside the demands of communicable and acute disease management. It addresses 
the need for improved diagnosis and management of NCDs with an integrated approach to 
primary health care. The programme comprises a clinical management tool, enhanced 
prescribing provisions for nurses, and educational outreach.  
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This thesis uses experience gained from a study in two districts of the Western Cape to 
address the needs and potential solutions to the needs of patients with NCDs attending 
primary care services. It examines multimorbidity, control and treatment of NCDs; 
socioeconomic and modifiable predictors of hypertension and depression control; and 
effectiveness of the PC101 programme in improving NCD care. 
1.2 Literature review 
This literature review provides the background to the problem of NCDs and multimorbidity 
globally and in South Africa, socioeconomic associations with hypertension and depression 
control, nurse-led primary care and task-sharing, and clinical tools including the PC101 
programme, necessary to understanding the motivation for the current studies. Additional 
background is provided in each of the four papers. 
 
1.2.1 The Burden of NCDs in South Africa and globally 
NCDs are the leading causes of death globally, killing more people each year than all other 
causes combined (WHO 2011a). In 2015, NCDs caused 71% of deaths globally (GBD 2015 
Mortality and Causes of Death Collaborators 2016). NCD deaths are projected to continue to 
rise worldwide, and the greatest increase is expected to be seen in low- and middle-income 
(LMIC) regions (WHO 2011a). In addition, NCDs are the leading cause of global disability-
adjusted life-years (DALYs) (GBD 2015 DALYs and HALE Collaborators 2016).  
 
The increasing significance of NCDs is the result of several factors, including population 
growth, the increasing average age of the world’s population, and decreasing death rates 
from communicable, maternal, neonatal, and nutritional causes (Lozano et al. 2012) 
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(Jamison et al. 2013). In African nations, NCDs are projected to exceed communicable, 
maternal, perinatal, and nutritional diseases as the most common causes of death by 2030 
(WHO 2011a). 
 
South Africa is experiencing a simultaneous burden of communicable and non-
communicable diseases (Mayosi et al. 2009). The burden of HIV and tuberculosis (TB), in 
particular, is high. In 2015, an estimated 7 million people in South Africa were living with 
HIV, and there were 180 000 deaths due to AIDS in that year (UNAIDS 2015). The World 
Health Organization (WHO) reported 454 000 cases of TB and 98 000 deaths from the 
disease in 2015 (WHO 2015).     
 
In parallel with these deaths from TB and HIV infection is a rise in NCDs in South Africa 
(Kasprowicz, Achkar, and Wilson 2011) (UNAIDS 2015). WHO estimates place the burden 
from NCDs in South Africa to be two to three times higher than in developed countries 
(Mayosi et al. 2009). Heart disease, diabetes and stroke together constitute the second 
most important cause of death in adult South Africans (Mayosi et al. 2009) and NCDs 
accounted for 39% of deaths and for considerable premature mortality in South Africa in 
2010 (Nojilana et al. 2016).  
 
Hypertension 
In 2010, high blood pressure was the leading risk factor for global disease burden, 
contributing to 7% of (DALYs) (Lim et al. 2012), and was estimated to be responsible for 7.5 
million deaths, about 12.8% of the total annual deaths worldwide (WHO 2011a). It is the 
leading cause of cardiovascular disease (CVD) including heart attacks, heart failure, stroke 
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and kidney failure. It is responsible for at least 45% of deaths due to heart disease and 51% 
of deaths due to stroke (WHO 2013a). The prevalence of high blood pressure globally in 
adults aged 25 and over was around 40% in 2008 (WHO 2011a), and raised blood pressure 
has a notably higher prevalence in LMICs (WHO 2011a). A recent survey in four provinces in 
South Africa found that hypertension was the commonest diagnosis and reason for 
attendance in public sector clinics (Mash et al. 2012).  
 
Diabetes 
In 2010, diabetes was the sixth leading cause of mortality and the eighth leading cause of 
DALYs worldwide (Murray and Lopez 2013). The Global Burden of Disease Study 2015 
ranked diabetes the sixth leading cause of global years lived with disability (YLDs) (GBD 2015 
Disease and Injury Incidence and Prevalence Collaborators 2016). Diabetes increases the risk 
of developing CVD, and is also a significant cause of blindness in adults, non-traumatic lower 
limb amputations, and end-stage renal disease requiring transplantation and dialysis (Tracey 
et al. 2016). The International Diabetes Federation estimates that 415 million people have 
diabetes worldwide and this is predicted to rise to 642 million by 2040 (IDF 2015). More 
than 80% of people with diabetes live in LMICs (Chan et al. 2016), and the number of people 
in South Africa with diabetes is estimated to be 2.3 million (IDF 2015). 
 
Chronic respiratory disease 
Chronic respiratory diseases are the third leading cause of NCD deaths (GBD 2015 Mortality 
and Causes of Death Collaborators 2016), with chronic obstructive pulmonary disease 




As many as 334 million people have asthma worldwide. Most people affected are in LMICs, 
where its  prevalence is estimated to be increasing fastest (Global Asthma Network 2014). In 
addition, more than 80% of asthma related deaths worldwide occur in LMICs. This high and 
increasing burden is probably related to both increasing prevalence and poor control (Beran 
et al. 2015). Disease severity among asthmatics has been found to be greater in lower 
socioeconomic groups in Cape Town, South Africa, and a strong positive association was 
found between social deprivation and admissions to intensive care units for asthma and (all-
age) mortality from asthma (Poyser et al. 2002). 
 
COPD mortality is also most common in low-resource regions (Beran et al. 2015). A 
community-based study of COPD in Cape Town found the prevalence of COPD (Stage 2 and 
above) to be 19% in persons aged 40 years and older, the highest of the 12 centres from 
different continents sampled (Buist et al. 2007).  
 
Depression 
There were an estimated 298 million cases of major depressive disorder worldwide in 2010 
(Ferrari et al. 2013) and this disorder was ranked the second leading cause of YLDs (Ferrari 
et al. 2013) (Vos et al. 2012). The Global Burden of Disease Study 2013 found that mental 
and substance abuse disorders accounted for 21% of YLDs, with major depressive disorder a 
crucial contributor in both developed and developing countries: it was the leading cause of 
YLDs in 56 countries, the second leading cause in 56 countries, and the third in 34 countries 
(Global Burden of Disease Study 2013 Collaborators 2015). In 2015, mental and substance 
use disorders were a leading cause of NCD burden (GBD 2015 DALYs and HALE Collaborators 
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2016) and depressive disorders were ranked the third leading cause of global YLDs (GBD 
2015 Disease and Injury Incidence and Prevalence Collaborators 2016). 
 
The South African Stress and Health (SASH) study indicated a lifetime prevalence of major 
depression of 9.7% and a 12 month prevalence of 4.9 % (Tomlinson et al. 2009). The 
relationships between mental disorders and other NCDs are complex and bidirectional 
(Patel and Chatterji 2015). Mental disorders increase risk for communicable and NCDs. 
Conversely, many health conditions increase the risk for mental disorder (Prince et al. 2007). 
 
1.2.2 Multimorbidity 
Worldwide, with ageing populations in almost all countries, most people with a chronic 
condition have more than one (Mercer et al. 2012) (Barnett et al. 2012). Multimorbidity is 
more common and occurs at an earlier age in patients of lower socioeconomic position 
(SEP) (Moffat and Mercer 2015) (Barnett et al. 2012).  
 
Some conditions may affect the risks of adverse outcomes associated with other conditions. 
For example, diabetes triples the risk of tuberculosis (Lönnroth, Roglic, and Harries 2014); 
people with COPD have a 2.5 times increased risk of cardiovascular disease (Chen et al. 
2015); and depression has been found to be an important risk factor for the development of 
ischaemic stroke (Rahman et al. 2013). 
 
Mental health problems such as depression are known to be common in patients with 
multimorbidity. The prevalence of mental health problems increases with increasing 
numbers of physical conditions within individuals (Moffat and Mercer 2015) (Gunn et al. 
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2012) (Barnett et al. 2012) and  negatively influences outcomes for chronic conditions, 
including acute admissions (Morrison et al. 2016) (Payne et al. 2013). In addition, mental 
combined with physical multimorbidity is 2–3 times more common in patients living in 
deprived areas compared with those in affluent areas (Moffat and Mercer 2015).  
 
Studies in South Africa have demonstrated high levels of comorbidity with hypertension and 
diabetes (Peer et al. 2013) (Steyn et al. 2008) (Lalkhen and Mash 2015), and psychological 
distress in women with physical disease (Mendenhall et al. 2013).  
 
Despite such evidence of multimorbidity, traditionally NCDs are managed separately, 
without adequate consideration of comorbidity in individual patients. There is an urgent 
need to integrate chronic disease care, including mental health (Patel and Chatterji 2015), 
and to equip primary health care providers to manage NCDs and the complexities of 
multimorbidity.  
 
1.2.3 Management of NCDs in the public sector in South Africa 
Chronic diseases and risk factors are often undiagnosed and inadequately treated in South 
Africa, resulting in high levels of uncontrolled hypertension, diabetes and chronic 
respiratory diseases (Mayosi et al. 2009) (Steyn K, Fourie J, and Temple N 2006) (Steyn et al. 
2008) (Rayner 2010).  
 
A survey in 18 community health centres in the Cape Peninsula, South Africa, carried out in 
1999 found that 67 % of hypertensive patients had uncontrolled blood pressure (> 140/90 
mmHg) and that the mean HbA1c among diabetic patients was 8.8% (Steyn et al. 2008). A 
8 
 
study of goldminers in Gauteng province, South Africa, in 2009/2010 found that only 42% of 
patients diagnosed with hypertension received antihypertensive medication, while 69% of 
patients on antihypertensive medication were poorly controlled (Maepe and Outhoff 2012). 
Notably, poor levels of hypertension control have also been associated with high levels of 
target organ damage (Peer et al. 2008).  
 
In the Global Initiative for Asthma report in 2004, South Africa ranked fourth of almost 70  
countries for asthma case fatality rates (Masoli et al. 2004), indicating inadequate 
management. The results of the South African Stress and Health (SASH) study indicated a 
high unmet need for treatment of mental health disorders with only 28% of those with 
severe and moderately severe mental disorders receiving treatment (Williams et al. 2008). 
 
1.2.4 Inequalities in South Africa and socioeconomic associations with 
hypertension and depression control  
South Africa is one of the most unequal countries in the world (Tregenna and Tsela 2012), 
with wide disparities in wealth and health (Benatar 2013). The Gini coefficient, a number 
between 0 and 1, where 0 indicates total equality and 1 indicates total inequality, was 
calculated to be approximately 0.65 based on expenditure data (per capita excluding taxes) 
and 0.69 based on income data (per capita including salaries, wages and social grants) in 
2011. These levels of inequality are amongst the highest in the world (Statistics South Africa 
2014). Consistent with global patterns, the burden of ill-health in South Africa has been 




The majority of the population of South Africa is dependent upon the public sector health 
services for their medical needs (van Rensburg 2014). Primary care in the public sector is 
nurse-led with support from doctors,  with nurses seeing over 85% of all patients (Mash et 
al. 2012). 
 
Studies have found associations between low socioeconomic position and increased risk of 
hypertension (Leng et al. 2015) (Kautzky-Willer et al. 2012) (Fan et al. 2015) (Grotto, Huerta, 
and Sharabi 2008) (Gorman and Sivaganesan 2007). In South African women, more 
education has been found to predict lower values of both diastolic and systolic blood 
pressure, while higher income predicted lower systolic blood pressure. This did not hold 
true for men (Cois and Ehrlich 2014). 
 
A number of studies in LMICs have shown an association between indicators of poverty and 
mental disorders (Lund et al. 2010) (Patel and Kleinman 2003). A systematic review found a 
consistent and strong association between common mental disorders and education, food 
insecurity, housing, social class, socio-economic status and financial stress; whereas income, 
employment and consumption (defined as household per capita expenditure) were found to 
be less consistently or strongly associated with mental disorders (Lund et al. 2010). Another 
systematic review in developing countries found most studies showed an association 
between risk of common mental disorders and low levels of education, and many studies 
also showed a relationship with other indicators of poverty such as poor housing or low 




1.2.5 Policy responses to NCDs 
Global policy response to NCDs 
The United Nations (UN) held a summit on NCDs in 2011 calling for a ‘whole-of-government’ 
and ‘whole-of-society’ approach for the prevention and management of NCDs (Beran 2015) 
(UNGA 2011). Following the United Nations summit, the World Health Organization 
developed the Global Action Plan, including a Global Monitoring Framework for the 
implementation of measures to prevent and control NCDs (WHO 2013b). This framework 
includes nine general NCD targets, with the overall goal of a 25% relative reduction in 
premature mortality from NCDs by 2025 (Beran 2015) (WHO 2013b). 
 
In order to achieve this, health systems will play an essential role and will need to be 
reoriented to meet the challenge (Beran 2015) (Reddy 2002). To aid priority setting and 
encourage immediate action for addressing NCDs, the WHO Global Status Report puts 
forward a series of highly cost effective ‘best buys’ – population-wide and individual 
healthcare interventions known to be effective, feasible, and affordable in any resource 
setting. Best buys include counselling and multi-drug therapy for people with a high risk of 
developing heart attacks and strokes (including those with established CVD), and preventive 
management of heart attacks with aspirin. Primary health care has been clearly identified by 
WHO as the best framework for implementing such interventions on an adequate scale to 





South African policy response to NCDs  
In 2013, following on from the UN summit, the South African National Department of Health 
released its Strategic Plan for the Prevention and Control of Non-communicable Diseases 
2013-17. This document establishes the framework for reducing morbidity and mortality 
from NCDs in the context of broad health reform in South Africa, such as the re-engineering 
of primary health care and planned introduction of a National Health Insurance. 
(Department of Health 2013a) (Department of Health 2015) (Public Health Association of 
South Africa 2011).  
 
The strategy has three major components: 1) to prevent NCDs and promote health and 
wellness at population, community and individual levels; 2) to improve control of NCDs 
through health systems strengthening and reform; and 3) to monitor NCDs and their main 
risk factors and conduct innovative research (Department of Health 2013a). Further, the 












Table 1. Strategic Plan for the Prevention and Control of Non-communicable Diseases 2013-17: 
2020 goals and targets (Department of Health 2013a) 
1. Reduce by at least 25% the relative premature mortality (under 60 years of age) from Non-
communicable Diseases by 2020 
2. Reduce by 20% tobacco use by 2020 
3. Reduce by 20% the per capita consumption of alcohol by 2020 
4. Reduce mean population intake of salt to <5 grams per day by 2020 
5. Reduce by 10% the percentage of people who are obese and/or overweight by 2020 
6. Reduce the prevalence of people with raised blood pressure by 20% by 2020 (through lifestyle 
and medication) 
7. Increase the prevalence of physical activity (defined as 150 minutes of moderate-intensity 
physical activity per week, or equivalent) by 10% 
8. Every woman with sexually transmitted diseases to be screened for cervical cancer every 5 
years, otherwise every woman to have 3 screens in a lifetime (and as per policy for women who 
are HIV/AIDS positive) 
9. Increase the percentage of people controlled for hypertension, diabetes and asthma by 30% by 
2020 in sentinel sites 
10. Increase the number of people screened and treated for mental disorder by 30% by 2030 
 
Since 2013 the National Department of Health has prioritised the Re-Engineering of Primary 
Care as part of efforts to work towards a National Health Insurance system (Department of 
Health 2015). This included initiatives to integrate care of communicable and NCDs at clinic 
level through a model initially known as Integrated Clinical Disease Management, based on 
the WHO’s Chronic Conditions Framework and incorporating PC101. This has evolved to the 
Integrated Clinical Services Management (Mahomed, Asmall, and Freeman 2014) 
(Mahomed and Asmall 2015) which now falls under the Ideal Clinic initiative which has 
established a list of core standards and indicators for primary care clinics (Department of 
Health 2016). PC101 forms the key clinical training component alongside the Integrated 




In addition to these clinical services initiatives, legislation has been introduced in an attempt 
to control NCDs and their risk factors, in particular smoking and dietary salt intake. South 
Africa became a Party to the WHO Framework Convention on Tobacco Control in 2005, and 
has a number of laws to restrict public smoking, regulate advertising, and ensure tobacco 
products carry health warnings (Campaign for Tobacco-Free Kids 2016). In 2013, legislation 
was passed to ensure a reduction in the salt content of certain foods, including bread, 
breakfast cereals, processed meat and stocks (Department of Health 2013b). A tax on sugar-
sweetened beverages based on sugar content is likely to be implemented in 2017 (National 
Treasury 2016). 
 
Despite this welcome policy and focus on NCD prevention and care, the scale of the HIV 
epidemic has been such that NCDs have had to take a back-seat to initiatives to combat HIV 
and TB and which have dominated the agenda of funding agencies, donor aid and public 
health programmes in South Africa. 
 
1.2.6 Nurse-led care and task-sharing 
Nurse substitution and supplementation in NCD care in high income settings are well 
recognised strategies (Laurant et al. 2009) (Horrocks, Anderson, and Salisbury 2002). A 
systematic review (Laurant et al. 2009) on the impact of non-physician clinicians identified 
18 reviews and studies focussing on nurse substitution and/or supplementation from 
developed countries, or where the geographic scope was not reported. The review 
concluded that role revision between physicians and non-physician clinicians does not 
jeopardise patient care and may sometimes improve its quality. Patients were significantly 
more satisfied with nurse-led care than physician-led care, and the process of care was 
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often improved by nurse–physician substitution. The evidence that role revision increases 
workforce efficiency or lowers costs is, however, weak and contradictory.  
 
A second systematic review (Horrocks, Anderson, and Salisbury 2002) of whether nurse 
practitioners working in primary care can provide equivalent care to doctors in developed 
countries, concluded that patients are at least as satisfied with care at the point of first 
contact with nurse practitioners as they are with first contact care from doctors. The quality 
of care and short term health outcomes seem to be equivalent to that of doctors. 
 
Evidence for nurse substitution and supplementation in NCD care in LMICs is sparse and 
limited to a few non-randomised studies (Labhardt et al. 2010) (Kengne et al. 2009) 
(Coleman, Gill, and Wilkinson 1998) (Gill et al. 2008). A study in rural districts of Cameroon 
concluded that the integration of hypertension and diabetes into primary health care at 
non-physician clinician facilities was feasible, accessible and showed promising blood 
pressure and blood glucose trends. However, low case-detection rates and a very high 
attrition among patients enrolled into care, limited the effectiveness of the programme 
(Labhardt et al. 2010). In another  study in Cameroon, involving five clinics, nurse-led 
protocol-driven hypertension care achieved significant blood pressure reduction in patients 
with hypertension (Kengne et al. 2009). An old study in rural South Africa demonstrated that 
appropriate management of patients with NCDs can be achieved in a resource-poor 
situation by optimising existing primary care services. Using practical stepwise diagnostic 
and treatment protocols, nursing staff managed to control most patients with hypertension, 
diabetes and asthma (Coleman, Gill, and Wilkinson 1998). A more recent study from rural 
South Africa devolving care to primary health clinics delivered by two nurses, concluded that 
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a diabetes care system based on a simple protocol and education could be successfully 
introduced and run by nurses in rural Africa (Gill et al. 2008). 
 
Antiretroviral treatment (ART) has transformed HIV/AIDs from an acute to a chronic 
condition. The scale-up of ART in South Africa, which began in 2004, had the favourable 
effect of prompting much-needed and urgent reforms to primary care services, to 
accommodate the extra clinical burden on these facilities. A major development was 
approval for nurses to play a greater role. In the context of HIV this initially comprised 
screening, staging and palliative care, but moved to nurse-initiated and managed ART 
(NIMART). An RCT evaluating nurse-monitored (but not initiated) ART in two South African 
primary care clinics, found that nurses were non-inferior to doctors in monitoring first-line 
ART (Sanne et al. 2010). A pragmatic RCT conducted by the University of Cape Town Lung 
Institute showed NIMART to be at least as effective, and for certain outcomes such as TB 
case detection, superior to doctor-led care (Fairall et al. 2012).  
 
Large-scale health system reforms such as NIMART can provide a platform for development 
of NCD programmes (Jamison et al. 2013) (Rabkin and El-Sadr 2011). PC101 aimed to 
leverage the health system reforms that accompanied the scale-up of ART to improve the 
quality of primary care for NCDs and mental health.  
 
1.2.7 Integrated care and clinical tools 
The WHO provides the following working definition of integrated service delivery: “The 
management and delivery of health services so that clients receive a continuum of 
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preventive and curative services, according to their needs over time and across different 
levels of the health system.” (WHO 2008a) 
 
Integrating service delivery to prevent inefficiencies and duplication that drive up costs and 
reduce health effects is particularly crucial for NCDs, which have clinical features that often 
need a comprehensive diagnostic and treatment approach. Further, most services can be 
delivered through primary care clinics, supported by community health workers and 
hospitals  (Jamison et al. 2013).  
 
Clinical guidelines are widely used globally and the development of global guidelines 
ensuring the appropriate use of evidence represents one of the core functions of the World 
Health Organization (WHO 2017). Guidelines, however, are largely created for individual 
diseases and rarely account for multimorbidity (Barnett et al. 2012) (Moffat and Mercer 
2015) (Barnett et al. 2012).  
 
In 2008, the WHO developed the Package of Essential Noncommunicable (PEN) disease 
interventions for primary health care in low-resource settings (WHO 2010). The goal of PEN 
is to close the gap between what is needed and what is currently available to reduce the 
burden and health-care costs due to NCDs (WHO 2013c). The interventions include 
protocols for the management of hypertension, diabetes, cardiovascular risk, asthma and 
chronic obstructive pulmonary disease (WHO 2013c). 
 
The PC101 programme is an approach to managing multimorbidity, and to contributing to 
improved NCD care in the primary care setting. It provides a single, systematic approach to 
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the most common symptoms and chronic diseases seen in the management of adults in 
primary care. It assists clinicians with providing integrated NCD care, by better enabling 
them to manage all the patient’s health needs at the same consultation, prompting targeted 
screening for NCDs among patients presenting with symptoms suggestive of a diagnosis (e.g. 
facial weakness or chest pain), and promoting identification and management of important 
co-morbidities (e.g. cardiovascular risk assessment among patients presenting for COPD 
follow-up). 
 
1.2.8 The PC101 programme 
Background  
In 1998 The World Health Organization initiated the Practical Approach to Lung Health 
(PAL), a syndromic approach to the management of patients who attend primary health 
care services for respiratory symptoms (WHO 2008b) (WHO 2005). PAL is aimed at 
improving the management of all respiratory disorders, and in the process enhances the 
identification of patients with TB (Murray, Pio, and Ottmani 2006). 
 
PALSA (PAL in South Africa) was developed to address the high incidence and delay in 
diagnosis of TB in South Africa. The programme was evaluated in a cluster randomised trial 
and showed modest improvements in quality of care across communicable (TB) and NCDs 
(asthma), and substantial improvements in detection of TB cases (Fairall et al. 2005) 




PALSA PLUS was developed in response to South Africa’s decision to implement a public 
sector ART programme. It extended the training of clinic nurses to include HIV/AIDS 
screening, and referral to physicians for diagnosis and initial prescribing of ART, with 
patients returning to nurses for monitoring. A cluster randomised trial of this  programme 
confirmed modest improvements in the quality of care, and a substantial impact on TB case 
detection (Zwarenstein et al. 2011).  
 
The scope of PALSA PLUS was subsequently expanded to support Nurse Initiated and 
Managed ART (NIMART). A third cluster randomised trial found that NIMART resulted in 
patients being managed as effectively as in physician-led programmes, and showed modest 
improvements in quality of care and outcomes for patients as well as further improvements 
in TB case detection (Fairall et al. 2012).  
 
PC101 is an expansion of PALSA PLUS to include NCDs, mental illness and women’s health, 
and is designed to support and expand nurses’ roles to cover the full gamut of priority 
conditions presenting to primary care and NCDs in particular.  
 
PALSA PLUS, the NIMART programme and PC101 have been scaled-up across South Africa, 
reaching more than 20 000 nurses in 3 500 clinics (Fairall et al. 2015). A summary of the 







Table 2: Development and evaluation of the PALSA and PC101 programmes 
Trial design Main outcome findings Interpretation of findings 
PALSA: adaptation for South Africa of WHO’s Practical Approach to Lung Health (PAL) 
Pragmatic RCT in 
the Free State 
province from 
2003  
(Fairall et al. 
2005) (Fairall et 
al. 2010) 
(Bachmann et al. 
2010) 
• Case detection of tuberculosis was 
higher in the intervention group (6.4% 
v 3.8%; odds ratio (OR) 1.72, 95% 
confidence interval (CI) 1.04 to 2.85)  
• Sputum testing for tuberculosis was 
similar between groups (22.6% in 
outreach group v 19.3% in control 
group; OR 1.22, CI 0.83 to 1.80) 
• More prescriptions for inhaled 
corticosteroids in the intervention 
group (13.7% v 7.7%; OR 1.90, CI 1.14 
to 3.18)  
• The number of antibiotic prescriptions 
was similar between groups (39.7% v 
39.4%; OR 1.01, CI 0.74 to 1.38) 
• The intervention was more costly than 
usual training in improving 
tuberculosis, asthma and urgent 
respiratory care but was also 
associated with fewer and shorter 
hospital admissions.  
• The syndromic approach increased 
cost-effectiveness by improving care 
of other conditions.  
• Educational outreach training 
in syndromic approaches to 
respiratory symptoms 
confirmed WHO’s original 
hypothesis that such 
approaches can strengthen 
passive case finding for 
tuberculosis.  
• It also showed simultaneous 
improvement in the care for 
communicable (TB) and non-
communicable conditions 
(asthma). 
• The intervention was 
sustainable, and implemented 
with limited interruption of 
clinical services and no 
additional trainers required.   
• PALSA provided the basis for 
PALSA PLUS to support 
nurses’ expanding role for HIV 
care. 
PALSA PLUS: PALSA expanded to include HIV/AIDS 
Pragmatic RCT in 





• Cotrimoxazole prophylaxis was more 
likely to be prescribed in the 
intervention group (OR 1.95, CI 1.11 to 
3.40) 
• Tuberculosis was more likely to be 
diagnosed  among patients attending 
intervention group clinics (OR 1.25, CI 
1.01 to 1.55) 
• No evidence that the intervention was 
effective in increasing recruitment 
into the HIV/AIDS/ART programme 
(OR 1.19, CI 0.51 to 2.77) 
• Educational outreach was 
effective in improving the 
comprehensiveness of care of 
patients with HIV/AIDS/ART, 
although no significant 
improvement was seen in 
detection of HIV in patients 
attending primary care clinics.  
• The effect on TB case 




STRETCH (Streamlining Tasks and Roles to Expand Treatment and Care for HIV): nurse initiated 
and managed ART (NIMART) 
Pragmatic RCT in 
the Free State 
province from  
2007-2010 
(Fairall et al. 
2012) 
• Adults with CD4 counts of ≤ 350 cells 
perμL who were not receiving ART 
(Cohort 1): 
o Time to death did not differ 
o In a pre-planned subgroup 
analysis of patients with   
baseline CD4 counts of 201–350 
cells per μL, mortality was slightly 
lower in the intervention group 
than in the control group (hazard 
ratio 0.73, CI 0.54-1.00; p=0.052) 
• Adults who had already received ART 
for at least 6 months and were being 
treated at enrolment (Cohort 2): 
o Viral load suppression 12 months 
after enrolment was equivalent 
in intervention (2156 [71%] of 
3029 patients) and control 
groups (2230 [70%] of 3202; risk 
difference 1.1%, CI –2.4 to 4.6). 
• Secondary outcome measures: 
o Detection of tuberculosis, 
programme retention, and CD4 
cell count at the end of follow-up 
were higher in the intervention 
group than in the control group.  
o In the intervention group, 965 
(26%) of 3712 ART initiations 
were by a nurse; in the control 
group, none were. 
• Expansion of primary-care 
nurses’ roles to include ART 
initiation and represcription 
can be done safely, and 
improve health outcomes and 
quality of care. 
• The effect of the intervention 
on TB case detection was 
shown for a third time despite 
the control clinics all receiving 




PC101: PALSA PLUS expanded to include non-communicable diseases, mental health and 
women’s health 
Pragmatic RCT in 
the Eden and 
Overberg districts 
of the Western 
Cape from 2011-
2013 
(Fairall et al. 
2016) 
• Treatment intensification rates in 
intervention clinics were not superior 
to those in the control clinics for 
hypertension, diabetes and chronic 
respiratory disease; nor was case 
detection of depression.  
• Pre-specified subgroup analyses 
showed that the intervention was 
associated with treatment 
intensification among diabetic 
patients with an HbA1c of 7% to 10% 
at baseline. 
• After disaggregation of the disease 
groups, other significant findings 
were:  
o higher rates of aspirin initiation 
among patients with 
hypertension and diabetes 
o higher use of angiotensin-
converting enzyme inhibitors in 
patients with known 
cardiovascular disease 
o more prescriptions of 
sulphonylureas in patients with 
diabetes and a high body mass 
index. 
• No adverse effects of the nurses' 
expanded scope of practice were 
observed. 
• Educational outreach to 
primary care nurses to train 
them in the use of a 
management tool involving 
an expanded role in managing 
NCDs was feasible and safe 
but was not associated with 
treatment intensification or 
improved case detection for 
index diseases.  
• This notwithstanding, the 
intervention, with 
adjustments to improve its 
effectiveness, has been 
adopted for implementation 
in primary care clinics 
throughout South Africa. 
 
 
The PC101 programme 
PC101 comprises a clinical management tool, education outreach training, and enhanced 





The clinical management tool is a 101-page evidence- and policy-informed clinical decision 
aid. The first half of PC101 covers 40 of the most common symptoms in adults attending 
primary care and prompts screening for the 20 chronic conditions included in the second 
half of the tool. Promotion of comprehensive and integrated care is a key objective of the 
tool. Clinic staff are trained to use the clinical management tool by trained nurse trainers, 
who deliver short, on-site, facilitated and case-based sessions. Nurses who completed this 
educational outreach training were authorised to prescribe an additional seven medications 
for NCDs previously restricted to doctors: enalapril and amlodipine for hypertension, 
glibenclamide and glicazide for diabetes, simvastatin for increased cardiovascular risk, 




This literature review identifies NCDs and multimorbidity as important contributors of 
disease burden and raises important questions regarding NCD care in the public sector 
primary care setting. Despite the rise in NCDs, these diseases remain under-diagnosed and 
under-treated in South Africa, resulting in poor disease control. Further, associations have 
been found between socioeconomic disadvantage and poor disease control, an important 
consideration in South Africa where the majority of the population is dependent upon public 
sector health services (van Rensburg 2014). The rising NCD burden necessitates an 
integrated approach to chronic disease care, including equipping primary health care 
providers, in South Africa’s case nurses, to manage NCDs and the complexities of 
multimorbidity. This thesis examines levels of multimorbidity and disease control, 
associations between socioeconomic disadvantage and the management of hypertension 
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and depression, and the effectiveness of a programme to assist nurses with an integrated 
approach to the management of NCDs in primary care.  
 
1.3 Hypotheses and aims 
This thesis addresses the following hypotheses: 
I. NCDs in South Africa are associated with high levels of multimorbidity. 
II. The burden of NCDs in the resource-restricted South African public sector remains 
characterised by suboptimal management of NCDs resulting in high levels of 
undertreated and uncontrolled disease. 
III. Associations exist between socioeconomic disadvantage and poor disease control 
and treatment. 
IV. A clinical management tool (PC101) aimed at addressing NCDs and multimorbidity 
with a systematic and integrated approach, assists nurses in the primary care 
management of adults, and improves NCD outcomes in primary care attenders. 
 
Our approach to addressing these hypotheses was to study a cohort of adult patients 
attending public sector primary care clinics in two districts of the Western Cape, with 
conditions representing the highest burden of disease, in order to understand the extent of 
multimorbidity, levels of control and treatment, socioeconomic predictors and, finally, in a  





The aims of this thesis are: 
1. To assess current levels of multimorbidity, control and treatment of NCDs in patients 
attending public sector primary care clinics in the Eden and Overberg districts of the 
Western Cape, South Africa. 
2. To investigate socioeconomic and modifiable predictors of hypertension control, and 
of treatment intensification in patients with uncontrolled blood pressure. 
3. To investigate socioeconomic and modifiable predictors of depression symptoms 
and treatment. 




Chapter 2: Overview Of Methods  
 
Methods are outlined in detail in each of the four papers and an overview provided in this 
chapter. Experimental and observational evidence for this thesis was obtained from the 
randomised trial cohort.  
 
2.1 RCT methods (Papers 1 and 4) 
The pragmatic RCT involved clusters of public sector primary health care clinics within six 
sub-district strata. Outcomes were measured at individual patient level.  
 
The cluster randomised design was appropriate for an intervention directed at groups of 
nurses working in clinics, reducing the risk of contamination of the intervention between 
arms. The pragmatic design allowed the intervention to be evaluated in ‘real-world’ 
circumstances with minimal research-related distortions of care delivery. Such a design is 
valuable for policy decision makers who want to know if an intervention will work when 
scaled-up in a health system and implemented under routine circumstances (Sackett 2011) 
(Thorpe et al. 2009). 
 
Thirty-eight clinics in the Eden and Overberg districts of the Western Cape (Figure 1) were 
randomised to receive the PC101 programme or to continue with usual care for NCDs. This 
region is typical of many low resource settings in South Africa, in which the public sector 
primary health care clinics are nurse-led with limited doctor support. The clinics are the 
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main providers of primary health care for local populations with high levels of 
unemployment and socioeconomic deprivation. 
 
Figure 1: Eden and Overberg districts of the Western Cape, South AFrica 
 
 
We recruited primary healthcare clinic attendees 18 years and older, planning to reside in 
the area for the next year so that they would be available for follow-up interviews, and 





Among patients who met these criteria, four cohorts representing patients with 
hypertension, diabetes, chronic respiratory disease and depression were identified. Patients 
were eligible for the hypertension and diabetes cohorts if they reported being on 
medication for hypertension or diabetes respectively. They were eligible for the respiratory 
cohort if they reported being on medication for chronic respiratory disease, or had 
symptoms of chronic respiratory disease and were not on current treatment for 
tuberculosis. Patients were eligible for the depression cohort if they scored ten or more on 
the 10-item Centre for Epidemiologic Studies Depression Scale (CESD-10) (Andresen et al. 
1994). Patients may have fulfilled inclusion criteria for more than one disease cohort.  
 
Participants were sampled consecutively within each clinic and invited to participate in the 
study, until the sample size required for each clinic was obtained. They were screened for 
eligibility with a questionnaire and, if they met the eligibility criteria, were then asked to 
provide informed consent to participate. 
 
At baseline trained fieldworkers administered the electronic questionnaire and took clinical 
measurements. Prescription charts were photocopied and reviewed, and chronic 
medication prescribed at the time of each participant’s interview for depression, 
hypertension, diabetes and respiratory disease was recorded.  
 
At follow-up the questionnaire, clinical measurements and prescription data were collected 
and recorded as for the baseline data. Baseline data collection began in March 2011 and 
ended in November 2011. Enrolment of patients was completed in intervention clinics 
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before educational outreach sessions to nurses began. Follow-up data collection started in 
May 2012 and ended in December 2012. 
 
The RCT primary outcome for the hypertension, diabetes and chronic respiratory disease 
cohorts was treatment intensification, indicated by an increase in dose or number of 
medications, or change in medication class. This was chosen after considering research 
identifying clinician inertia as a key reason for failure to control these conditions (van 
Bruggen et al. 2009) (Schmittdiel et al. 2008); because it is associated with improved control 
(Berlowitz et al. 1998) (Berlowitz et al. 2005) (Carter et al. 2008); was likely appropriate for 
the study population where under-treatment was highly prevalent (Mayosi et al. 2009) 
(Steyn et al. 2008) (Williams et al. 2008); fitted well with the focus of the intervention on the 
clinical practice of nurses and the expansion of their prescribing with training; and could be 
applied across three of the four chronic conditions of interest. The primary outcome for the 
depression cohort was case detection, as this condition is recognised to be severely under-
diagnosed and under-treated in primary care (Williams et al. 2008).   
 
Intervention effects in the RCT were estimated using binomial regression models with 
treatment as the main effect, adjusted for stratification by sub-district and intraclass 
correlation of outcomes by clinic, and are reported with 95% confidence intervals. 
 
2.2 Observational methods (Papers 2 and 3) 
While the RCT evaluated the PC101 programme, socioeconomic and potentially modifiable 
associations with hypertension control and treatment intensification, and with depression 
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symptoms and treatment were assessed on the whole trial cohort at baseline and follow-up, 
combining the intervention and control arms of the trial. These observational analyses 
included cross-sectional baseline data and longitudinal cohort data, allowing analyses on 
changes from baseline to follow up and inference of causal relations. Multiple regression 
methods investigated independent effects of both patient and health service characteristics 
on control and treatment of hypertension and depression. In all analyses the study’s cluster 
sampling design was accounted for in regression models, and intervention or control arm of 
the RCT was accounted for in all longitudinal analyses. 
 
2.3 Ethical considerations 
The trial is registered with Current Controlled Trials (ISRCTN20283604). Ethical approval for 
the trial was obtained from the University of Cape Town Human Research Ethics Committee 
(reference number 119/2010) and the Western Cape Provincial Department of Health. A 
randomised controlled trial was important in order to provide evidence for the effectiveness 
of the PC101 programme, but also to ensure that the programme does not cause harm, an 
assumption that could not be made. The probability of the intervention being harmful was 
considered to be low, and the potential for harm was offset by the value of the evidence 
needed to inform public health policies. Patients provided written consent for data 
collection after randomisation of clinics and prior to data collection. Participation in the 
study did not influence patients’ care, and patients were free to withdraw from the study at 
any time. Fieldworkers and members of the research team signed a confidentiality 
agreement. While no primary outcomes showed a significant benefit of the intervention, 
there was also no evidence that the intervention caused harm. 
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Chapter 3: Results In The Form of Published Papers 
 
3.1 Multimorbidity, control and treatment of noncommunicable 
diseases among primary healthcare attenders in the Western Cape, 
South Africa 
Paper overview 
This paper describes the characteristics of the study population at enrolment. It reports high 
levels of multimorbidity, poor control and unmet treatment needs for NCDs. It stresses the 
need for primary health care services to provide better integrated NCD care. 
 
Contribution to the thesis and novelty 
This paper, describing the characteristics of the patient cohort at baseline, provides 
background context for the thesis and subsequent papers, and addresses the first aim of the 
thesis. There are few recent studies addressing multimorbidity, control and treatment of 
NCDs in public sector primary health care clinics in South Africa. The findings confirm 
previous reports of poor control and treatment of NCDs, and demonstrate little 
improvement in NCD control since these earlier studies were conducted. 
 
Role of the candidate 
I oversaw data collection for the study and was responsible for data management, including 
cleaning the data and preparing it for analysis. I drafted the manuscript, incorporated input 
from co-authors and was responsible for finalising and submitting the final version of the 




Role of the co-authors 
LF, MB, NL, and KS conceptualised the paper with NF and assisted with the original draft. VT 
was the data architect. All authors reviewed the manuscript and approved it for submission.  
 
Publication status 
Published in the South African Medical Journal 2015. 
Folb N, Timmerman V, Levitt NS, Steyn K, Bachmann MO, Lund C, et al. Multimorbidity, 
control and treatment of noncommunicable diseases among primary healthcare attenders in 
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South Africa (SA) faces a rise in non-communicable 
diseases (NCDs) in both rural and urban populations, 
driven by an increase in risk factors such as tobacco 
use, physical inactivity and unhealthy diets.[1] These 
place a heavy burden on public sector primary 
healthcare (PHC) services. A recent cross-sectional survey of reasons 
for consultations in PHC in four SA provinces confirmed that 
management of hypertension was the most common reason for 
attendance, with NCDs accounting for 14% of visits.[2,3]
PHC in the public sector is nurse-led with support from doctors, 
with nurses seeing over 85% of all patients.[2] However, at present 
nurses working at PHC clinics often do not have the necessary skills 
or capacity to deal adequately with NCDs.[1] Chronic diseases and risk 
factors are often undiagnosed and inadequately treated, resulting in 
high levels of poor control and morbidity.[1,4-6]
There is renewed focus on NCD care in SA. However, despite 
the magnitude of the NCD burden, there are few recent studies 
addressing multimorbidity, control and treatment of NCDs in this 
country. In particular, little is known about the multimorbidity of 
depression with other NCDs.
We present an analysis of the clinical characteristics, level of disease 
control, presence of multimorbidity and treatment of patients with 
hypertension, diabetes, chronic respiratory disease and symptoms 
of depression, identified in PHC clinics in the Eden and Overberg 
districts of the Western Cape Province, SA, as part of the Primary 
Care 101 trial described below.
Methods
This study describes the characteristics of patients participating 
in the Primary Care 101 trial at enrolment. The Primary Care 101 
programme comprised a customised clinical practice guideline and 
training programme aimed at assisting healthcare providers, largely 
nurses, with the primary care management of adults. The pragmatic 
cluster randomised controlled trial evaluated the effects of the 
Background. South Africa (SA) is facing a heavy burden of non-communicable diseases (NCDs). Few studies address multimorbidity, 
control and treatment of NCDs in patients attending primary healthcare (PHC) clinics.
Objectives. To describe multimorbidity, related risk factors, disease severity and treatment status of patients with four important NCDs 
attending public sector PHC clinics in two districts in SA.
Methods. A cross-sectional sample of patients completed baseline data collection for a randomised controlled trial of a health systems 
intervention. The study population comprised adults attending PHC clinics in the Eden and Overberg districts of the Western Cape in 2011. 
Four subgroups of patients were identified: hypertension, diabetes, chronic respiratory disease and depression. A total of 4 393 participants 
enrolled from 38 clinics completed a baseline structured questionnaire and had measurements taken. Prescription data were recorded.
Results. Of participants with hypertension, diabetes, respiratory disease and depression, 80%, 92%, 88% and 80%, respectively, had at 
least one of the other three conditions. There were low levels of control and treatment: 59% of participants with hypertension had a blood 
pressure ≥140/90 mmHg, the mean haemoglobin A1c (HbA1c) value in participants with diabetes was 9%, 12% of participants in the 
depression group were prescribed an antidepressant at a therapeutic dose, and 48% of respiratory participants were prescribed a b2-agonist 
and 34% an inhaled corticosteroid.
Conclusion. Considerable multimorbidity and unmet treatment needs exist among patients with NCDs attending public sector PHC 
clinics. Improved strategies are required for diagnosing and managing NCDs in this sector.
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programme on the quality and outcomes of care for hypertension, 
diabetes, chronic respiratory disease and depression. Clinics were 
randomised either to receive the intervention or not. The main results 
of the trial will be published elsewhere.
The 33 largest clinics in the Eden district that provided NCD 
care, and a convenience sample of five clinics in the neighbouring 
Overberg district, were included in the study. Each clinic had at least 
10 000 attendances per year and was staffed by nurse practitioners, 
doctors, and community health workers who manage clinic patients 
in the communities. These clinics are the main providers of PHC 
for local populations with high levels of unemployment and 
socioeconomic deprivation.
Eligible participants were clinic attenders aged 18 years or older, 
likely to reside in the area for the next year, and able to engage in 
an interviewer-administered questionnaire. Patients attending each 
clinic were interviewed to assess their eligibility for inclusion in 
the hypertension, diabetes, chronic respiratory and/or depression 
groups, until the sample size required for each group was reached. 
For the hypertension and diabetes groups, a self-reported history 
of medication use for these conditions was required. For the 
respiratory group, a self-report of prescription of medications for 
chronic respiratory disease or symptoms of chronic respiratory 
disease (cough or difficult breathing for >2 weeks),[7] and no current 
or recent treatment for tuberculosis, was required. The depression 
group comprised participants with a score of ≥10 on the 10-item 
Center for Epidemiologic Studies Depression Scale (CESD-10).[8] 
Individuals could be included in more than one group. In this article 
‘comorbidity’ refers to two coexisting conditions and ‘multimorbidity’ 
to three or more coexisting conditions.
For trial purposes the sample sizes for each disease group were 
calculated separately, and were 27 participants per clinic for the 
chronic respiratory disease group and 60 per clinic for each of 
the other three groups. These target sample sizes were attained or 
exceeded for all disease groups except the diabetes group, which 
reached 48 participants per clinic.
Fieldworkers invited patients attending the trial clinics to be 
screened for inclusion in the study using a structured questionnaire. 
Eligible patients who provided informed consent were enrolled 
and completed another, baseline, questionnaire. Between March 
and October 2011, 4 904 patients were screened, of whom 4  393 
were enrolled. The questionnaire was available in Afrikaans, 
isiXhosa and English. It included questions relating to demographic 
characteristics, socioeconomic factors, medical history and smoking 
status. Three blood pressure (BP) readings were taken at least 
2 minutes apart with an Omron automatic monitor. The first reading 
was excluded and the values from the second and third readings 
were averaged.[9] Height, weight and waist circumference were 
measured using standardised techniques. Height and weight were 
measured with participants barefoot and wearing light clothing. 
A flexible tape was used to measure waist circumference, 2.5 cm 
above the umbilicus. Haemoglobin A1c (HbA1c) was measured 
only in 20 randomly selected clinics because of cost and logistical 
constraints. Diabetic participants in the 20 clinics were referred to a 
clinic nurse at the end of the interview for an HbA1c test, which was 
processed by the National Health Laboratory Service.
The severity of respiratory disease was assessed with the Symptom 
and Activity domains of the St Georges Respiratory Questionnaire 
(SGRQ)[10] in participants enrolled in the respiratory disease group. 
Scores are expressed as percentages, with 100% representing worst 
and 0% best possible health status. The presence of symptoms 
of depression was assessed with the CESD-10 scale, which was 
administered to all participants enrolled in the study.[8] The items 
were scored from 0 (rarely or none of the time) to 3 (most of the 
time).
Treatment for depression was defined as having received coun-
selling or been referred to psychiatric services within the past year, 
or currently receiving an antidepressant. Counselling was defined as 
a consultation that intended to seek solutions to problems or provide 
emotional support, and not simply give advice on medication use. 
Participants who reported receiving counselling from a mental health 
nurse, clinic counsellor, social worker, psychiatrist or psychologist 
were considered to have received counselling, and those who reported 
receiving counselling from a mental health nurse, psychiatrist or 
psychologist were considered to have been referred to psychiatric 
services.
Chronic medication prescribed to participants at the time of their 
interview for depression, hypertension, diabetes and respiratory dis-
ease was recorded. Fieldworkers photocopied all available prescription 
charts for the year preceding the interview. The trial manager (NF) 
examined the prescription charts of each participant to identify 
medications prescribed at the time of their interview. A data 
capturer entered the prescription data (drug names, doses and 
frequencies) into an access database, and a total daily dose for each 
drug was calculated. Prescription charts were available for 99.3% of 
participants.
Quality control measures included supervision of fieldworkers, 
electronic alert messages for fieldworkers who entered unusually 
high or low values, and regular monitoring of the data to identify 
unusual values or trends. Quality control checks performed on the 
capturing of prescription data included double entry and checking 
all unusually high or low doses and frequencies.
The trial was registered with Current Controlled Trials 
(ISRCTN20283604) and the Office for Human Research Protections 
Database. Ethical approval was obtained from the University of Cape 
Town Human Research Ethics Committee and the Western Cape 
Provincial Department of Health. Participants provided written 
informed consent for their interview and prescription data to be 
collected and analysed. All data were anonymised for analysis, and 
participant identities were revealed only to the fieldworker and a 
limited number of researchers who received and prepared the data 
for analysis.
Results
Thirty-eight clinics were included in the study. The median number 
of nurses per clinic was four. Forty per cent of clinics had daily doctor 
support, the remainder had sessional support from doctors, and 42% 
of clinics had an on-site pharmacy.
A total of 4 393 participants were enrolled into the study, of 
whom 73% were women. The median age was 52 years, and 73% had 
hypertension, 42% diabetes, 26% chronic respiratory disease and 56% 
a CESD-10 score of ≥10 and so could be considered to be at risk of 
depression.
The majority of the participants (84%) were Afrikaans speaking, 
75% were unemployed, 7% had never attended school, and 42% 
had achieved high-school education. Fifty-eight per cent reported 
receiving a social welfare grant, including 44% of participants under 
the age of 60 years. The median income in the month prior to the 
interview date was ZAR1 140, including personal non-grant income 
plus any household grant that benefited the participant, such as a 
disability or child grant.
Although 31% of participants were current smokers, their median 
pack-year history was only 7.5. Twenty-five per cent of participants 
provided a history of cardiovascular disease (heart attack, angina 
or stroke), 11% had a history of tuberculosis (TB), 2% reported 
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being on medication for TB at the time of 
the interview, and 2% reported being on 
antiretroviral drugs.
The NCD-related health characteristics 
of participants in each of the four disease 
groups are presented in Table 1.
In the hypertension group (3 227 parti-
cipants), 59% had a BP ≥140/90 mmHg and 
10% had a BP ≥180/110 mmHg, indicating 
poor control. Their mean body mass index 
(BMI, kg/m2) was 31, 27% were current 
smokers, and 26% reported a history of 
cardiovascular disease. Of the 1 166 parti-
cipants not in the hypertension group, 25% 
had a BP ≥140/90 mmHg and were not on 
medication for hypertension.
The diabetes group comprised 
1 842 participants, of whom 704 had their 
HbA1c measured. The mean HbA1c value 
was 9.1% and 77% had an HbA1c above 
the target of 7%, indicating poor glycaemic 
control. The mean BMI for all participants 
with diabetes was 32, 23% were current 
smokers, and 23% reported a history of 
cardiovascular disease. An elevated BP 
(≥140/80 mmHg)[11] was present in 77%, and 
8% had a BP ≥180/110 mmHg.
The chronic respiratory disease group 
comprised 1 157 participants, of whom 
50% reported being on medication for 
respiratory disease and 50% were identified 
by symptoms alone. Eighteen per cent had a 
previous history of TB and 39% were current 
smokers. Their median pack-year history 
was 7.5. The median symptom and activity 
domain scores of the SGRQ were 60 and 74, 
respectively.
The depression group comprised a total 
of 2 466 participants. Their median CESD-
10 score was 14 (interquartile range (IQR) 
12 - 18).
Of participants with hypertension, 
diabetes, respiratory disease and depression, 
80%, 92%, 88% and 80%, respectively, had at 
least one of the other three conditions, and 
34%, 45%, 53% and 42% had at least two 
other conditions (Fig. 1). Hypertension was 
the commonest comorbidity in participants 
with other categories of chronic disease, 
followed by depression, diabetes and chronic 
respiratory disease. Forty-seven per cent 
of participants in the hypertension group 
also had diabetes, 84% of participants with 
diabetes also had hypertension, 22% of 
participants with hypertension or diabetes 
also had chronic respiratory disease, and 51% 
of participants with hypertension, diabetes 
or respiratory disease had a CESD-10 score 
of ≥10.
Treatment received by participants in the 
hypertension group at the time of their 
interview is presented in Table 2. Four per 
cent of participants in the hypertension 
group had no evidence of having received 
antihypertensive medication, 14% were on 
one antihypertensive agent, and 15% were 
on three or more antihypertensive drugs 
at optimal dosages. Fifty-five per cent of 
participants with hypertension were pre-
scribed aspirin and 34% a statin.




Systolic BP (mmHg), mean (SD) (n=3 220) 139 (23.6) 
Diastolic BP (mmHg), mean (SD) (n=3 220) 90 (13.2) 
BP ≥140/90 mmHg, n (%) 1 917 (59.4)
BP ≥180/110 mmHg, n (%) 334 (10.4)
BMI (kg/m2), mean (SD) (n=3 066) 31.1 (7.5) 
BMI, proportion obese (BMI ≥30), n (%) 1 628 (50.5)
Waist circumference (cm), mean (SD) (n=3 194) 100.5 (15.6) 
Waist circumference (cm), proportion greater than ideal,* n (%) 2 293 (71.1)
Current smokers, n (%) 885 (27.4)
Pack-year history for current smokers, median (IQR) (n=756) 8 (4.8 - 13.8) 




HbA1c (%),‡ mean (SD) (n=704) 9.1 (2.5) 
Proportion HbA1c ≥7%, n (%) 544/704 (77.3) 
SBP (mmHg), mean (SD) (n=1 840) 137 (23.2) 
DBP (mmHg), mean (SD) (n=1 840) 88 (12.4) 
BP ≥140/80 mmHg, n (%) 1 414 (76.8)
BP ≥180/110 mmHg, n (%) 139 (7.5)
BMI, mean (SD) (n=1 742) 32.0 (7.3) 
BMI, proportion obese (BMI ≥30), n (%) 1 011 (54.9)
Waist circumference, mean (SD) (n=1 822) 103.6 (14.8) 
Waist circumference, proportion greater than ideal,* n (%) 1 436/1 842 (78.0) 
Current smokers, n (%) 415 (22.5)
Pack-year history for current smokers, median (IQR) (n=353) 8.25 (4.8 - 16.0) 
Cardiovascular disease,† n (%) 423 (23.0)
Chronic respiratory disease group
All participants
(N=1 157)
Self-reported CRD on respiratory medication, n (%) 699 (60.4)
Self-reported CRD symptoms and not on respiratory medication, n (%) 458 (39.6)
SGRQ symptom domain (% maximum weight), median (IQR) (n=833) 59.50 (36.4 - 74.8) 
SGRQ activity domain (% maximum weight), median (IQR) (n=1 054) 73.71 (53.6 - 92.5) 
Current smokers, n (%) 454 (39.2)
Pack-year history for current smokers, median (IQR) 7.8 (4.4 - 13.5)




CESD-10 score, mean (SD); median (IQR) 15.3 (4.3); 14 (12 - 18)
Current smokers, n (%) 860 (34.9)
Pack-year history for current smokers, median (IQR) (n=754) 7.2 (3.9 - 13.5) 
SD = standard deviation.
*≥88 cm for women, ≥102 cm for men.
†History of heart attack, angina or stroke.
‡HbA1c measured in a preplanned subgroup of 20 randomly selected clinics.
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Treatment received by participants in the 
diabetes group is presented in Table 3. Sixty-
one per cent of participants with diabetes had 
been prescribed an oral hypoglycaemic agent 
(without insulin) and 32% were prescribed 
insulin (with or without oral hypoglycaemic 
agents). Aspirin had been prescribed for 
63% in the diabetes group, and statins 
for 51%. Seven per cent of participants 
with diabetes had had no hypoglycaemic 
agents prescribed. In both the hypertension 
and diabetes groups, we observed higher 
medication use in participants with poorer 
control.
In the respiratory group, 48% of 
participants had been prescribed a 
b2-agonist metered dose inhaler (MDI) or 
nebuliser, 34% an inhaled corticosteroid 
(any dose), 8% an ipratropium bromide 
MDI or nebuliser, and 11% slow-release 
theophylline as maintenance treatment 
(Table 4).
In the depression group, 12% of participants 
had been prescribed a therapeutic dose of 
antidepressant and 10% a subtherapeutic 
dose (<50 mg/d) of amitriptyline or imi-
pramine (Table 5). Twenty-five per cent 
were receiving treatment for depression, 
defined as receiving counselling, referral 
to psychiatric services or being on an 
antidepressant at a therapeutic dose. Forty-
five per cent were not receiving treatment, 
and it could not be established whether the 
remaining 30% were receiving treatment 
for depression, either because prescription 
charts were not available (14 participants) 
or because the participant failed to answer 
the question regarding counselling and 
psychiatric referral (729 participants).
Discussion
This study described the clinical profile, 
disease control, multimorbidity and 
treatment received by patients with the 
target conditions attending PHC clinics in 
two districts in SA. The results indicated 
poor disease control, high levels of multi-
morbidity and unmet treatment needs in the 
public sector in these districts.
These findings confirm previous reports 
of poor control and treatment of NCDs, 
and demonstrate little improvement in 
NCD control since these earlier studies 
were conducted. A study of 1 089 patients 
in 18 community health centres in 1999 
demonstrated poor levels of control of 
hypertension and diabetes in community 
health centres in the Cape Peninsula, with 
67% of hypertensive patients recording a 
BP  ≥140/90 mmHg and a mean HbA1c 
of 8.8% in diabetic patients.[4] A study of 
goldminers in Gauteng Province, SA, in 
2009/2010 found that only 42% of patients 
diagnosed with hypertension received 
antihypertensive medication, while 69% of 
patients on antihypertensive medication 
were poorly controlled.[12] The South African 
Stress and Health Study, a community survey 
of 4 351 adult South Africans between 2002 
and 2004, found that only one-quarter 
of patients with depression, anxiety and 
substance use disorders received treatment. [6] 
Comorbidity of hypertension and diabetes 
was found to be high in a cross-sectional 
study in Cape Town townships in 2008/2009, 
with 21% of participants with hypertension 
also having diabetes, compared with 7% of 
non-hypertensive patients having diabetes. [9] 
The cross-sectional study in the Cape 
Peninsula in 1999 found 31% of participants 
with hypertension to have diabetes and 
64% of participants with diabetes to have 
hypertension.[4] A more recent survey of 
SA PHC found that 18% of patients with 
Hypertension group (N=3 227) Chronic respiratory disease group (N=1 157)
















































Fig. 1. Venn diagram of multimorbidity associated with hypertension, diabetes, chronic respiratory disease 
and depression. (HPT = hypertension; DM = diabetes; CRD = chronic respiratory disease; DEP = depression.)












No hypertension medication 129 (4.0) 80 (62.0) 47 (36.4)
1 hypertension medication 436 (13.5) 207 (47.5) 229 (52.5)
≥2 hypertension medications 2 638 (81.7) 1 003 (38.0) 1 631 (61.8)
 ≥3 antihypertensive 
medications at optimal dosage 
482 (14.9) 140 (29.0) 341 (70.8)
Missing information 24 (0.7)
Aspirin 1 760 (54.5) 711 (40.4) 1 047 (59.5)
Statin 1 093 (33.9) 445 (40.7) 647 (59.2)
*BP <140/90 mmHg.
†Frequencies and row percentages exclude 7 participants with missing BP readings.
‡BP ≥140/90 mmHg.
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hypertension also had diabetes, and 63% 
of patients with diabetes also had hyper-
tension.[3] Our study demonstrated higher 
levels of comorbidity than these studies, 
with 47% of participants with hypertension 
also having diabetes, and 84% of participants 
with diabetes also having hypertension. A 
study of urban SA women demonstrated 
high rates of comorbid psychological distress 
with physical disease,[13] consistent with 
our finding of 51% of participants with 
hypertension, diabetes or chronic respiratory 
disease also having symptoms of depression. 
However, the high rates of multimorbidity 
in our study, particularly in the reporting 
of diabetes in the hypertension group, may 
partly be due to the sampling strategy, as 
explained in ‘Study limitations’ below.
Study limitations and strengths
This study had several limitations. It did 
not consider other potential comorbid 
conditions such as osteoarthritis which 
are likely in such patient populations, so 
multimorbidity and comorbidity were 
probably underestimated. The study was 
not intended to provide estimates of 
the prevalence of NCDs or depression 
symptoms, but its inclusion criteria may 
have influenced the interpretation of results. 
Because the inclusion criteria for each 
condition involved self-reporting, there 
was misclassification; some participants’ 
reported diseases were not confirmed, 
while others were found to be receiving 
medications for a disease that they had not 
reported. For example, of 1 166 participants 
not enrolled in the hypertension group 
(denying receiving medication for this 
diagnosis), 13% had received a prescription 
for antihypertensive medication and 
30% had a BP ≥140/90 mmHg. Further, 
of 3  227 participants who reported being 
on medication for hypertension, 5% 
had no evidence of a prescription for 
hypertension. The inclusion criterion 
for the diabetes group was self-reported 
diabetes medication. Patients with diabetes 
on dietary control alone were therefore 
not included in the study. The study’s 
chronic respiratory disease definition was 
probably more inclusive than usual clinical 
practice and so may have overestimated 
disease prevalence. Spirometry was not 
used to diagnose respiratory disease. We 
did not distinguish between asthma, chronic 
obstructive pulmonary disease or other 
symptomatic chronic lung diseases, and 
severity was not assessed by lung function 
tests. For these reasons, the appropriateness 
of treatments prescribed could not be 
assessed for individual participants. The 
study’s definition of possible depression 
indicates, but does not confirm, clinical 
depression. In addition, the percentage 
receiving counselling or referral is an 
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medications 














Aspirin 1 155 (62.7) 477 (67.8) 101 (21.2) 376 (78.8)
Statin 931 (50.5) 407 (57.8) 82 (20.1) 325 (79.9)
ACE inhibitor 1 215 (66.0) 475 (67.5) 108 (22.7) 367 (77.3)
ACE = angiotensin-converting enzyme.
*HbA1c <7%.
†HbA1c ≥7%.











No chronic respiratory disease 
medications 
567 (49.0) 52.6 (29.8 - 68.5) 67.2 (47.7 - 85.8)
Selective b2-agonist 558 (48.2) 64.6 (44.9 - 78.9) 79.8 (59.5 - 92.5)
Inhaled corticosteroids (any dose) 388 (33.5) 64.6 (42.8 - 79.3) 80.3 (60.3 - 92.5)
Inhaled corticosteroid (≥800 µg/d) 346 (29.9) 64.9 (41.8 - 80.2) 80.4 (60.3 - 92.5)
Theophylline 121 (10.5) 70.4 (51.8 - 83.0) 79.8 (60.4 - 92.5)
Ipratropium bromide 91 (7.9) 69.7 (52.2 - 81.6) 85.8 (60.4 - 93.2)
Table 5. Treatment, depression group







No antidepressant medications 1 902 (77.1) 14 (12 - 17)
Antidepressant at therapeutic dose 294 (11.9) 19 (14 - 22)
Antidepressant at subtherapeutic dose 250 (10.1) 15 (12 - 19)
Missing information 20 (0.8)
Received counselling in past year 402 (16.3) 15 (12 - 20)
Psychiatric referral in past year 175 (7.1) 17 (13 - 21)
Antidepressant at therapeutic dose or counselling in 
past year or psychiatric referral in past year
614 (24.9) 16 (12 - 20)
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underestimate owing to an error resulting in this question not 
being administered to all participants. Finally, the sampling 
strategy may have led to over-representation of reported 
comorbidities. For the randomised controlled trial we estimated 
that 60 patients were needed per clinic for each disease group 
except for the respiratory group, which required 27 patients per 
clinic. Owing to the high prevalence of hypertension in this clinic 
population, targets were easily met for the hypertension group, 
although it was more difficult to do the same for the diabetes group. 
Fieldworkers were asked to continue recruitment until targets were 
met for all four groups, with the result that targets were exceeded 
for all groups except diabetes, where recruitment fell short (81% 
of target). Since the majority of patients with diabetes also had 
hypertension, extended recruitment of this group may have led to 
an over-representation of the proportion of those with hypertension 
who also had diabetes.
The study had a number of strengths. The sample size was large, 
data were collected for four disease groups, and prescription data 
were collected for 99% of participants. There are few other recent 
studies addressing multimorbidity, control and treatment of NCDs in 
public sector PHC clinics in SA.
Conclusion
The rising prevalence of NCDs is a major challenge facing healthcare 
systems worldwide, with multimorbidity becoming the norm for 
people with chronic diseases. Despite this, health systems tend 
to be configured for individual diseases.[14] The high levels of 
multimorbidity demonstrated in this study stress the need for PHC 
services to provide better-integrated NCD care. Clinicians need to 
consider potential coexistence of, and interactions between, diseases. 
Training of clinicians to manage multimorbidity is essential, and 
should address both appropriateness of prescribing and adherence 
to medication. Management of NCDs and multimorbidity need to be 
addressed at a health systems level and factored into clinical training. 
The Integrated Chronic Disease Management[15] and Primary Care 
101[16] programmes are important current initiatives aimed at 
integrating chronic disease care and addressing multimorbidity. 
After a decade of focusing on scaling up antiretroviral therapy 
programmes, management of NCDs in PHC needs to be prioritised 
and requires similar investment in order to improve outcomes and 
limit the impact on morbidity and mortality. With limited time 
and resources in the PHC setting, careful consideration of how to 
prioritise care is required.
Understanding the causes of poor NCD control will assist in 
prioritising care and resources. Further research is required into the 
development and evaluation of interventions to address the burden 
and unmet treatment needs of NCDs, including mental health.
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3.2 Socioeconomic and modifiable predictors of blood pressure control 
for hypertension in primary care attenders in the Western Cape, South 
Africa 
Paper overview 
The aim of this study was to investigate the extent to which indicators of socioeconomic 
position, and characteristics of primary health care facilities, predict blood pressure control 
at baseline and follow-up, and treatment intensification at follow-up in patients with 
uncontrolled blood pressure at baseline.   
 
Blood pressure control at baseline was more likely in participants with more education and 
who chose to complete the interview in English compared to Afrikaans. Treatment 
intensification was more likely in participants with higher blood pressure at baseline, 
concurrent diabetes, more education, and in participants who attended more resourced 
clinics offering community-based medication supply, with a doctor every day, or with more 
nurses. 
 
Contribution to the thesis and novelty 
This study addresses the second aim of the thesis. The majority of studies in the field of 
hypertension in South Africa are community-based surveys (e.g. the first Demographic and 
Health Survey (DHS) from 1998 and the first wave of the National Income Dynamics Study 
(NIDS) from 2008) (Steyn et al. 2001) (Cois and Ehrlich 2014) and/or prevalence studies 




Few studies address determinants of hypertension control and treatment in patients 
attending primary care services, and modifiable factors associated with improved control, as 
we have done.  One study that examined quality of care for patients attending primary care 
clinics was performed 12 years earlier than ours (in 1999). Steyn et al investigated health 
care provider-related determinants of diabetes and hypertension management in patients 
attending community health centres (CHCs) in the Cape Peninsula (Steyn et al. 2008).  They 
reported that poor blood pressure control was associated with older age, male gender and 
higher blood pressure at a previous visit. Further, they reported that patients receiving a 
disability grant had better blood pressure control than those who were employed. The 
authors concluded that primary care for patients with hypertension and diabetes at public 
sector CHCs was suboptimal, and stressed the need to improve health care for patients with 
these conditions. This data is now outdated for informing current policies, and did not 
address clinic factors associated with blood pressure control or predictors of treatment for 
hypertension.  
  
Paper 2 provides important and useful new insights into the care of patients with 
hypertension in primary care facilities in South Africa, and potentially modifiable factors that 
could improve the situation. It suggests that even seemingly small changes in health 
facilities, for example, the number of nurses per clinic, the extent of doctor support, and 
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High blood pressure is a leading cause of mortality and disability 
worldwide.[1] In South Africa (SA), the prevalence of hypertension 
is estimated to be 21% in people aged ≥15 years,[2] and in a survey 
performed in public sector clinics in four provinces, hypertension 
was the most common diagnosis and reason for attendance.[3] Several 
reports point to poor levels of blood pressure control and low levels 
of treatment.[4-6]
The burden of ill-health and of chronic diseases such as 
hypertension is strongly influenced by socioeconomic status.[7-9] Few 
publications have considered the impact of socioeconomic status 
on control of blood pressure and potentially modifiable factors 
associated with better blood pressure control in SA.
We studied a cohort of primary care clinic attenders with 
hypertension, recruited as part of a randomised controlled trial. The 
objective of this study was to investigate the extent to which patient-
related and socioeconomic factors, and characteristics of primary 
healthcare facilities, were associated with blood pressure control and 




The study population comprised adults ≥18 years of age residing in 
the Eden District and two sub-districts in the Overberg, Western 
Cape, SA, who were participating in a pragmatic cluster randomised 
controlled trial to evaluate the effectiveness of a training programme 
for primary healthcare providers in the use of the Primary Care 
101 (PC101) patient management tool.[10,11] The study focused on 
improving the quality of care for four specified chronic diseases. 
The study population for this article was confined to patients who 
reported current use of a medication for hypertension, in both the 
intervention and control arms.
Patients were recruited from the largest 38 public sector primary 
care clinics in the Eden District and two Overberg sub-districts, each 
of which report more than 10 000 client visits per year. Services in 
these clinics are nurse led, with varying levels of doctor involvement 
(often part-time). The communities served by these clinics are 
characterised by high levels of unemployment and socioeconomic 
deprivation, typical of many rural and small urban areas in SA.
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Background. Low socioeconomic status is associated with the risk of hypertension. There are few reports of the effect of socioeconomic 
and potentially modifiable factors on the control of hypertension in South Africa (SA).
Objectives. To investigate associations between patients’ socio economic status and characteristics of primary healthcare facilities, and 
control and treatment of blood pressure in hypertensive patients. 
Methods. We enrolled hypertensive patients attending 38 public sector primary care clinics in the Western Cape, SA, in 2011, and followed 
them up 14 months later as part of a randomised controlled trial. Blood pressure was measured and prescriptions for antihypertension 
medications were recorded at baseline and follow-up. Logistic regression models assessed associations between patients’ socioeconomic 
status, characteristics of primary healthcare facilities, and control and treatment of blood pressure.
Results. Blood pressure was uncontrolled in 60% (1 917/3 220) of patients at baseline, which was less likely in patients with a higher level 
of education (p=0.001) and in English compared with Afrikaans respondents (p=0.033). Treatment was intensified in 48% (892/1 872) of 
patients with uncontrolled blood pressure at baseline, which was more likely in patients with higher blood pressure at baseline (p<0.001), 
concurrent diabetes (p=0.013), more education (p=0.020), and those who attended clinics offering off-site drug supply (p=0.009), with a 
doctor every day (p=0.004), or with more nurses (p<0.001).
Conclusion. Patient and clinic factors influence blood pressure control and treatment in primary care clinics in SA. Potential modifiable 
factors include ensuring effective communication of health messages, providing convenient access to medications, and addressing staff 
shortages in primary care clinics.
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Patients who reported current use of a medication for hypertension 
were eligible for inclusion if they were likely to reside in the same 
health district for the duration of the study and were capable of 
engaging in an interviewer-administered questionnaire in their pre-
ferred language (English, Afrikaans or isiXhosa). Participants were 
recruited in clinic waiting rooms and, if eligible, provided informed 
consent prior to study procedures. Their blood pressure was mea-
sured and prescription data were collected at baseline (in 2011) and 
14 months later.[11] 
Data collection
At baseline, trained fieldworkers administered an electronic ques-
tionnaire and took clinical measurements. The baseline question naire 
covered demographic characteristics, level of education, employment 
status, income during the last month, language, and presence of 
comorbidities. 
Fieldworkers photocopied all available prescription charts for the 
year preceding the interview. These were reviewed by a medically 
qualified researcher (NF) to identify hypertension medications pre-
scribed at baseline.
Blood pressure was measured with the patient in the seated position 
after at least 5 minutes’ rest, using a calibrated automatic monitor, the 
Omron M6 Comfort (OMRON Healthcare, The Netherlands). The 
second and third of three readings were averaged and recorded.[12] 
Follow-up assessment involved completion of a questionnaire, 
clinical measurements and collection of prescription data in a similar 
manner to assessment at baseline. Baseline data were collected from 
March to November 2011 and follow-up data from May to Decem-
ber 2012. 
Uncontrolled blood pressure was defined as systolic blood 
pressure ≥140 mmHg or diastolic blood pressure ≥90 mmHg. The 
assessment of treatment intensification for hypertension was based 
on treatment steps in the PC101 clinical management tool, which 
conformed to prescribing policies of the relevant health authorities, 
an approach used in previous reported studies employing treatment 
intensification as an outcome measure.[10,13,14] Treatment intensifica-
tion was defined as: (i) an increase in dose of an antihypertensive; or 
(ii) a switch to an antihypertensive in another medication class; or 
(iii) the addition of an antihypertensive in the same or different class; 
or (iv) a switch of an antihypertensive within a class but at a higher 
dose; or (v) the addition of aspirin; or (vi) the addition of or increase 
in statin dose.
Statistical methods
The statistical analyses investigated associations between participants’ 
health and socioeconomic indicators, their blood pressure control, 
characteristics of their clinics, and intensification of hypertension 
treatment during the study. 
Differences in the characteristics of patients with and without 
blood pressure control at baseline, and of their clinics, were first 
tested with logistic regression models, with control as outcome, each 
characteristic as the explanatory variable, and a separate model for 
each characteristic. The patient and clinic characteristics included in 
these models are shown in Table 1. 
Independent predictors of uncontrolled blood pressure at baseline 
and at follow-up were investigated with multiple logistic regression 
models, first including all potential predictors as covariates, and then 
retaining only those covariates that were independent predictors at 
the 5% significance level. Models to identify predictors of change in 
hypertension control between baseline and follow-up used analysis 
of covariance (ANCOVA), with control at follow-up as outcome 
and control at baseline as a covariate. This was done to account for 
regression to the mean. 
Analyses identifying predictors of treatment intensification among 
patients with uncontrolled blood pressure at baseline included the 
same patient and clinic characteristics used in the blood pressure 
control models, and also baseline blood pressure level. We report 
on the full model, including all characteristics as covariates, and a 
restricted model, including only covariates that were independent 
predictors at the 5% significance level. These analyses were repeated 
in all patients, including those with controlled blood pressure at 
baseline. 
In all analyses the study’s cluster sampling design was accounted 
for in regression models with robust adjustment for intraclinic cluster 
correlation of outcomes, using Stata version 13.0 (StataCorp LP, 
USA) statistical software. The p-values for education were estimated 
by modelling education as a continuous variable, with values of 0, 1, 
2 and 3 indicating higher levels of education. A p-value ≤0.05 was 
considered statistically significant. The intervention v. the control 
arm of the randomised controlled trial was included as a covariate in 
all longitudinal analyses to account for the study design. 
The trial was registered with Current Controlled Trials (ISRCTN 
20283604). Ethical approval for the trial was obtained from the 
University of Cape Town Human Research Ethics Committee (HREC 
119/2010) and the Western Cape Provincial Department of Health. 
All participants provided written informed consent to participate in 
the study.
Results
A total of 3 220 participants with hypertension and baseline blood 
pressure readings were enrolled in the study, of whom 91% were 
interviewed at follow-up. Prescription data were available for 3 197 
(99%) participants at baseline and for 3 137 (97%) at follow-up. 
The sociodemographic characteristics of patient and clinic partici-
pants at baseline, and the difference between patients with and 
without blood pressure control at baseline, are reported in Table 1. 
The majority of participants (75%) were women and half were aged 
≥50 years. The majority of participants had not completed secondary 
school education (56%), were unemployed (77%) and were receiving 
a welfare grant (61%). The average monthly income of participants, 
of whom 23% reported having no income, was ZAR1 105 (USD160). 
Sixty per cent (1 917) of participants had uncontrolled blood 
pressure at baseline. Table 1 shows that at baseline a higher level 
of formal education was associated with blood pressure control 
(p=0.001), and participants with controlled blood pressure were more 
likely to have secondary or tertiary education (47% of patients with 
controlled v. 42% with uncontrolled blood pressure). Participants 
with controlled blood pressure were more likely to attend larger clinics 
(p=0.033) or clinics with a larger complement of nurses (p=0.037). 
Logistic regression analyses identified independent associations 
between health and socioeconomic indicators and blood pressure 
control (Table 2). At baseline, a higher level of education, and 
English v. Afrikaans language, were associated with lower odds of 
uncontrolled blood pressure. There was no interaction between 
education and language (p=0.76) when an interaction term was 
added to the model. At follow-up, patients with higher incomes 
had lower odds of uncontrolled blood pressure in the full model 
with all covariates. In the restricted model, from which all other 
covariates except baseline control and the trial arm were removed, 
this association became non-significant (p=0.086). No clinic-related 
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factors were independently associated with blood pressure control at 
baseline or at follow-up. 
Hypertension treatment was intensified in 48% of 1 872 patients 
in whom blood pressure was uncontrolled at baseline. In participants 
whose blood pressure was uncontrolled at baseline, treatment 
intensification was independently more probable in those who had 
a higher mean systolic blood pressure at baseline (p<0.001), diabetes 
(p=0.013), a higher level of education (p=0.020), and attended a 
clinic with the option of off-site drug supply (p=0.009), with a doctor 
present daily (p=0.004), with a larger number of nurses (p<0.001) 
or in the intervention arm of the trial (p<0.001) (Table 3). There 
was no interaction between education and language (p=0.92) when 
an interaction term was added to the model. When all patients, 
including those with controlled blood pressure at baseline, were 
included in the analysis, the association with number of clinic nurses 
remained significant. 
Discussion
This study, performed in a cohort of hypertensive low-income patients 
with generally low levels of formal education attending public sector 
Table 1. Participants’ baseline characteristics 
Characteristics
Patients (N=3 220), 
n (%) 
BP controlled* at 
baseline (N=1 303), 
n (%)
BP uncontrolled† at 
baseline (N=1 917), 
n (%) p-value‡
Participant characteristics
Age (years): mean (SD)§ 54.81 (12.0) 54.36 (12.5) 55.11 (11.7) 0.092
Sex 0.546
Female 2 419 (75.1) 986 (75.7) 1 433 (74.8) 
Male 801 (24.9) 317 (24.3) 484 (25.2) 
Diabetes 1 538 (47.8) 647 (49.7) 891 (46.5) 0.162
Known cardiovascular disease¶ 848 (26.3) 347 (26.6) 501 (26.1) 0.698
Language 0.054
Afrikaans 2 732 (84.8) 1 095 (84.0) 637 (85.4) 
isiXhosa 220 (6.8) 79 (6.1) 141 (7.4)
English 268 (8.3) 129 (9.9) 139 (7.3) 
Highest education n=2 938 n=1 184 n=1 754 0.001
None 242 (8.2) 86 (7.3)  156 (8.9) 
Primary 1 397 (47.5) 538 (45.4)  589 (49.0) 
Secondary 1 244 (42.3) 526 (44.4) 718 (40.9) 
Tertiary 55 (1.87) 34 (2.9) 21 (1.2)
Total monthly income (ZAR): mean (SD)§ 1 104.9 (1 120.0) 
(n=3 215)
1 142.5 (1 226.1) 
(n=1 301)
1 079.3 (1 041.2)  
(n=1 914)
0.125
Unemployed 2 472 (76.9) 
(n=3 215)
1 002 (77.0) 
(n=1 301)
1 470 (76.8) 
(n=1 914)
0.865








Pharmacist in clinic 1 487 (46.2) 622 (47.7) 865 (45.1) 0.456
Drug supply available away from clinic 2 124 (66.0) 840 (64.5) 1 284 (67.0) 0.437
Doctor at clinic every day 1 333 (41.4) 562 (43.1) 771 (40.2) 0.405
Clinic location 0.951
Urban 1 977 (61.4) 804 (61.7) 1 173 (61.2) 
Peri-urban 511 (15.9) 202 (15.5) 309 (16.1) 
Rural 732 (22.7) 297 (22.8) 435 (22.7) 
Clinic patients/year/1 0000: mean (SD)§ 3.7 (3.7) 3.9 (3.9) 3.6 (3.5) 0.033
Clinic nurses: mean (SD)§ 5.4 (2.9) 5.6 (2.9) 5.2 (2.9) 0.037
Clinic nurses (n) 0.051
<5 1 564 (48.6) 581 (44.6) 983 (51.3)
≥5 1 656 (51.4) 722 (55.4) 934 (48.7)
Intervention v. control clinic 0.234
Intervention 1 553 (48.2) 660 (50.7) 893 (6.6) 
Control 1 667 (51.8) 643 (49.4) 1 024 (53.4) 
HPT = hypertension; BP = blood pressure; SD = standard deviation; CVD = cardiovascular disease. 
* Controlled: systolic BP <140 mmHg and diastolic BP <90 mmHg.
† Uncontrolled: systolic BP ≥140 mmHg or diastolic BP ≥90 mmHg.
‡ p-values from logistic regression models adjusted for intraclinic correlation of outcome. 
§ Mean and SD for continuous variables.
¶ History of angina, heart attack or stroke.
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primary care clinics, confirms both patient and clinic-related factors 
that are associated, first, with the likelihood of blood pressure control 
(patient factors), and secondly, treatment intensification during the 
study period (patient and clinic-related factors). The importance of 
these findings is that some of these predictors may be modifiable, 
and should be considered in the planning of chronic disease control 
strategies and in the organisation of clinical services.
Patient factors associated with uncontrolled blood pressure at 
baseline included lower levels of education and communication in 
either isiXhosa or Afrikaans, rather than English. These associations 
need to be interpreted with caution for several reasons. First, while 
statistically significant, the absolute differences in blood pressure 
control associated with these risk factors were relatively small, 
reflecting the large sample size. Secondly, the association with 
patients’ choice of language may have been influenced by issues 
relating to the conduct of the trial. Communication might have been 
poor, as not all interviewers were fluent in isiXhosa. Furthermore, 
language selection might serve as a proxy for factors not measured 
in this study, such as household conditions, informal education, and 
less prior exposure to health messages in patients’ language of choice. 
Health literacy has complex associations, extending beyond formal 
education, and is rooted in the conditions under which patients 
live and the support they receive to accept and adhere to health 
advice. Murphy et al.,[15] in a qualitative study of hypertensive and 
diabetic patients attending three public sector community health 
centres in Cape Town, concluded that patients experienced ‘multiple 
impediments to effective self-management and behaviour change, 
including poor health literacy, a lack of self-efficacy and perceived 
social support’. Although the introduction of PC101 seeks to address 
some of these needs, the results at baseline in our study are consistent 
with this assessment. 
Perhaps more relevant are the features associated with treatment 
intensification, as the latter is likely to result in improved health 
outcomes in patients with hypertension. Again, in our study, 
a lower level of formal education was associated with a lower 
probability of treatment intensification. This finding might reflect 
Table 2. Predictors of uncontrolled blood pressure in participants with hypertension at baseline
Outcome
Uncontrolled* BP at baseline: 
full model (N=3 220)
Uncontrolled BP* at baseline: 
limited model (N=3 220)
Uncontrolled BP* at follow-up: 
 full model (N=3 220)
Explanatory baseline 
variable OR 95% CI p-value OR 95% CI p-value OR 95% CI p-value
Age (per year) 1.01 1.00 - 1.01 0.170 1.00 0.99 - 1.01 0.469
Male v. female 1.08 0.90 - 1.30 0.412 1.11 0.95 - 1.29 0.178
Uncontrolled blood 
pressure*
3.88 3.30 -4.56 <0.001
Diabetes 0.93 0.76 - 1.14 0.508 1.04 0.88 - 1.22 0.654
Known cardiovascular 
disease
0.98 0.84 - 1.13 0.758 1.05 0.86 - 1.28 0.616
Language 0.008† 0.033† 0.794†
Afrikaans (reference) 1.00 1.00 1.00
isiXhosa 1.38 0.99 - 1.94 0.057 1.11 0.86 - 1.44 0.432 1.10 0.76 - 1.59 0.623
English 0.78 0.55 - 1.09 0.145 0.74 0.57 - 0.96 0.026 0.93 0.60 - 1.42 0.724
Highest education 0.002‡ 0.001‡ 0.822‡
None (reference) 1.00 1.00 1.00
Primary 0.89 0.67 - 1.19 0.439 0.88 0.68 - 1.16 0.367 1.17 0.87 - 1.57 0.294
Secondary 0.77 0.57 - 1.03 0.081 0.76 0.58 - 0.99 0.042 1.08 0.80 - 1.46 0.623
Tertiary 0.33 0.17 - 0.65 0.001 0.35 0.18 - 0.68 0.002 1.04 0.56 - 1.92 0.905
Total monthly income 
(ZAR)
0.97 0.88 - 1.06 0.441 0.90 0.82 - 0.99 0.027
Unemployed v. employed 0.92 0.74 - 1.12 0.368 0.82 0.64 - 1.06 0.128
Welfare grant received 0.91 0.75 - 1.12 0.382 0.99 0.80 - 1.23 0.962
Pharmacist in clinic 1.01 0.70 - 1.46 0.944 1.00 0.76 - 1.33 0.985
Drug supply available away 
from clinic
1.19 0.86 - 1.66 0.297 0.80 0.57 - 1.13 0.206
Doctor at clinic every day 1.10 0.80 - 1.52 0.541 0.99 0.68 - 1.45 0.978
Clinic location 0.760† 0.623†
Urban (reference) 1.00 1.00
Peri-urban 1.02 0.74 - 1.42 0.900 0.84 0.57 - 1.22 0.357
Rural 0.87 0.56 - 1.34 0.528 0.97 0.65 - 1.45 0.868
Clinic patients/year/1 000 1.03 0.98 - 1.08 0.235 1.00 0.94 - 1.06 0.992
Clinic nurses (n) 0.93 0.87 - 1.01 0.079 0.98 0.89 - 1.07 0.594
Intervention v. control 
clinic
1.06 0.76 -1.48 0.748
OR = odds ratio; CI = confidence interval.
*Uncontrolled BP: systolic BP ≥140 mmHg or diastolic BP ≥90 mmHg.
†Wald test for all categories of variable.
‡Test for trend.
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the fact that effective communication and health literacy increase 
the likelihood of treatment changes – whether through increased 
willingness of clinicians to change treatment, or patients to accept 
it.[16] Of concern, and contrary to expectations, is that the known 
presence of cardiovascular disease was not associated with treatment 
intensification, suggesting that clinicians missed the opportunity to 
provide secondary prevention for cardiovascular events. However, 
higher blood pressure and comorbid diabetes did increase the 
likelihood of treatment intensification, which is clinically appropriate. 
The finding that housing density, receipt of welfare grants and total 
monthly income did not predict blood pressure control or treatment 
intensification may reflect the relative homogeneity of the study 
population, the majority of whom were poor (mean monthly income 
ZAR1 100 and 98% earning  less than ZAR5 000 per month) and 61% 
receiving welfare grants. It is also partly because these factors are 
associated with education and language, which were controlled for. 
An increased risk of hypertension has previously been associated 
with low socioeconomic indicators, with associations particularly 
evident for level of education.[8] In SA, a higher level of education 
has been found to predict lower values of both diastolic and systolic 
blood pressure in women, while higher income predicted lower 
systolic blood pressure.[9] Interestingly, this did not hold true for 
men. Our study, which comprised predominantly women, adds new 
evidence for an association between low levels of education and 
poorer hypertension control and treatment intensification in SA. 
The poor levels of blood pressure control in this study (60% of 
participants uncontrolled) are in keeping with previous studies. A 
1999 survey in 18 community health centres in the Cape Peninsula, 
SA, found that 67% of hypertensive patients had uncontrolled blood 
pressure (>140/90 mmHg).[5] In a 2009 - 2010 study of goldminers in 
Gauteng Province, SA, only 42% of patients diagnosed with hyper-
tension had received antihypertensive medication, and 69% of those 
on antihypertensive medication were poorly controlled.[6] 
Our study has several strengths. The sample size was large, high rates 
of follow-up were achieved, and a range of socioeconomic variables 
were investigated. Furthermore, the longitudinal design enabled 
analysis of change in control and treatment. There were, however, 
several limitations. Patients were included in the hypertension group 
on the basis of self-reported use of medication for hypertension. On 
review of baseline prescription records, evidence of hypertension 
Table 3. Predictors of treatment intensification in participants with uncontrolled blood pressure at baseline
Outcome
Treatment intensification of HPT if 
uncontrolled BP at baseline:* 
full model† (N=1 872)
Treatment intensification of HPT 
if uncontrolled BP at baseline:* 
limited model† (N=1 872) 
Explanatory baseline variable OR 95% CI p-value OR 95% CI p-value
Patient characteristics
Age (per year) 1.00 0.98 - 1.01 0.391
Male v. female 0.94 0.74 - 1.21 0.650
Mean systolic BP 1.01 1.01 - 1.02 <0.001 1.01 1.01 - 1.02 <0.001
Diabetes 1.30 1.05 - 1.62 0.018 1.31 1.06 - 1.62 0.013
Known cardiovascular disease 0.97 0.74 - 1.28 0.835
Language 1.00‡
Afrikaans (reference) 1.01
isiXhosa 0.78 0.67 - 1.50 0.980
English 1.01 0.70 - 1.47 0.946
Highest education 0.040§ 0.020§
None (reference) 1.00 1.00
Primary 1.50 0.98 - 2.27 0.059 1.45 0.97 - 2.17 0.072
Secondary 1.63 1.05 - 2.54 0.030 1.63 1.07 - 2.49 0.024
Tertiary 1.95 0.66 - 5.74 0.228 2.24 0.78 - 6.43 0.134
Total monthly income 1.04 0.91 - 1.18 0.565
Unemployed v. employed 1.12 0.86 - 1.44 0.402
Welfare grant received 0.91 0.70 - 1.19 0.500
Clinic characteristics
Pharmacist in clinic 0.78 0.54 - 1.13 0.192
Drug supply available away from clinic 1.40 1.06 - 1.86 0.018 1.44 1.10 - 1.89 0.009
Doctor at clinic every day 1.73 1.25 - 2.40 0.001 1.64 1.17 - 2.31 0.004
Clinic location 0.070‡
Urban (reference) 1.00
Peri-urban 1.05 0.74 - 1.48 0.779
Rural 0.66 0.45 - 0.97 0.034
Clinic patients/year/1 000 0.95 0.89 - 1.01 0.089
Clinic nurses (n) 1.22 1.10 - 1.34 <0.001 1.15 1.08 - 1.23 <0.001
Intervention v. control clinic 1.80 1.34 - 2.40 <0.001 1.78 1.31 - 2.41 <0.001
*Uncontrolled BP: systolic BP ≥140 mmHg or diastolic BP ≥90 mmHg.
†Change modelled with ANCOVA, i.e. with baseline as covariate.
‡Wald test for all categories of variable.
§ Test for trend.
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treatment was not found in 5% (153) of participants. Secondly, no 
assessments of adherence were performed at baseline – clinicians 
who suspected significant non-adherence may have elected not to 
intensify treatment. A further potential limitation was language of 
communication, i.e. the possibility that interviewers might not have 
communicated effectively in the participant’s language of choice. 
Finally, the homogeneity (limited range of socioeconomic status) 
of the population may have limited the assessment of the impact of 
individual determinants of blood pressure control. 
In spite of these limitations, our findings have implications for 
clinicians and policymakers. Health services need to be sensitive to 
the impact of socioeconomic factors, and, in particular, lower levels 
of education. Emphasis must be placed on effective communication 
in the patient’s language of choice, using educational materials and 
programmes prepared and presented in forms that are appropriate 
to their levels of education and health literacy. Secondly, our study 
points to clinic factors that may be addressed to improve the care 
of hypertensive patients. Besides attempting to improve staffing of 
clinics (preferably with doctors in attendance), this includes off-site 
access to maintenance medications. The latter finding is likely to be 
relevant to the care of all chronic diseases, and points to the need for 
expansion of drug delivery services in SA. Together, these measures 
should be viewed as achievable opportunities for improving the 
management of hypertension in primary care in SA.
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3.3 Socioeconomic predictors and consequences of depression among 
primary care attenders with non-communicable diseases in the Western 
Cape, South Africa: cohort study within a randomised trial 
Paper overview 
Mental disorders are an important but neglected cause of disease burden in South Africa. 
This paper investigates the extent to which socioeconomic position predicts depression 
symptoms over time, and the extent to which socioeconomic position and health service 
characteristics predict treatment of depression over time. The results show that 
socioeconomic disadvantage appears to be both a cause and consequence of depression, 
and may also be a barrier to treatment.  
 
Contribution to the thesis and novelty 
This study addresses the third aim of the thesis and provides new evidence from South 
Africa in support of the bidirectional relationship between poverty and depression, 
supporting both the ‘social causation’ and ‘social selection’ theories. The majority of past 
studies looking at socio-economic associations with depression in LMICs have been cross-
sectional, making it difficult to draw conclusions on direction of causal effects (Lund et al. 
2010). Few studies have addressed predictors of change in depression symptoms, and 
predictors of change in treatment for depression over time. In addition, few studies have 
explored the health and economic impact of depression over time. 
 
The findings suggest that addressing potentially modifiable clinic factors such as the 
availability of pharmacists and providing community-based medication supply could 
improve management of depression in primary care. Further, the evidence in support of a 
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bidirectional link between depression symptoms and social disadvantage reinforces 
arguments for the expansion of mental health services and for improving the prevention, 
detection and treatment of depression in primary health care settings in South Africa. 
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Abstract
Background: Socioeconomic predictors and consequences of depression and its treatment were investigated in
4393 adults with specified non-communicable diseases attending 38 public sector primary care clinics in the Eden
and Overberg districts of the Western Cape, South Africa.
Methods: Participants were interviewed at baseline in 2011 and 14 months later, as part of a randomised
controlled trial of a guideline-based intervention to improve diagnosis and management of chronic diseases. The
10-item Center for Epidemiologic Studies Depression Scale (CESD-10) was used to assess depression symptoms,
with higher scores representing more depressed mood.
Results: Higher CESD-10 scores at baseline were independently associated with being less educated (p = 0.004)
and having lower income (p = 0.003). CESD-10 scores at follow-up were higher in participants with less education
(p = 0.010) or receiving welfare grants (p = 0.007) independent of their baseline scores. Participants with CESD-10
scores of ten or more at baseline (56 % of all participants) had 25 % higher odds of being unemployed at follow-
up (p = 0.016), independently of baseline CESD-10 score and treatment status. Among participants with baseline
CESD-10 scores of ten or more, antidepressant medication at baseline was independently more likely in
participants who had more education (p = 0.002), higher income (p < 0.001), or were unemployed (p = 0.001).
Antidepressant medication at follow up was independently more likely in participants with higher income
(p = 0.023), and in clinics with better access to pharmacists (p = 0.053) and off-site drug delivery (p = 0.013).
Conclusions: Socioeconomic disadvantage appears to be both a cause and consequence of depression, and may
also be a barrier to treatment. There are opportunities for improving the prevention, diagnosis and treatment of
depression in primary care in inequitable middle income countries like South Africa.
Trial registration: The trial is registered with Current Controlled Trials (ISRCTN20283604).
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Background
Depression is a common mental disorder, causing a high
level of disease burden. There were an estimated 298
million cases of major depressive disorder worldwide in
2010 [1] and this disorder was ranked the second leading
cause of years lived with disability (YLD) [1, 2].
Mental disorders are also an important cause of dis-
ease burden in South Africa. The South African Stress
and Health (SASH) study indicated a lifetime prevalence
of major depression of 9.7 % and a 12 month prevalence
of 4.9 % [3].
Approximately 80 % of South Africans are estimated
to be dependent on public health sector services [4],
which are inadequately equipped to address the high
prevalence of mental disorders. There is marked under-
treatment of mental disorders in primary care in South
Africa. Three quarters of adults with a mental disorder
in the SASH study received no treatment in the year of
the interview [5]. This treatment gap is consistent with
evidence from many low and middle income countries
(LMICs) [6].
South Africa is one of the most unequal countries in
the world [7], with wide disparities in wealth and health
[8]. Income inequality has been shown to be positively
associated with mental illness [9–11]. A study among
older Americans found those living in counties with
higher income inequality were more depressed, inde-
pendent of their demographic characteristics, socioeco-
nomic status, and physical health [10]. In South Africa,
the burden of ill-health has been demonstrated to be
greater among lower socio-economic groups [12].
A number of studies in LMICs have shown an asso-
ciation between indicators of poverty and mental dis-
orders [11, 13]. A systematic review of the
relationship between poverty and common mental
disorders in LMICs found a relatively consistent and
strong association between common mental disorders
and education, food insecurity, housing, social class,
socio-economic status and financial stress; whereas
income, employment and consumption were found to
be more equivocal [11]. A second systematic review
of poverty and common mental disorders in develop-
ing countries found most studies showed an associ-
ation between risk of common mental disorders and
low levels of education, and many studies also showed
a relationship with other indicators of poverty such as
poor housing or low income [13].
Associations have been found between depression and
non-communicable diseases. High depression scores
have been found to be an independent risk factor for
hypertension, and there is evidence for an association
between mental disorder and diabetes. In addition, de-
pression has been shown to be associated with poor gly-
caemic control [14].
Depression has been shown to be associated with
more frequent exacerbations in patients with chronic
obstructive pulmonary disease (COPD), worse short-
term survival, and higher rates of post-exacerbation re-
admission to hospital. An interaction effect has also
been reported between symptoms of depression and
death among patients with COPD [15].
The majority of past studies looking at socio-
economic associations with depression in LMICs have
been cross-sectional, making it difficult to draw conclu-
sions on causality [11]. Two explanations have been pro-
posed for the inverse relationship between psychiatric
disorders and socioeconomic status. Social causation
postulates that adversity and stress due to conditions of
poverty increase the risk of mental illness, whereas social
selection/drift postulates that people with mental illness
are at increased risk of drifting into or remaining in pov-
erty due to factors such as loss of employment, reduced
productivity, stigma and increased health expenditure
[16]. Although these causal pathways are complex, evi-
dence suggests social causation may be more important
for common mental disorders such as depression, par-
ticularly in women, while social selection/drift processes
may be more important for schizophrenia [17].
Few studies have addressed predictors of change in de-
pression symptoms, and predictors of change in treat-
ment for depression over time in LMICs. In addition,
few studies have explored the health and economic im-
pact of depression over time.
The aims of this cohort study were to investigate the
extent to which socioeconomic position and physical ill-
ness (hypertension, diabetes, chronic respiratory disease)
predict depression symptoms over time among primary
care attenders, and the extent to which these factors and
health service characteristics predict treatment of de-
pression over time.
Methods
Study design and context
This paper reports on a cohort study within a cluster ran-
domised controlled trial (RCT), including cross-sectional
baseline data and longitudinal data on changes from base-
line to follow up. The aim of the RCT was to evaluate the
effectiveness of the Primary Care 101 guideline training
programme for primary health care providers [18, 19], and
to assess whether the programme improved quality of care
for specified chronic diseases. Primary Care 101 consists
of three elements: a 101-page algorithmic guideline that
covers common symptoms and conditions in adults; an
educational outreach programme in which nurse trainers
deliver interactive training sessions on-site to all staff at a
facility, using the Primary Care 101 guideline and case sce-
narios; and additional prescribing provisions for nurses
who successfully complete their training.
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Thirty-eight clinics in the Eden and Overberg districts
of the Western Cape, South Africa, were cluster rando-
mised either to receive the Primary Care 101 training
programme for health care providers, or to continue
with usual care. Eligible patients, defined below, who
provided consent were interviewed at baseline in 2011
and once more, 14 months later [19]. The analyses for
this study included data from the whole RCT cohort at
baseline and follow-up, combining the intervention and
control arms.
Study population and sample
The study population comprised adults attending public
sector primary care clinics in two districts of the
Western Cape province of South Africa. The communi-
ties served by the public sector clinics in these two dis-
tricts are characterised by high levels of unemployment
and socio-economic deprivation. In 2011, unemploy-
ment rates were 22.5 and 17.0 % in the Eden and Over-
berg districts respectively [20], and the Eden district was
rated as the poorest in the Western Cape province [21].
The study site is typical of many low resource rural and
small urban settings in South Africa, in which the public
sector primary health care clinics are nurse-led with
some doctor support.
Thirty-eight of the largest primary care clinics in the
Eden district and two Overberg sub-districts were se-
lected. Each clinic services at least 10 000 attendances
per year and they are staffed by nurse practitioners, doc-
tors and community health workers. The study popula-
tion was restricted to adults 18 years or older, planning
to reside in the area for the next year, and capable of ac-
tively engaging in an interviewer-administered question-
naire at the time of recruitment.
Among patients who met these criteria, four groups
representing patients with hypertension, diabetes,
chronic respiratory disease and depression were identi-
fied. Patients were eligible for the hypertension and dia-
betes groups if they reported being on medication for
hypertension or diabetes respectively. They were eligible
for the respiratory group if they reported being on medi-
cation for chronic respiratory disease, or had symptoms
of chronic respiratory disease and were not on treatment
for tuberculosis. Patients were eligible for the depression
group if they scored ten or more on the 10-item Centre
for Epidemiologic Studies Depression Scale (CESD-10)
[22]. Patients may have fulfilled inclusion criteria for
more than one disease group. Participants were sampled
consecutively within each clinic and invited to partici-
pate in the study, until the sample size required for each
clinic was obtained. They were screened for eligibility by
orally questioning them and, if they met the eligibility
criteria, were then asked to provide informed consent to
participate.
Data collection and coding
At baseline trained fieldworkers administered the elec-
tronic questionnaire and took clinical measurements
after eligible participants provided informed consent.
The baseline questionnaire included questions about
demographic characteristics, comorbidities, and socio-
economic factors. Participants were asked about the
highest level of education they had achieved (no school-
ing, grade 1–7, grade 8–12 or tertiary/diploma), their
employment status (employed, self-employed, student/
learner or unemployed), and their employed and pen-
sion/grant income in the last month.
The presence of depression symptoms was assessed
with the 10-item CES-D scale which was administered
to all participants. The 20-item CES-D was originally
developed by Radloff (1977) to measure symptoms of
depression in the general population [23, 24]. A
shortened 10-item version was created by Andresen
et al. [22] The CESD-10 items are: “1. I was bothered
by things that usually don't bother me. 2. I had
trouble keeping my mind on what I was doing. 3. I
felt depressed. 4. I felt that everything I did was an
effort. 5. I felt hopeful about the future. 6. I felt fear-
ful. 7. My sleep was restless. 8. I was happy. 9. I felt
lonely. 10. I could not get going.” The individual
items are scored from 0 (rarely or none of the time)
to 3 (most of the time) and a score is assigned by to-
talling all item scores. The possible range of scores is
0–30 for the 10-item scale, with higher scores repre-
senting greater degrees of depressed mood [22]. Both
the 10- and 20- item CES-D have been used and vali-
dated in a number of countries including among HIV
infected individuals in South Africa [25, 26].
All participants were asked if they had received psy-
chological counselling in the year leading up to their
baseline interview. Counselling was defined as talking
with someone in a way that helps to find solutions to
problems, or receive emotional support, and not just re-
ceiving advice on how to take medication. Participants
who reported receiving counselling from a mental health
nurse, clinic counsellor, social worker, psychiatrist or
psychologist were considered to have received counsel-
ling. Participants who reported receiving counselling
from a mental health nurse, psychiatrist or psychologist
were considered to have been referred to psychiatric
services.
Chronic medication prescribed at the time of each par-
ticipant’s interview for depression, hypertension, diabetes
and respiratory disease was recorded. Fieldworkers
photocopied all available prescription charts for the year
preceding the interview. The trial manager (NF) ana-
lysed the prescription charts to identify medication for
chronic conditions prescribed for each participant at the
time of their interview.
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It is common practice in the Eden and Overberg dis-
tricts for amitriptyline or imipramine to be prescribed at
a low dose (25 mg daily) for pain management and in-
somnia. We considered amitriptyline and imipramine at
a dose less than 50 mg daily to be sub-therapeutic for
depression [6]. Other antidepressants were not pre-
scribed at sub-therapeutic doses [27]. We therefore de-
fined being on an antidepressant at a therapeutic dose as
prescription of amitriptyline or imipramine of 50 mg or
more daily, or on any other antidepressant.
Disease-specific control indicators were measured at
baseline and follow-up [19]. Systolic and diastolic blood
pressure were measured in all participants. Ten year risk
of cardiovascular deaths was calculated, based on age,
sex, systolic blood pressure, smoking status, reported
diabetes and body mass index [28]. The severity of re-
spiratory disease was assessed with the Symptom and
Activity domains of the St Georges Respiratory Ques-
tionnaire (SGRQ) [29] in participants enrolled in the re-
spiratory disease group. Glycated haemoglobin (HbA1c)
was measured in a sub-sample of 704 diabetic partici-
pants from 20 randomly selected clinics.
The following clinic characteristics were identified at
baseline: availability of a pharmacist, availability of drug
supply away from clinic, psychiatric nurse at clinic, doc-
tor at clinic every day, clinic location, clinic patients per
year, clinic patients per nurse per year, and intervention
versus control clinic.
At follow-up the questionnaire, clinical measurements
and prescription data were collected and recorded as for
the baseline data. Baseline data collection began in
March 2011 and ended in October 2011. Follow-up data
collection started in May 2012 and ended in January
2013.
Statistical methods
The statistical analyses investigated associations between
participants’ health and socioeconomic indicators, and
their symptoms and treatment of depression. We also in-
vestigated associations between depression symptoms re-
ported at baseline and subsequent changes in participants’
income and employment, ten year risk of death from car-
diovascular disease and, in participants with hypertension,
diabetes, or respiratory disease, in blood pressure control,
glycaemic control and respiratory symptoms respectively.
Analyses of treatments included the following clinic char-
acteristics as potential explanatory variables: pharmacist in
clinic, drug supply available away from clinic, psychiatric
nurse at clinic, doctor at clinic every day, clinic location,
clinic patients per year, clinic patients per nurse per year,
and intervention versus control clinic. These clinic charac-
teristics were investigated because they could potentially
influence access to necessary treatment directly, or be in-
direct indicators of the quality of care.
In all analyses the study’s cluster sampling design
was accounted for in regression models with robust
adjustment for intra-clinic cluster correlation of out-
comes, using Stata version 12.0 statistical software
[30]. A p value 0.05 or less was considered statisti-
cally significant.
Intervention or control arm of the randomised con-
trolled trial was accounted for in all longitudinal ana-
lyses. Variables independently associated with the
outcome in each model were selected using backwards
stepwise selection. At each step, explanatory variables
with a p value of less than 0.10 were removed from each
model. The purpose of stepwise selection of explanatory
variables for each model was to estimate the effects of
each socioeconomic indicator without confounding by
other socioeconomic indicators or patient characteris-
tics. Even though all of the socioeconomic indicators
could theoretically have causally influenced depression
and its care, it was not appropriate to keep all of them
in every model because of the likelihood that overadjust-
ment for collinear variables would obscure relevant
associations.
The primary analyses of variables associated with de-
pression symptoms were multiple linear regression
models with CESD-10 score as the continuous outcome
variable. Secondary analyses of depression symptoms
used multiple logistic regression models with CESD-10
scores coded as high (greater than or equal to ten) or
low (less than ten).
Analyses with treatments (antidepressant medication,
counselling, or referral to psychiatric services) as out-
comes were confined to participants with CESD-10
scores greater than or equal to ten at baseline and used
multiple logistic regression models. Primary analyses of
antidepressant medication coded treatment as present
only if drug doses were defined as therapeutic. Second-
ary analyses coded antidepressant treatment as present
at any dose.
Longitudinal data analysis was as follows. Changes
between baseline and follow-up in depression symp-
toms, antidepressant medication, employment or in-
come used analysis of covariance (ANCOVA) in the
multiple regression models, that is, with the follow-up
variable as outcome and with the baseline variable as
a covariate. This was done to account for regression
to the mean, that is, individuals with exceptionally
high or low values at baseline would at follow-up
tend to have values closer to the mean, due to chance
alone [31]. Analyses of changes all included trial arm
as a potential explanatory variable.
The trial is registered with Current Controlled Trials
(ISRCTN20283604). Ethical approval for the trial was
obtained from the University of Cape Town Human Re-
search Ethics Committee and the Western Cape
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Provincial Department of Health. All participants pro-
vided informed consent to participate in the study.
Results
A total of 4393 participants were enrolled at baseline, of
whom 90.5 % were followed up. Prescription records
were available for 4364 (99.3 %) participants at baseline
and 4284 (97.5 %) participants at follow up.
Table 1 shows the socio-demographic characteristics
of participants at baseline. The majority of participants
(73 %) were women and half were over the age of
50 years. Seventy-four percent had hypertension, 42 %
had diabetes, 26 % had chronic respiratory disease or
symptoms and 56 % had CESD-10 scores of ten or more.
The majority of participants had not completed second-
ary school education (52 %), were unemployed (75 %)
and receiving a welfare grant (58 %). The average
monthly income was equivalent to about US$4.90 per
day in 2011 [32], but this includes 26 % who reported
having no income. These socioeconomic indicators were
all significantly associated with each other, except that
non-grant income was not associated with language
group.
Baseline CESD-10 scores had a mean value of 10.8
units (standard deviation (SD) 6.4, median 11, interquar-
tile range 6 to 15). Change in CESD-10 scores had a
mean value of 3.1 units (SD 7.0, median 7, interquartile
range −1 to 8). Both baseline and change in CESD-10
score had symmetrical bell-shaped distributions, except
that the baseline score was truncated at zero. However
both distributions were significantly different from Nor-
mal according to Stata’s combined skewness and kurtosis
tests for Normality. At baseline, CESD-10 scores were
positively associated with female sex, chronic respiratory
disease, antidepressant use and housing density, and
were inversely associated with age, hypertension, dia-
betes and income.
Linear regression models estimated the independent
associations of CESD-10 scores with the health and so-
cioeconomic indicators (Table 2). Baseline CESD-10
scores were higher in participants who had chronic re-
spiratory disease, were unemployed or receiving a wel-
fare grant, and were lower in participants who were
older, male, had hypertension or diabetes, were more ed-
ucated or had higher incomes at baseline. CESD-10
scores at follow-up had increased since baseline in par-
ticipants who had chronic respiratory disease, spoke
Xhosa, or received welfare grants. CESD-10 scores at
follow-up were lower in participants who were older,
male, had hypertension, or were more educated at
baseline.
The secondary analyses mostly confirmed the ro-
bustness of the results reported in Table 2, as follows.
An equivalent logistic regression model with higher
(greater than or equal to ten) versus lower baseline
CESD-10 scores as binary outcome found the same
variables as in Table 2 to be significant predictors, ex-
cept that language was not significant (p = 0.360), and
employment was (p = 0.013). Housing density was not
independently associated with CESD-10 score as a
continuous outcome variable (p = 0.148), but was as-
sociated with higher CESD-10 score modelled as a
binary outcome variable (p = 0.05). Logistic regression
with higher CESD-10 score at follow-up as a binary
outcome variable, adjusted for baseline CESD-10
score, found age, sex, chronic respiratory disease, edu-
cation and welfare grant, but not hypertension, to be
significant predictors. Greater housing density was in-
dependently associated with increasing CESD-10
scores in linear and in logistic regression models.
Participants with CESD-10 scores of ten or more at
baseline had 25 % higher odds of being unemployed at
follow-up, and had R55 higher income per month from
welfare grants at follow-up, independently of their em-
ployment status or grant income at baseline, and other
confounding variables (Table 3). Baseline CESD-10
scores were not independently associated with changes
in non-grant income or total income.
Baseline CESD-10 score, whether coded as a continu-
ous or binary variable, was not associated with changes
in blood pressure control, glycaemic control, respiratory
symptom score or ten year risk of death from cardiovas-
cular disease.
Logistic regression models estimated the independ-
ent effects of participant and clinic characteristics on
antidepressant medication at baseline and follow-up,
among participants with baseline CESD-10 scores of
ten or more, and who consequently may have bene-
fited from diagnosis and treatment of their depression
symptoms (Table 4). Receipt of any treatment (anti-
depressant medication, counselling or psychiatric re-
ferral) was more likely in participants with higher
CESD-10 scores in every model. Antidepressant medi-
cation at therapeutic doses at baseline was more likely
in participants with more education, higher income,
unemployed, or in clinics with a pharmacist, and was
less likely in males and Xhosa speakers, independently
of their baseline CESD-10 score. In the case of educa-
tion, there appeared to be a dose–response relation-
ship, indicated by a steady increase in treatment
access with more years of education. Receipt of thera-
peutic doses of antidepressant drug at follow-up was
more likely in women, participants with higher in-
come or in clinics with a pharmacist, drugs supplied
off-site, daily doctor support, lower patient to nurse
ratios, or peri-urban or rural location, independently
of baseline CESD-10 score and antidepressant
medication.
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Table 1 Participants’ baseline characteristics and associations with baseline CESD-10a scores
Numberb Percentb CESD-10 Mean CESD-10 SD pc
Health indicators
Age (years): mean (SD) 51.6 (13.5) n = 4393 <0.001
Sex <0.001
• Women 3193 72.7 11.2 6.4
• Men 1199 27.3 9.7 6.2
Hypertension <0.001
• No 1166 26.6 12.8 6.2
• Yes 3226 73.5 10.0 6.3
Diabetes <0.001
• No 2551 58.1 11.8 6.4
• Yes 1841 41.9 9.3 6.0
Chronic respiratory Disease <0.001
• No 3235 73.7 10.2 6.3
• Yes 1157 26.3 12.2 6.4
CESD-10 score ≥10
• <10 1926 43.9 4.9 2.8
• ≥10 2466 56.2 15.3 4.3
Antidepressant, any dose <0.001
• No 3545 81.3 10.2 6.1
• Yes 818 18.8 13.2 7.0
Antidepressant, therapeutic dose <0.001
• No 3971 91.0 10.3 6.1
• Yes 392 9.0 15.1 7.3
Socioeconomic indicators
Language 0.88
• Afrikaans 3679 83.8 10.8 6.6
• Xhosa 337 7.7 10.1 5.3
• English 376 8.6 10.6 5.3
Highest education 0.35
• None 291 7.3 10.8 6.2
• Primary 1757 44.2 11.0 6.2
• Secondary 1853 46.6 10.6 6.5
• Tertiary 75 1.9 9.9 6.4
Total monthly income (Rand): mean (SD) 1084 (1254) n = 4378 <0.001
Unemployed 0.12
• No 1096 25.0 10.4 6.4
• Yes 3282 75.0 10.9 6.4
Welfare grant 0.87
• No 1850 42.3 10.7 6.4
• Yes 2528 57.7 10.8 6.4
Housing density (occupants/rooms): mean (SD) 1.8 (1.2) n = 2930 <0.001
a CESD-10 10-item Center for Epidemiologic Studies Depression Scale
b Except mean and standard deviation (SD) for continuous variables
c Linear regression models adjusted for cluster sample design
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Psychiatric referral between baseline and follow-up
was more likely in participants with tertiary education or
higher income and was less likely in participants who
were older, male, Xhosa-speaking or in intervention
clinics.
Counselling between baseline and follow-up was more
likely in participants with more education or receiving
welfare grants, and in clinics that supplied drugs away
from the clinics, and was less likely in participants who
were older or had hypertension, and in intervention
clinics or clinics with a psychiatric nurse.
Discussion
This study shows that depression symptoms in adults at-
tending primary care clinics in two districts of South
Africa, most of whom had common chronic conditions,
were strongly and independently associated with several
indicators of disadvantaged socioeconomic position. De-
pression symptoms, as indicated by higher CESD-10
scores at baseline, were independently associated with
being less educated and having lower income. CESD-10
scores at follow-up had increased since baseline in par-
ticipants who were less educated or receiving welfare
grants. Level of education was however not associated
with baseline CESD-10 score in the crude analysis, being
confounded by the other socioeconomic indicators. This
is consistent with findings from several other LMICs,
where education was less frequently associated with
common mental disorders in bivariate analyses than in
multivariate analyses [11].
Previous studies, the majority of which have been
community based, have similarly demonstrated associa-
tions between common mental disorders and socioeco-
nomic factors, including less education [11, 13, 33, 34],
low socio-economic status [11] and low income [13, 34].
Our study population comprised patients already using
primary care facilities, and therefore relatively easy to
reach for diagnosis and treatment of depression. It
showed that, at baseline, participants were less likely to
have received treatment with antidepressants if they
were socially disadvantaged, in particular if they had
lower income or less education. However, participants
were more likely to receive treatment if they were un-
employed. This may be because it is easier for un-
employed participants to attend clinics for treatment. In
contrast, the SASH study found no significant associa-
tions between receiving treatment for mental disorders
and income or level of education [35]. At follow-up,
clinic characteristics were more important than socio-
economic factors in predicting depression treatment,
Table 2 Patients’ baseline characteristics independently associated with CESD-10a score at baseline and with changeb in CESD-10
score: linear regression models
Outcome Baseline CESD-10a score Follow-up CESD-10a scoreb
Explanatory variable Coefficient 95 % CIa p Coefficient 95 % CIa p
Age (per year) −0.06 −0.08 −0.04 <0.001 −0.06 −0.08 −0.04 <0.001
Men vs. women −1.66 −2.19 −1.13 <0.001 −0.96 −1.46 −0.46 <0.001
Hypertension −1.93 −2.60 −1.27 <0.001 −0.53 −1.07 0.00 0.052
Diabetes −1.75 −2.27 −1.24 <0.001
Chronic respiratory disease 1.21 0.51 1.91 <0.001 1.06 0.58 1.54 <0.001
Highest education 0.004c 0.010c
• None (reference) 1.00 1.00
• Primary −0.24 −1.31 0.84 0.656 −0.35 −1.34 0.63 0.473
• Secondary −1.19 −2.33 −0.05 0.042 −1.48 −2.50 −0.47 0.005
• Tertiary −0.93 −2.70 0.83 0.291 −1.64 −3.03 −0.25 0.022
Language 0.038c
• Afrikaans (reference) 1.00
• Xhosa 1.90 0.42 3.37 0.013
• English 1.66 −0.66 3.98 0.156
Income (per 1000 Rand per month) −0.23 −0.37 −0.08 0.003
Unemployed 0.53 −0.08 1.15 0.086
Welfare grant baseline 0.54 −0.02 1.10 0.060 0.66 0.19 1.13 0.007
Baseline CESD-10 scoreb NA 0.32 0.27 0.37 <0.001
a CESD-10 10-item Center for Epidemiologic Studies Depression Scale, CI confidence interval, NA not applicable
b Change modelled with analysis of covariance, that is, with baseline value as covariate
c Wald test for all categories of variable
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with participants less likely to have received antidepres-
sant medication if they attended less resourced clinics,
without a pharmacist or off-site drug delivery, or if they
had lower income. Primary care clinics should be ad-
equately staffed and have pharmacists on site but also
enable patients to collect their repeated medicines at
more convenient locations. Strategies to deal with the
shortage of doctors and nurses in the South African
public sector, especially in rural areas, have included
community service for doctors, monetary incentives,
introducing a cadre of mid-level workers such as phar-
macists, contracting non-professional health workers to
take on various responsibilities such as counselling and
adherence support, and introducing innovative clinical
guidelines to enable nurses to manage patients who
would otherwise be seen by doctors [36]. Nevertheless,
our results reflect the effects of variation in patient:staff
ratios within a resource-constrained system, and suggest
the need to equalise workloads between clinics, with
existing resources. Our finding that patients in clinics
with a psychiatric nurse were less likely to receive coun-
selling at follow-up is counter-intuitive. It may be that
psychiatric nurses are managing patients with more se-
vere psychiatric disease, that is, psychoses mostly treated
with drugs, and do not have the time or skills to provide
counselling for depression.
Patients who were more depressed at baseline were
more likely to receive antidepressant medication subse-
quently. Causal inference about the cross-sectional asso-
ciation between depression symptoms at baseline and
treatment at baseline is not as clear, but it is more plaus-
ible that depression led to treatment rather than that
treatment led to depression. Women were more likely
than men to have higher CESD-10 scores and to receive
treatment with antidepressants at baseline and follow-
up. These findings are consistent with work from HIV
cohorts in Southern Africa which have shown that pro-
portionally more women than men are on antiretroviral
therapy [37], and highlights the need to identify barriers
to men accessing healthcare [38, 39]. The role of gender
in the causation, experience, reporting and care of de-
pression is however an enormous subject which was be-
yond the scope of this study.
Depression could potentially have affected participants’
physical health through biological mechanisms, or
through their health care use, treatment adherence or
interpretation of physical symptoms. However, we found
that depression symptoms at baseline were not associ-
ated with changes in blood pressure control, glycaemic
control, respiratory symptom score or ten year risk of
death from cardiovascular disease. This differs from
studies which have shown a positive association between
Table 3 Patient characteristics independently associated with changesa in unemployment and welfare grant income: logistic and
linear regression models
Outcome Unemployed at follow-upb Monthly welfare grant income at follow up (Rand)c
Explanatory variable ORd 95 % CI p Coefficient 95 % CId p
CESD-10 score≥10 at baseline 1.25 1.04 1.51 0.016 55 18 91 0.004
Age (per year) 1.05 1.04 1.06 <0.001 9 7 11 <0.001
Men vs. women 0.70 0.57 0.86 0.001
Chronic respiratory disease 66 25 108 0.003
Diabetes 27 0 55 0.048
Highest education <0.001e 0.017 e
• None (reference) 1.00 0
• Primary 0.78 0.54 1.13 0.186 −38 −85 8 0.105
• Secondary 0.59 0.38 0.90 0.014 −67 −115 −19 0.007
• Tertiary 0.19 0.10 0.35 <0.001 3 −212 218 0.975
Language 0.052e <0.001e
• Afrikaans (reference) 1.00 0
• Xhosa 0.68 0.46 1.00 0.047 −158 −228 −88 <0.001
• English 1.21 0.85 1.73 0.288 −99 −162 −37 0.003
Unemployed at baselinea 13.9 10.7 18.2 <0.001
Grant income at baseline (per 1000 Rand per month)a 602 522 682 <0.001
a Change modelled with analysis of covariance, that is, with baseline value as covariate
b Logistic regression model
c Linear regression model
d OR odds ratio, CI confidence interval
e Wald test for all categories of variable
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Table 4 Baseline health, socioeconomic and clinic characteristics independently associated with mental health treatments at baseline and at follow-upa, in patients with CESD-
10 score of ten or more: logistic regression models
Outcome Therapeutic dose of antidepressant
drug at baseline
Therapeutic dose of antidepressant
drug at follow-upa




ORb 95 % CIb P OR 95 % CI P OR 95 % CI P OR 95 % CI P
Patient
characteristics
Age (per year) 0.97 0.95 0.98 <0.001 0.97 0.96 0.98 <0.001
Men vs. women 0.31 0.19 0.49 <0.001 0.34 0.22 0.53 <0.001 0.67 0.43 1.03 0.069
Hypertension 0.75 0.60 0.95 0.016
Diabetes 0.72 0.49 1.06 0.094 0.71 0.48 1.04 0.079
Highest education 0.002c 0.006c 0.022c
• None (reference) 1.00 1.00 1.00
• Primary 1.36 0.75 2.47 0.314 1.11 0.51 2.38 0.797 0.85 0.51 1.41 0.529
• Secondary 1.98 1.10 3.55 0.022 1.37 0.62 2.99 0.435 0.81 0.49 1.33 0.401
• Tertiary 2.06 0.91 4.66 0.082 4.00 1.57 10.15 0.004 1.99 1.08 3.68 0.028
Language <0.001c 0.003c
• Afrikaans (reference) 1.00 1.00
• Xhosa 0.23 0.15 0.35 <0.001 0.16 0.05 0.45 0.001
• English 0.85 0.54 1.35 0.488 1.10 0.64 1.90 0.732
Income (per 1000 rand per
month)
1.31 1.18 1.44 <0.001 1.21 1.03 1.43 0.023 1.19 1.05 1.34 0.005
Unemployed 2.01 1.32 3.09 0.001
Welfare grant 1.35 0.96 1.90 0.082 1.36 1.13 1.64 0.001
Baseline CESD-10 score (per
unit)
1.15 1.12 1.19 <0.001 1.06 1.00 1.11 0.033 1.11 1.06 1.15 <0.001 1.06 1.03 1.10 <0.001
Therapeutic dose of
antidepressant at baselinea
NAb 136.90 77.25 242.61 <0.001 NA NA
Clinic characteristics
Pharmacist in clinic 1.86 1.25 2.78 0.002 1.58 0.99 2.51 0.053
Drug supply available away
from clinic
1.67 1.11 2.50 0.013 1.59 0.95 2.66 0.078
Psychiatric nurse at clinic 0.32 0.13 0.80 0.015
Doctor at clinic every day 1.48 0.95 2.30 0.084
Clinic location 0.038c













Table 4 Baseline health, socioeconomic and clinic characteristics independently associated with mental health treatments at baseline and at follow-upa, in patients with CESD-
10 score of ten or more: logistic regression models (Continued)
• Peri-urban 1.17 0.66 2.08 0.599
• Rural 2.60 1.18 5.76 0.018
Clinic patients per year/10,000 1.04 0.99 1.10 0.081
Clinic patients per nurse per year/1000 0.93 0.88 0.99 0.022
Intervention vs. control clinic 1.39 0.97 1.98 0.073 0.57 0.35 0.91 0.020 0.54 0.33 0.88 0.013
a Change modelled with analysis of covariance, that is, with baseline value as covariate
b OR odds ratio, CI confidence interval, NA not applicable













depression and poor glycaemic control in diabetic pa-
tients [14].
Our findings suggest that the association between de-
pression symptoms and socio-economic position is bidir-
ectional. That is, in addition to disadvantaged social
position predicting worse depression symptoms at
follow-up, participants who had depression symptoms at
baseline were more socially disadvantaged at follow-up,
showing 25 % higher odds of being unemployed. The bi-
directional link between depression symptoms and social
disadvantage therefore supports both the social caus-
ation and social selection theories. Our findings suggest
that, in this study setting, socioeconomic disadvantage is
both a cause and a consequence of depression, and may
also be a barrier to treatment, with participants less
likely to receive treatment if they had a lower income
(baseline and follow-up) or less education (baseline).
The study had a number of strengths. The sample size
was large, high rates of follow-up were achieved, and a
wide range of socio-economic variables were investi-
gated. A key strength of the study was the longitudinal
design, which allowed potential causal relationships to
be identified, demonstrating that the relationship be-
tween socioeconomic position and depression worked in
both directions.
There were a number of limitations to the study. The
CESD-10 questionnaire was used to identify participants
with depression symptoms, but not to confirm the clin-
ical diagnosis of depression. It was originally derived and
validated on an older adult population [22] but has sub-
sequently been validated in a younger population on
antiretroviral therapy [25]. Participants were only en-
rolled into the study if they had hypertension, diabetes,
chronic respiratory disease or depression symptoms, so
the results may not be generalisable to primary care at-
tenders without these conditions. Thirty-four percent of
participants in the depression group did not answer the
question at baseline on whether they had received coun-
selling in the past year. This was due to an error in the
electronic questionnaire that resulted in this question
being skipped during several weeks of fieldwork before it
was detected and corrected. Socioeconomic factors that
could influence depression symptoms that were not
measured include food insecurity, poor housing, lack of
social support, and disability.
Further research is needed to investigate the relative
contributions of both social causation and social selec-
tion/drift mechanisms to the well documented associ-
ation between socio-economic disadvantage and
depression in LMICs; to identify what specific interven-
tion strategies are needed to reach vulnerable low socio-
economic populations living with depression; and to
evaluate the effectiveness of interventions that are de-
signed to target each of the above mechanisms. Feasible
examples might include brief psychological interventions
with financial risk protection as part of universal health
coverage.
Conclusion
This study provides new evidence from South Africa in
support of the bidirectional relationship between poverty
and depression. Mental health interventions have been
shown to be associated with improved economic out-
comes in LMICs [16]. This study reinforces arguments
for the expansion of mental health services and improv-
ing the prevention, detection and treatment of depres-
sion in primary health care settings in South Africa and
other LMICs, for clinical and economic reasons. While
there is currently an emphasis on integrating communic-
able and non-communicable chronic disease care in
South Africa, we must not lose sight of the importance
of ensuring better management and access to mental
health care.
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3.4 Educational outreach with an integrated clinical tool for nurse-led 
non-communicable chronic disease management in primary care in 
South Africa: a pragmatic cluster randomised controlled trial 
Paper overview 
This paper reports on the RCT evaluating the PC101 programme. The programme was found 
to be feasible and safe but was not associated with the primary outcomes of treatment 
intensification for NCDs or case detection for depression. This notwithstanding, the 
intervention, with adjustments to improve its effectiveness, has been adopted for 
implementation in primary care clinics throughout South Africa. 
 
Contribution to the thesis and novelty 
This paper addresses the fourth aim of the thesis. The benefits of nurse substitution and 
supplementation in NCD care in high income settings are well recognised, but evidence from 
low- and middle-income countries is limited.  
 
The PC101 intervention is a further development of the PALSA PLUS programme, which 
focussed on HIV/AIDS and respiratory disease including tuberculosis. PC101 includes all 
common symptoms and conditions among adults attending primary care services and is 
designed to support and expand nurses’ roles in NCD care. 
 
Our trial covered all three NCDs profiled in the series of implementation science calls from 
the Global Alliance for Chronic Diseases (hypertension, diabetes, chronic respiratory 
disease) (GACD 2016), and also addressed depression,  the second leading cause of years 
lived with disability worldwide (Vos et al. 2012).   
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While no primary outcomes showed significant benefit, the upper confidence limits included 
the possibility of meaningful clinical improvements, and the direction of results in three of 
the four primary endpoints in the study was consistent and positive. Furthermore, there was 
no evidence of harm and the programme was perceived to be a highly feasible and 
acceptable approach to the expansion of skills for NCDs. The National Department of Health 
has adopted the programme for implementation in primary care clinics throughout South 
Africa. 
 
Role of the candidate 
I oversaw data collection for the study and was responsible for data management, including 
cleaning the data and preparing it for analysis. I collaborated with Professor Carl Lombard 
and Associate Professor Lara Fairall in the statistical design and analyses. I drafted the 
manuscript with co-lead author Associate Professor Lara Fairall, incorporating input from 
co-authors, and was responsible for finalising and submitting the final version of the 
manuscript for publication.  
 
Role of the co-authors 
LF, NF, KS, RC, GF, and NL developed and implemented the intervention. NF, LF, VT, KS and 
NL oversaw data collection. CLom led the analysis with assistance from NF, LF and MB. LF 
and NF wrote the original draft. All authors contributed to preparation of the manuscript 
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In many low-income countries, care for patients with non-communicable diseases (NCDs)
and mental health conditions is provided by nurses. The benefits of nurse substitution and
supplementation in NCD care in high-income settings are well recognised, but evidence
from low- and middle-income countries is limited. Primary Care 101 (PC101) is a pro-
gramme designed to support and expand nurses’ role in NCD care, comprising educational
outreach to nurses and a clinical management tool with enhanced prescribing provisions.
We evaluated the effect of the programme on primary care nurses’ capacity to manage
NCDs.
Methods and Findings
In a cluster randomised controlled trial design, 38 public sector primary care clinics in the
Western Cape Province, South Africa, were randomised. Nurses in the intervention clinics
were trained to use the PC101 management tool during educational outreach sessions
delivered by health department trainers and were authorised to prescribe an expanded
range of drugs for several NCDs. Control clinics continued use of the Practical Approach to
Lung Health and HIV/AIDS in South Africa (PALSA PLUS) management tool and usual
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training. Patients attending these clinics with one or more of hypertension (3,227), diabetes
(1,842), chronic respiratory disease (1,157) or who screened positive for depression
(2,466), totalling 4,393 patients, were enrolled between 28 March 2011 and 10 November
2011. Primary outcomes were treatment intensification in the hypertension, diabetes, and
chronic respiratory disease cohorts, defined as the proportion of patients in whom treatment
was escalated during follow-up over 14 mo, and case detection in the depression cohort. Pri-
mary outcome data were analysed for 2,110 (97%) intervention and 2,170 (97%) control
group patients. Treatment intensification rates in intervention clinics were not superior to
those in the control clinics (hypertension: 44% in the intervention group versus 40% in the
control group, risk ratio [RR] 1.08 [95% CI 0.94 to 1.24; p = 0.252]; diabetes: 57% versus
50%, RR 1.10 [0.97 to 1.24; p = 0.126]; chronic respiratory disease: 14% versus 12%, RR
1.08 [0.75 to 1.55; p = 0.674]), nor was case detection of depression (18% versus 24%, RR
0.76 [0.53 to 1.10; p = 0.142]). No adverse effects of the nurses’ expanded scope of practice
were observed. Limitations of the study include dependence on self-reported diagnoses for
inclusion in the patient cohorts, limited data on uptake of PC101 by users, reliance on pro-
cess outcomes, and insufficient resources to measure important health outcomes, such as
HbA1c, at follow-up.
Conclusions
Educational outreach to primary care nurses to train them in the use of a management tool
involving an expanded role in managing NCDs was feasible and safe but was not associated
with treatment intensification or improved case detection for index diseases. This notwith-
standing, the intervention, with adjustments to improve its effectiveness, has been adopted
for implementation in primary care clinics throughout South Africa.
Trial Registration
The trial is registered with Current Controlled Trials (ISRCTN20283604)
Author Summary
Why Was This Study Done?
• Non-communicable diseases (NCDs) are the leading cause of deaths worldwide,
even in low- and middle-income countries (LMICs) that continue to battle to con-
trol communicable diseases like HIV and tuberculosis (TB).
• Effective and affordable treatments prevent complications from NCDs like heart
attacks and strokes, but access is limited by the variable availability and limited
capacity of primary care health workers to detect and effectively manage these con-
ditions. In many LMICs, non-physicians such as nurses provide primary care for
NCDs.
• Over the past 16 years, we have developed, evaluated, and refined integrated clinical
management tools and training programmes that employ problem-based
approaches to common symptoms like cough and priority health conditions
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including TB, HIV, asthma, and emphysema. We have shown them to be effective
in improving the quality and outcomes of care for communicable diseases.
• We have expanded this programme to include almost all NCDs and mental health.
This study evaluated the impact, both benefits and harms, of introducing the
expanded programme, called Primary Care 101 (PC101), in terms of the quality of
primary care for four common chronic diseases: hypertension, diabetes, chronic
respiratory disease, and depression.
What Did the Researchers Do and Find?
• We compared the care offered to patients with one of these four chronic diseases in
18 clinics in which primary care health workers were trained in the use of PC101
with that in 18 clinics where nurses continued to use the predecessor tool, which
focused on communicable diseases.
• The trial had a pragmatic design, meaning it was conducted under usual conditions
of health system operational constraints. Clinics in urban and rural areas serving
people living in socio-economically deprived areas of South Africa were selected.
• We enrolled 4,393 patients with one or more of the NCDs of interest and followed
them up for 14 mo after introduction of PC101 at the intervention clinics. The pri-
mary outcome of interest was intensification of treatment (or diagnosis, in the case
of depression) for the four NCDs, analysed separately.
• The results confirmed very high rates of multimorbidity (patients having more
than one condition at a time), under-diagnosis, under-treatment, and poor disease
control.
• Introducing PC101 did not result in intensification of treatment for the four NCDs,
but neither was there evidence of harm from the nurses’ expanded scope of
practice.
What Do These Findings Mean?
• The trial confirmed that multimorbidity and poor detection and control of NCDs
and depression are common in this setting. Interventions are necessary to limit the
impact of these conditions on people’s health and quality of life.
• PC101 offered a practical and acceptable tool to help expand the scope of practice
of non-physician clinicians to include NCD care, but we were not able to show
improvements in care, as we have previously done for communicable diseases.
• The study illustrates the limitations of trials designed to study the effects of complex
system interventions in real life, where even small changes across many endpoints,
as seen in our study, may be useful to decision-makers under pressure to respond
constructively to the rise of multimorbidity and NCDs.
• PC101 has been adopted for country-wide implementation in primary care clinics
in South Africa.
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Introduction
South Africa is facing a quadruple burden of disease: HIV and tuberculosis (TB); non-communi-
cable diseases (NCDs), including mental health conditions; injury and violence; and maternal,
neonatal, and childhood illnesses [1]. The past 15 years have seen concentrated efforts to
strengthen the capacity of the public health system to treat HIV and TB. These investments seem
at last to be paying off, with a rise in life expectancy, a decline in mortality [2], and fewer new HIV
infections [3]. Yet the burden of NCDs and mental health remains unchecked; cardiovascular dis-
ease is now the second leading cause of death in South Africans after communicable diseases [4,5].
In South Africa, responsibility for the detection and treatment of NCDs lies at the primary
care level, with nurses seeing nine out of ten patients, most of whom have more than one pre-
senting condition [6]. However, the quality of NCD care is generally poor, characterised by
under-diagnosis, under-treatment, and poor clinical control [1,7,8]. We have previously suc-
cessfully piloted and trialled task-sharing interventions for communicable diseases, increasing
the capacity of nurses to take on assessment and prescribing roles for HIV and TB previously
restricted to doctors [9–15]. This programme has been scaled up throughout South Africa as
part of the national government’s accelerated response to HIV and TB launched in 2010 [16].
A similar programme has been developed for use in other countries including Malawi,
Botswana, Brazil, and Mexico [17]. We have since expanded this programme, now called Pri-
mary Care 101 (PC101), to include NCDs and mental health, hoping to leverage the health sys-
tem reforms that accompanied the scale-up of antiretroviral therapy (ART) to improve the
quality of primary care for other priority conditions.
These integrated programmes of care seek to overcome the limitations of vertical services
that tend to neglect multimorbidity [18–23], and to expand the roles of nurses, increasing the
number and distribution of health workers providing treatment for common NCD conditions.
While the benefits of nurse substitution and supplementation for a limited number of
NCDs in high-income settings are well recognised [24], evidence from low- and middle-
income countries (LMICs) is sparse and limited to a few pilot studies [25–28]. Fewer studies
still have sought to improve care across several NCDs simultaneously. Meta-analyses of com-
plex interventions in health systems confirm only small effect sizes (ranging from 0.4% to
6.3%) for carer behaviour (improved care), but given the size of the populations affected, these
effect sizes are considered important, provided the interventions are introduced without harm.
We report here the findings of the PC101 Trial, a pragmatic cluster randomised study evaluat-
ing the effectiveness of the PC101 intervention, which combines provision of an integrated
management tool with educational outreach to nurses. The primary outcomes of interest were
intensification of treatment for hypertension, diabetes, and chronic respiratory disease and
case detection of depression in overlapping cohorts of patients with these conditions.
Methods
Ethical approval for the trial was obtained from the University of Cape Town Human Research
Ethics Committee (reference number 119/2010) and the Western Cape Department of Health.
Study Design
This was a pragmatic, parallel-group cluster randomised controlled trial performed in the
Eden and Overberg districts of the Western Cape Province. Clusters were public sector pri-
mary healthcare clinics randomised within six sub-district strata. Outcome measures in each
of four cohorts were assessed in individual patients. Patient cohorts overlapped; patients with
more than one condition of interest were included in each applicable cohort, and cohorts were
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powered and analysed separately. This study design, with multiple cohorts, each with its own
primary outcome evaluated simultaneously, aimed to reflect the realities in primary care clinics
that nurses are required to diagnose and manage a wide range of conditions, that NCDs are
associated with multimorbidity, and that a focus on one condition may compromise the man-
agement of others [29]. The Western Cape Department of Health provided consent for the
inclusion and randomisation of clinics, before randomisation was performed. Patients provided
written consent for data collection after randomisation of clinics and prior to data collection.
Participants
Clinics. The study was conducted in the predominantly rural districts of Eden and Over-
berg, where public sector clinics serve a population of around 800,000, mainly people with
lower socio-economic status. Busy town clinics had fulltime doctors, but most clinics were
nurse led, with doctors in attendance on a sessional basis (Table A in S1 Appendix).
Eligible clinics provided services, including for NCDs, at least five days a week and reported
more than 10,000 attendances per year, so were likely able to contribute sufficient numbers of
patients to the study. Of 124 clinics in the Eden district, 33 clinics in five sub-districts met
these criteria. We supplemented this sample with five clinics from a sub-district in an adjacent
district (Overberg), to increase the number of clinics available for randomisation and
strengthen the study’s power.
The health districts in the study are representative of health services offered to more than
80% of the population of South Africa, comprising clinics both from medium-sized towns and
rural areas [6].
Patients. The study population comprised patients with one or more of the following:
hypertension, diabetes, chronic respiratory disease, or depression. Initial eligibility criteria
were being 18 y or older, likely to reside in the area for the next year, and capable of actively
engaging in an interviewer-administered questionnaire at the time of recruitment. Inclusion
criteria for the four cohorts were as follows (Table 1): for the hypertension and diabetes
cohorts, if patients reported being on medication for hypertension or diabetes, respectively;
for the respiratory disease cohort, if they reported receiving medication for chronic airway dis-
ease (asthma or chronic obstructive pulmonary disease [COPD]) or reported a cough and/or
difficult breathing for 2 wk or more prior to enrolment and were not on treatment for TB [30];
for the depression cohort, if they scored ten or more on the 10-item Center for Epidemiologic
Studies Depression Scale (CESD-10) [31,32]. We selected this instrument because the 20-item
version has been validated in a similar setting in South Africa [33], and the 10-item version in
primary care populations elsewhere [34–36]. The shorter version was necessary to limit the
length of the screening process for all four conditions. Patients were eligible even if at the time
of enrolment they had no record of current treatment for their condition.
In keeping with the study’s pragmatic design, enrolment was not restricted to patients with
uncontrolled disease or to patients considered to be adherent to current treatment [40].
Although encouraging adherence was included in the management tool, it was not monitored.
Randomisation. Clinics within each of six health sub-district strata were randomised to
avoid potential confounding resulting from geographically determined differences in manage-
ment of clinical services. Two strata contained equal numbers of clinics, meaning that rando-
misation could be done in a 1:1 ratio. The four strata containing odd numbers of clinics were
randomly allocated to have either one more or one fewer intervention clinic than control clin-
ics, to achieve an equal number of clinics in each group (19 per group, 38 in total).
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Randomisation was completed by the trial statistician using nQuery Advisor after recruit-
ment of clinics, independently of the managers giving permission for the clinics to be included
in the trial, and prior to patient recruitment and implementation of the intervention.
Setting and Programme
Usual care for non-communicable and communicable diseases (control group). South
African primary care clinics provide free services for communicable disease and NCDs.
Patients are seen by a clinician, usually a nurse, and stable patients with NCDs are seen at
intervals of 3–6 mo, but are required to collect medications each month either from the clinic
or from an off-site medication pick-up point. The clinical load borne by nurses is great; in
2008 the median number of patients per nurse seen each working day in the clinics studied
Table 1. Eligibility criteria, primary outcome definitions, and required sample size estimates for each cohort.
Cohort Eligibility Criteria Primary
Outcome












(1) an increase in the number of
antihypertensive medication classes
and/or (2) an increase in dose of at
least one antihypertensive and/or (3)
a switch to an antihypertensive in
another medication class and/or (4) a
switch to an antihypertensive in the
same medication class provided that
the new dose is equivalent to a
higher dose of the previous
antihypertensive and/or (5) addition
of aspirin and/or (6) the addition or
increase in dose of a statin.






(1) the addition or increase in dose of
metformin and/or (2) the addition or
increase in dose of a sulphonylurea
and/or (3) the addition or increase in
dose of insulin and/or (4) the addition
or increase in dose of an ACE
inhibitor and/or (5) addition of aspirin
and/or (6) the addition or increase in
dose of a statin.






medication OR cough and/or
difficult breathing >2 wk (and
not on TB treatment)5
Treatment
intensification
(1) the addition or increase in dose of
an inhaled corticosteroid and/or (2)
addition of a beta-agonist and/or (3)
addition of ipratropium bromide and/
or (4) addition of theophylline.
36 0.30 0.15 0.02
[15]3
Depression CESD-10 10 Case detection (1) addition of antidepressant
medication and/or (2) receipt of
counselling by a mental health
practitioner and/or (3) referral to
mental health services.
60 0.10 0.04 0.04
[39]3
1All calculations are for two-sided tests and are powered at 90%. Sample sizes have been inflated by 20% to allow for loss to follow-up at 14 mo.
2Patients included in this cohort responded yes to the following question: “Are you taking medicine for high blood pressure (hypertension)?”
3These parameters were derived from earlier publications.
4Patients included in this cohort responded yes to the following question: “Are you taking medicine for diabetes (“sugar”)?”
5Patients included in this cohort responded yes to either of the following questions: “Are you taking medicine for asthma or chronic bronchitis or
emphysema?” or “Do you have cough or difficult breathing which has lasted for more than two weeks?”
CESD-10, 10-item Center for Epidemiologic Studies Depression Scale; ICC, intraclass correlation coefficient.
doi:10.1371/journal.pmed.1002178.t001
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was 25. Although all clinics were attended by doctors, in more than half this was on a part-
time basis rather than daily (Table A in S1 Appendix). National regulations require that pre-
scriptions be renewed and co-signed by a doctor at least every 6 mo, a process that is time-con-
suming, reducing opportunities for the doctor to review complex cases and mentor nurses.
The selection of medications and level of prescribing provisions (nurse versus doctor) are gov-
erned by the South African national essential medicines list and standard treatment guidelines
[41], which are revised by the National Department of Health every 5 y. Nurse prescribing pro-
visions differ by province and, prior to the trial, were limited in the Western Cape to first-line
medications such as thiazide diuretics for hypertension, metformin for diabetes, and low-dose
inhaled corticosteroids for asthma. Prescription of antidepressants, which is governed by regu-
latory conditions for high schedule medications, is restricted to doctors.
Guidelines and policies for communicable diseases change more frequently than those for
NCDs. Guidelines for both tend to be lengthy and text-heavy, at times containing confusing
differences in recommendations for the same condition. To address this issue, we developed
and implemented the Practical Approach to Lung Health and HIV/AIDS in South Africa
(PALSA PLUS), a management tool that integrates guidelines and configures them concisely
and simply in an algorithmic format that more closely aligns with presentations in primary
care (symptoms and follow-up for chronic conditions) and ensures harmonisation of disease-
specific guidelines. It also clarifies prescriber levels (nurse versus doctor) [13,17,42]. It was
implemented in two provinces in 2006 (Western Cape and Free State), and in all nine prov-
inces of South Africa between 2010 and 2011. Since 2007 it has included provision for nurse
initiation and re-prescription of ART. This inclusion was based on the results of a large prag-
matic randomised controlled trial performed in the Free State Province that showed that
nurses were as effective as doctors in providing ART care [9,11,12], and on a second trial in
the Western Cape and Gauteng Provinces that evaluated nurse re-prescription of ART [43].
This development was prompted by the urgent need to expand ART services in South Africa.
Use of the latest (2011/2012) version of PALSA PLUS was the standard of care in control clin-
ics during the PC101 Trial. Prior to the development of PC101, nurses were required to man-
age NCDs, but they received relatively little training and support, resources for NCD
management were not user-friendly, and initiation or intensification of NCD medications was
largely dependent on the availability of doctors. The introduction of PALSA PLUS was the
first attempt to change this pattern; providing more user-friendly management tools that
expanded nurses’ scope of practice and prescribing with increasing “diagonal” integration.
A second key component of the PALSA PLUS programme is training clinicians to use the
management tool. This component employs an educational outreach model [44] in which facil-
ity trainers, typically nurse middle managers, are trained and equipped to deliver repeated short
(1.5 h), onsite, interactive training sessions using carefully constructed case scenarios [42]. Cli-
nicians are trained to use the tool as a care pathway in case management and to use it during
each consultation. Follow-up “refresher” training accompanied distribution of the revised man-
agement tool each year. By 2011, around 70% of all nurses working in the trial districts had
received initial training in PALSA PLUS, and training continued as usual in the control clinics.
An unanticipated change in usual care in the health districts under study was a shift in
focus from communicable disease care to NCD care. Midway through the trial, the district
health department launched a 3-mo campaign called Chronic Disease Season in all clinics to
improve NCD recognition and care. Chronic Disease Season focused on hypertension and dia-
betes and involved both community and clinic health workers. The community-level interven-
tions included several “health screening days” in which free blood pressure and finger-prick
glucose measurements were offered at venues such as shopping centres and town halls. People
with high values were referred to local clinics. In addition, around 10% of community health
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workers (33 in total) were equipped to provide basic education on lifestyle measures including
diet and physical activity.
Intervention rationale. The PC101 intervention was a further development of the PALSA
PLUS programme, aimed to include all common symptoms and conditions, including NCDs,
among adults attending primary care services. This expanded scope was strongly motivated by
input from primary care nurses and managers, who reported that coverage for NCDs in
PALSA PLUS, particularly hypertension and diabetes, would greatly improve its usefulness.
The implementation of PC101 aimed to use the same educational outreach approach as used
for PALSA PLUS. This educational approach was shown in three pragmatic trials to be effec-
tive for the management of communicable diseases. Beneficial effects included reproducible
and substantial improvements in TB case detection [9,13,15]; increases in appropriate pre-
scribing, including inhaled corticosteroids for asthma [15], co-trimoxazole prophylaxis for
HIV [13], and appropriate switching to second-line ART [9]; and appropriate referral of severe
[15] and complex cases [9]. Changes in healthcare utilisation included fewer and shorter hos-
pital admissions and a higher number of primary care visits [9,13,15]. The impact on health
worker morale was also documented in parallel qualitative evaluations, with nurses reporting a
sense of empowerment and emphasising the value of combining simplified diagnostic and
treatment algorithms, onsite training, and expansions in prescribing provisions [12,42]. No
harmful effects of the intervention were noted.
Intervention materials. The main intervention material was a 101-page evidence- and pol-
icy-informed algorithmic management tool. Based on PALSA PLUS, it was developed over a
period of 5 y (2006–2011) with input from specialist clinicians, primary care doctors and nurses,
allied health professionals, managers, and representatives of patient advocacy groups. The selec-
tion of content was based on the results of a cross-sectional survey in 18,000 consultations in
primary care clinics across four provinces in South Africa of the most common reasons for
attendance. The first half of PC101 covers 40 of the most common symptoms in adults attending
primary care and prompts screening for the 20 chronic conditions included in the second half of
the tool [6]. The selection of chronic conditions took a health services approach, including those
that required regular planned follow-up in primary care. Included were communicable diseases
(HIV, TB, sexually transmitted infections), NCDs (diabetes, hypertension, asthma, COPD, epi-
lepsy), mental health conditions (depression, substance abuse, schizophrenia, dementia), and
women’s health (contraception, antenatal care). Content was extracted from existing disease and
policy guidelines and structured in a simple summative form: one page for “diagnosis” and one
to two pages for follow-up “routine care” (organised under the headings of “assess”, “advise”,
and “treat”) for each condition. Promotion of integrated care was a key objective. Extensive use
was made of algorithms and checklists to optimise presentation of content, and provide action-
able support that is readily applied during consultations. Content for diverse conditions was
organised in a standard format; symptom pages prompted screening for multiple chronic condi-
tions, and pages on the routine care of chronic conditions included screening for common
comorbidities. In addition, care was taken to ensure that recommendations that were applicable
to multiple pages of the tool, such as blood pressure thresholds for diagnosis, treatment, and life-
style advice, were harmonised and consistently reflected. The management tool was provided as
a ring-bound, high-quality, full-colour illustrated booklet to every clinician (nurse and doctor)
responsible for primary care in the 19 intervention clinics. The tool is updated annually to reflect
changes in evidence, policy, and feedback from clinicians and managers. For examples of
updated content, see http://knowledgetranslation.co.za/programmes/pack-adult/.
The case scenarios used for training built on a set that had been extensively used during
PALSA PLUS implementation. An illustration of a typical waiting room scene provided a cast
of characters, each of whom was fleshed out in a case scenario (Table B in S1 Appendix). The
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cases were carefully constructed to build familiarity with use of the management tool, grow
knowledge specifically related to NCDs and depression, and scaffold development of knowl-
edge and skills [45], moving from straightforward clinical presentations toward greater com-
plexity and multimorbidity. The cases formed the basis for the educational training sessions
(Table B in S1 Appendix). A desk-blotter with a calendar illustrating key messages for priority
conditions was provided to all staff in intervention clinics, to facilitate booking of follow-up
appointments and to remind clinicians of essential elements of care.
Training. Six health department nurse trainers with experience in primary care and with
responsibility for existing training initiatives within the study districts—including Integrated
Management of Childhood Illness, PALSA PLUS, and ad hoc training in the TB programme—
and with a support role for nurses were employed as facility trainers for the study. They were ini-
tially trained in PC101 during a 5-d live-in training course in May 2011. This course was led by
an experienced adult education practitioner with a background in nursing (G. F.) and the family
doctor who had led the expansion of the management tool (R. C.). The programme adopted a
strong experiential focus, and gave as much attention to equipping the nurse trainers to be edu-
cators as it did to the expanded content of the management tool. It included multiple practice
sessions during which the nurse trainers facilitated case-scenario-based training sessions with
their peers, followed by critical feedback. It included exercises to help each trainer understand
their own learning style [46] and to learn reflective practice. Facility trainers delivered eight
short (1.5 h), on-site, interactive educational outreach sessions using the PC101 management
tool and case scenarios to all clinical staff at intervention clinics over several weeks. In all, 155
face-to-face educational outreach sessions were held at the 19 intervention clinics, eight sessions
in each clinic. Owing to clinical demands and absences due to night duties or annual sick or
study leave, not all staff were able to attend every session. In total, 81 nurses (who each partici-
pated in a median of six sessions), five pharmacists, and four doctors were trained. The trainers
received no payment from the research team. In addition to on-site training, nurse trainers pro-
vided support to staff through regular visits during which they would discuss difficult cases,
review folders of patients whose care nurses had changed using PC101, or jointly see patients.
The nurse trainers themselves were supported through quarterly 1-d workshops, facilitated
by G. F. These workshops included opportunities to report back on training at the clinic, trou-
bleshoot difficulties in scheduling or completing educational outreach sessions, resolve queries
related to the clinical content of the management tool, and practise facilitation skills. They also
aimed to continue the community of practice that had been established during the initial live-
in training.
Expanded prescribing provisions. Professional nurses who successfully completed the
educational outreach were authorised by the district manager to prescribe an additional seven
medications for NCDs previously restricted to doctors: enalapril and amlodipine for hyperten-
sion, glibenclamide and gliclazide for diabetes, simvastatin for increased cardiovascular risk,
inhaled budesonide for asthma, and short courses of oral prednisone for exacerbations of
COPD (Table C in S1 Appendix). These expansions were clearly reflected in the management
tool, which colour-coded all medications to reflect whether they could be prescribed by a doc-
tor or a nurse or only by a doctor, and were also communicated to clinic managers by way of a
circular from the district managers. The expanded prescribing provisions initially resulted in
some tensions between nurses, doctors, and pharmacists. These were resolved through a facili-
tated group session and informal communication within clinics, sometimes involving the
nurse trainer. This intervention was the only modification to the training during the trial.
Intervention monitoring. The integrity of the intervention was assessed in several ways.
Nurse trainers were observed during the initial live-in course and at quarterly follow-up work-
shops. Two nurse trainers were interviewed, and, in December 2011, focus group discussions
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were held with nurses in four intervention clinics. Nurses representing both rural and small
town locations were enthusiastic about the management tool and recognised that it was a new
way of strengthening care for NCDs. In particular they appreciated the format and the stan-
dardised framework for providing routine care, and the familiar features shared with PALSA
PLUS. Consistent with our previous experience with PALSA PLUS, some variation in uptake
of the management tool by nurses was reported. There was a tendency for nurses who formerly
used PALSA PLUS to adopt PC101 and use it regularly, whereas nurses who had not used
PALSA PLUS were less likely to begin to use the new management tool routinely [11,12].
Uptake by the trainers was considered excellent, and trainers completed planned sessions in all
intervention clinics, some repeating sessions to ensure coverage of most staff.
Data Collection
Fieldworkers recruited from local communities were trained to collect the trial data. They
invited patients seated in the waiting rooms to be considered for the study and screened them
using a structured questionnaire. Patients who met the eligibility criteria (Table 1) and pro-
vided informed consent were enrolled in the trial and completed the baseline questionnaire in
Afrikaans, isiXhosa, or English, administered by the fieldworker using a handheld electronic
device. Anthropometry (weight, height, waist circumference) and blood pressure were
recorded [47]. Patients were asked to attend a follow-up interview 14 mo after their baseline
interview. The lengthy period between interviews was intended to allow adequate opportunity
for health workers to intervene in the care of trial patients, given that chronic disease patients
are seldom reviewed at clinics more often than every 3–6 mo.
The questionnaire included questions on medical history, smoking status, mental health,
health-related quality of life, and socio-economic status. The severity of respiratory symptoms
among patients in the respiratory cohort was assessed using the symptom and activity domains
of the St George’s Respiratory Questionnaire [48]. Patients who chose to complete the inter-
view in isiXhosa were excluded from this section of the interview as there is no tested isiXhosa
translation of this instrument. The presence of symptoms of depression was assessed with the
CESD-10, administered to all patients enrolled in the study [32].
Depression treatment was defined as having received counselling, having been referred to
psychiatric services, or being on an antidepressant at a therapeutic dose. Low-dose amitripty-
line and imipramine are widely prescribed in South Africa for pain management or insomnia.
We therefore defined antidepressant use at a therapeutic dose as prescription of amitriptyline
or imipramine 50 mg daily and/or any other antidepressant. Counselling was defined as
“talking with someone in a way that helps to find solutions to problems, or receive emotional
support, and not just receiving advice on how to take medication.”
Fieldworkers extracted and photocopied patients’ prescription charts from their folders,
clinic stores, and pharmacies for the year preceding the baseline interview. The medically qual-
ified trial manager (N. F.) analysed all prescription charts and recorded prescriptions of
chronic medication for each patient at the time of their interview. A data capturer entered the
prescription data (medication, dose, and frequency) into a database, and the total daily dose
for each medication was calculated. Prescription, interview, and laboratory data were imported
and stored in a SQL server database, and a single longitudinal record constructed for every
patient by the study database scientist (V. T.).
Reminder letters and cell phone text messages were sent to patients in the month preceding
their scheduled follow-up interview. Patients who failed to attend this appointment were
traced by phone or home visit. Patients received a gift voucher for a local grocery store with a
value of ZAR100 (US$12.25) on completion of the follow-up interview, to compensate for
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travel costs and time. The follow-up questionnaire was similar to the baseline questionnaire,
and fieldworkers repeated the anthropometry and blood pressure measurements. At follow-
up, prescription data for the period since baseline were extracted, photocopied, analysed, and
documented in the same way as at baseline.
Quality control measures included supervision of fieldworkers, electronic alert messages
for fieldworkers if unusually high or low values were entered into the electronic questionnaire,
monitoring of the data to identify unusual values or trends, and double entry of prescription
data. At follow-up, prescription data were queried if they were missing, if the date of the pre-
scription fell outside of a 1-mo window period based on the scheduled re-interview date, or if
cohort-specific medications were excluded.
Blinding of the intervention was not possible at the clinic level due to the nature of the
intervention.
Outcome Measures
The primary outcome for hypertension, diabetes, and chronic respiratory disease was treat-
ment intensification, reflected by an increase in dose or number of medications or change in
medication class. This outcome was chosen after considering research identifying clinician
inertia as a key reason for failure to control these conditions [49,50]; treatment intensification
is associated with improved control [51–53]; was likely appropriate for the study population,
where under-treatment was highly prevalent [1,7,8]; fitted well with the focus of the interven-
tion on the clinical practices of nurses and the expansion of their prescribing with training;
and could be applied across three of the four chronic conditions of interest. Definitions of
treatment intensification by cohort are summarised in Table 1. For the depression cohort, case
detection was selected as the primary outcome because depression is recognised to be under-
diagnosed and under-treated in primary care [54].
Secondary outcome measures were as follows: disaggregation of primary outcomes by type
of medication; cardiovascular disease risk and risk factors such as blood pressure, body mass
index (BMI), and smoking status; health-related quality of life measured using the EuroQol-
5D [55] and the World Health Organization Disability Assessment Schedule 2.0 (WHODAS
2.0) [56]; mortality; and healthcare utilisation. These last four outcomes were designed to
detect evidence of harm resulting from shifting clinical responsibility from doctors to nurses,
an often overlooked consideration in evaluations of task-shifting [57].
Sample Size and Statistical Power
The study was powered to detect clinically important differences in primary outcomes within
each cohort, accounting for the cluster randomisation design. With 38 clinics available for ran-
domisation, we calculated the number of patients needed per clinic for each cohort to detect
differences in primary outcomes of between 10% and 15%, with 90% power, 5% significance,
and intraclass correlations of outcome based on previous studies, and assuming 20% loss to
follow-up (Table 1). Baseline rates of treatment intensification were not available in South
Africa, and so we used rates from studies completed in high-income settings [50,58].
HbA1c was measured as part of the pre-planned blood sampling strategy in a subgroup of
clinics because resource limitations meant that we could not measure it in all diabetic patients
in all 38 clinics. We estimated that HbA1c tests were needed from 30 diabetic patients in 10
clinics in each group (i.e., 600 diabetic patients from 20 clinics in total) in order to a show a dif-
ference of 0.5% (HbA1c of 8.8% in the control group versus HbA1c of 8.3% in the intervention
group, assuming a standard deviation of 3.4%).
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Analysis
We compared baseline clinic and patient characteristics between treatment groups. All clinics
and patients were analysed in the treatment group to which they were randomly assigned. Pri-
mary and secondary outcomes were analysed at the patient level, separately within each cohort.
No adjustment was made for the multiple disease-specific primary outcomes. The cluster ran-
domisation design was accounted for using robust cluster variance-covariance estimates.
Intervention effects were estimated using binomial regression models with treatment as the
main effect, adjusted for stratification, and are reported with 95% confidence intervals. Sec-
ondary analyses were further adjusted for potentially confounding baseline characteristics
such as treatment status and disease control at baseline, smoking status, age, sex, and co-mor-
bidity with one of the study diseases.
We carried out pre-specified subgroup analyses of the primary outcomes stratified by base-
line level of disease control using binomial regression models including baseline disease con-
trol as a covariate. Baseline disease control of hypertension was defined as blood
pressure < 140/90 (or, in patients with diabetes or a history of cardiovascular disease, <130/
80), and for diabetes, as HbA1c < 7%. For depression, since the outcome was detection, “con-
trol” was defined as any patient receiving treatment for depression as follows: being on antide-
pressant medication at therapeutic dosage or having received counselling in the past year or
having been referred to psychiatric services in the last year. No definition of disease control
was applied to patients with chronic respiratory disease. Heterogeneity of the intervention
effect was assessed by looking at the interaction between treatment and baseline disease con-
trol. In addition, we pre-specified secondary analyses of the primary outcomes disaggregated
by component. For the primary outcomes, missing data were considered not to have occurred.
We used linear regression to compare changes between baseline and follow-up in blood
pressure, waist circumference, weight, BMI, HbA1c, and health status measures between the
treatment groups, adjusted for stratification. Similarly, we used ordinal logistic regression to
compare readiness to quit smoking, and Poisson regression to compare rates of healthcare uti-
lisation between the treatment groups. Stata version 13.0 statistical software was used for all
analyses.
Results
Fig 1 shows the trial profile. All 38 randomised clinics completed the trial. In all, 4,904 patients
were screened, of whom 4,393 patients met the eligibility criteria and were enrolled in the trial.
Recruitment targets were exceeded for all cohorts except for diabetes, where recruitment fell
short of targets. Enrolment of patients took place between 28 March 2011 and 10 November
2011 and was completed in intervention clinics before educational outreach sessions to nurses
began. Follow-up data collection began on 21 May 2012 and ended on 13 December 2012.
In all, 1,927 patients in the intervention group were interviewed at follow-up (1,927/2,166;
89%), and 2,050 in the control group (2,050/2,227; 92%). Reasons for not being re-interviewed
were similar between groups: death (63 in the intervention group versus 54 in the control
group); relocation (42 in the intervention group versus 26 in the control group); too ill to be
re-interviewed (two in the intervention group versus zero in the control group); and could not
be traced (132 in the intervention group versus 97 in the control group). Prescription charts
could be traced, and thus the primary outcome ascertained, for 206 patients who were not re-
interviewed in the intervention group, and 151 in the control group, accounting for the very
high rates of patients contributing data to the primary endpoint analysis (Fig 1).
Baseline patient characteristics are presented in Table 2 and detailed in a separate publica-
tion [47]. Baseline clinic characteristics are provided in Table A in S1 Appendix. Intervention
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Fig 1. Trial profile. NCD, non-communicable disease.
doi:10.1371/journal.pmed.1002178.g001
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Table 2. Characteristics of patients allocated to an educational outreach programme (intervention
group) or no new training (control group).
Characteristic Intervention Control
Patients recruited 2,166 (49) 2,227 (51)
Women 1,573 (73) 1,621 (73)
Age (years): median (IQR) 51 (42–61) 53 (44–62)
Language selected for the interview
• Afrikaans 1,794 (83) 1,885 (85)
• isiXhosa 145 (7) 192 (9)
• English 227 (11) 150 (7)
Highest education level achieved
• Tertiary education 40 (2) 35 (2)
• Secondary school education 923 (43) 930 (42)
• Primary school education 818 (38) 940 (42)
• No schooling 146 (7) 145 (7)
• Not obtained 239 (11) 177 (8)
Employed or self-employed 557 (26) 531 (24)
Receiving a social government grant 1,205 (56) 1,323 (59)
Housing density1: median (IQR) 2 (1–2), n = 1,426 2 (1–2), n = 1,505
Multimorbidity
• Hypertension only 304 (14) 326 (15)
• Diabetes only 72 (3) 76 (3)
• Chronic respiratory disease only 61 (3) 74 (3)
• Depression only 269 (12) 220 (10)
• Two conditions 911 (42) 949 (43)
• Three or four conditions 549 (25) 582 (26)
Past medical history
• Known cardiovascular disease (heart attack, angina,
stroke)
605 (28) 505 (23)
• Previous tuberculosis 237 (11) 255 (12)
• History of hypertension 1,590 (73) 1,718 (77)
• History of diabetes 854 (39) 998 (45)
• History of depression 525 (24) 558 (25)
Smoking history
• Current 652 (30) 731 (33)
• Past 464 (21) 550 (25)
• Never 1,022 (47) 921 (41)
• Not obtained 28 (1) 25 (1)
Pack-year history for current and ex-smokers: median (IQR) 7 (3–15), n = 869 7 (3–13), n = 1,064
Hospitalisation in 3-mo period preceding interview 134 (6) 136 (6)
BP 140/90 mm Hg2 1,055 (49) 1,216 (55)
BP 180/110 mm Hg2 166 (8) 193 (8)
Weight (kg): mean (SD) 77 (20), n = 2,111 77 (19), n = 2,179
BMI (kg/m2): mean (SD) 30 (8), n = 2,060 30 (8), n = 2,104
Obese (BMI 30 kg/m2) 972 (45) 1,008 (45)
Waist circumference (cm): mean (SD) 98 (16), n = 2,140 98 (16), n = 2,205
Waist circumference more than ideal2 1,316 (61) 1,381 (62)
10-y non-laboratory-based cardiovascular disease death risk
(percent)3: mean (SD)
22 (20), n = 1,335 26 (21), n = 1,327
(Continued )
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and control clinics had similar numbers of nurses and doctors. Control clinics tended to be
larger and, by chance, had more psychiatric services and on-site pharmacy facilities.
Baseline patient characteristics were generally well balanced between arms. Seventy-three
percent of patients were women, and the median age was 52 y. There were high levels of unem-
ployment and receipt of social welfare grants. Multimorbidity was common: 42% of patients
had two conditions, and 26% more than two. The percentage of patients with a single condi-
tion of interest was as follows: hypertension, 20% (630 of 3,227); depression, 20% (489 of
2,466); diabetes, 8% (148 of 1,842); and chronic respiratory disease, 12% (135 of 1,157). A
quarter of patients reported established cardiovascular disease. Eleven percent reported previ-
ous TB, and 2% reported being on ART. There were signs of under-treatment and under-diag-
nosis, with 18% of hypertensive patients reporting no or only one current antihypertensive
medication, only 51% of diabetic patients receiving statins, only 50% of those with chronic
respiratory disease or symptoms receiving any respiratory medication, and only 25% of those
who screened positive for depression reporting some form of relevant treatment for the
condition.
There was poor control of hypertension and diabetes despite treatment: blood pressure was
140/90 mm Hg in 59% of hypertensive patients, and HbA1c was7% in 77% of those with
diabetes in whom HbA1c was measured at baseline (704/1,842; 38%).
Treatment intensification in the hypertension and diabetes cohorts across both the inter-
vention and control groups was common during the study period (Table 3), slightly favouring
the intervention group (44% versus 40% for hypertension and 57% versus 50% for diabetes),
although these differences were not significant when adjusted for stratification by sub-district
and clustering. For hypertension, the risk ratio (RR) was 1.08 (95% CI 0.94 to 1.24; p = 0.252);
for diabetes, the RR was 1.10 (95% CI 0.97 to 1.24; p = 0.126). Rates of treatment intensification
in the chronic respiratory disease cohort were low (14% in the intervention group versus 12%
in the control group) and not significantly different between groups (RR 1.08; 95% CI 0.75 to
1.55; p = 0.674). Fewer patients who screened positive for depression in the intervention group
reported receiving treatment for depression at follow-up than their control group counterparts
(18% versus 24%), but there was no difference between groups after adjustment for the trial’s
design (RR 0.76; 95% CI 0.53 to 1.10; p = 0.142). Adjustment for baseline characteristics
(Table 2) did not materially alter these results. The full regression models are presented in
Table D in S1 Appendix.
Pre-specified subgroup analyses by baseline level of disease control (Table 4) showed that,
in the diabetic cohort, the intervention was associated with treatment intensification only
among patients with baseline HbA1c of 7%–10% (RR 1.30; 95% CI 1.16 to 1.47; p-value for
interaction = 0.010). In the other cohorts, there were no significant differences in effectiveness
Table 2. (Continued)
Characteristic Intervention Control
HbA1c (percent): mean (range), median (IQR) 9 (4–17), 8 (7–10), n
= 310
9 (5–17), 9 (7–11), n
= 394
HbA1c 7% 227 (73), n = 310 317 (81), n = 394
Values are n (percent) unless stated otherwise.
1Housing density: number of occupants/number of rooms.
2Waist circumference >88 cm for women, >104 cm for men.
3Ten-year risk of cardiovascular disease death (sudden cardiac or stroke death). Score calculated for
patients with no known cardiovascular disease.
BMI, body mass index; BP, blood pressure; IQR, interquartile range; SD, standard deviation.
doi:10.1371/journal.pmed.1002178.t002
Evaluation of an Integrated Clinical Management Tool for Non-communicable Diseases
in Primary Care: A Cluster Randomised Trial
PLOS Medicine | DOI:10.1371/journal.pmed.1002178 November 22, 2016 15 / 27
between subgroups. However, treatment intensification tended to be more common, in both
arms, in subgroups with poorer control at baseline. The non-significant difference in depres-
sion treatment, which favoured the control group, was mostly among those already receiving
treatment for depression at baseline.
Disaggregated primary outcomes are presented in Table E in S1 Appendix. Notable findings
include apparently significantly higher rates of aspirin initiation among patients with hyper-
tension and diabetes attending intervention clinics, even though aspirin prescribing was
restricted to doctors. Angiotensin-converting enzyme (ACE) inhibitor use was significantly
higher among intervention group patients with known cardiovascular disease, as was sulpho-
nylurea use among intervention group diabetic patients with BMI 30 kg/m2. In the depres-
sion cohort, the higher rate of depression treatment in the control arm was because more
control group patients reported receiving counselling (15% in the intervention arm versus
22% in the control arm) and referral to psychiatric services (5% in the interventional arm ver-
sus 9% in the control arm). There was no significant difference between groups in the use of
antidepressants, which was very low (<5%).
Table 5 reports differences in cardiovascular risk factors between baseline and follow-up.
There were no differences between groups in terms of blood pressure, waist circumference,
BMI, or HbA1c. Smoking quit rates were high overall, but similar between groups. However,
readiness to quit smoking was significantly higher in the intervention group (odds ratio 1.73;
95% CI 1.17 to 2.57).
There were no differences between groups in health outcomes measured with the EuroQol-
5D [55], CESD-10 [32], or World Health Organization Disability Assessment Schedule 2.0
[56] (Table 6). Mortality did not differ between groups (Table 6). Healthcare utilisation, as
measured by clinic visits and hospital admissions during the 3 mo before the follow-up visit,
was similar between groups, but there was a statistically non-significant higher number of hos-
pital admissions in the intervention group (Table 7).
Table 3. Primary outcomes for each disease cohort.




Effect Estimate: Risk Ratio ICC











685/1,555 (44) 673/1,672 (40) 1.08 (0.94 to
1.24)





481/851 (57) 498/991 (50) 1.10 (0.97 to
1.24)







81/586 (14) 68/571 (12) 1.08 (0.75 to
1.55)
0.674 1.223 (0.88 to
1.68)
0.228 0.011
Depression Case detection 224/1,253 (18) 283/1,186 (24) 0.76 (0.53 to
1.10)
0.142 0.804 (0.57 to
1.10)
0.167 0.077
1Adjusted for age, sex, body mass index, smoking status, diabetes, chronic respiratory disease, blood pressure control, maximal medical therapy at
baseline, history of cardiovascular disease.
2Adjusted for sex, body mass index, smoking status, hypertension, history of cardiovascular disease at baseline.
3Adjusted for age, smoking status, diabetes, history of tuberculosis, whether or not receiving respiratory medication at baseline.
4Adjusted for sex, smoking status, hypertension, history of depression, 10-item Center for Epidemiologic Studies Depression Scale score at baseline,
whether or not receiving antidepressant medication at baseline.
ICC, intraclass correlation coefficient.
doi:10.1371/journal.pmed.1002178.t003
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Discussion
This paper reports our evaluation of the clinical effectiveness of a complex health systems
intervention, based on task-shifting by adding nurse-led NCD and depression care to a proven
effective, and scalable, integrated care model for nurse-led care of communicable diseases, in
the context of limited availability of physicians to treat a high burden of multimorbid and
poorly controlled NCDs in a middle-income country.
The primary analyses found no statistically significant effects of the intervention on the pri-
mary outcomes for any of the four disease cohorts. These cohorts were analysed separately,
equivalent to four parallel trials; adjustment for having four primary outcomes instead of one
would only have decreased statistical differences. Health status outcomes also did not differ
between the intervention and control groups. But neither was there evidence of harm for any
of these endpoints, or in terms of reduced well-being or excess hospitalisations or deaths. In
Table 4. Subgroup analyses: primary outcomes stratified by level of disease control at baseline.












BP uncontrolled2 546/1,127 (49) 545/1,268 (43) 1.12 (0.97 to
1.28)
0.113




HbA1c < 7% 34/83 (41) 29/77 (38) 1.08 (0.77 to
1.52)
0.638
HbA1c 7%–10% 97/140 (69) 93/170 (55) 1.30 (1.16 to
1.47)
<0.001
HbA1c > 10% 62/87 (71) 107/147 (73) 0.97 (0.81 to
1.16)
0.703
Chronic respiratory disease: symptom score
subgroup
0.532
SGRQ symptom scoremedian 20/189 (11) 19/228 (8) 1.17 (0.66 to
2.07)
0.581
SGRQ symptom core > median 37/221 (17) 35/195 (18) 0.95 (0.65 to
1.39)
0.802
Chronic respiratory disease: activity score
subgroup
0.693
SGRQ activity scoremedian 36/256 (14) 34/273 (13) 1.07 (0.7 to 1.65) 0.744




Receiving any treatment for depression3 76/278 (27) 127/336 (38) 0.74 (0.54 to
1.02)
0.063
Not receiving any treatment for depression3 148/990 (15) 156/860 (18) 0.84 (0.49 to
1.42)
0.510
1p-Values for arm-subgroup interaction.
2BP uncontrolled defined as130/80 mm Hg for patients with diabetes or a history of cardiovascular disease, and140/90 mm Hg for all other patients.
3Receiving treatment for depression defined as being on antidepressant medication at therapeutic dosage or having received counselling in the past year or
having been referred to psychiatric services in the last year.
BMI, body mass index; BP, blood pressure; SGRQ, St George’s Respiratory Questionnaire.
doi:10.1371/journal.pmed.1002178.t004
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addition, the intervention was not associated with higher healthcare utilisation at the primary
care or hospital level. A pre-planned subgroup analysis by baseline level of diabetes control
showed a benefit of the intervention in the subgroup of patients with moderately uncontrolled
diabetes (HbA1c 7%–10% at baseline), but the two other pre-specified subgroup analyses (for
hypertension and depression by baseline level of disease control) did not show a significant dif-
ference between groups.
While no primary outcomes showed a significant benefit of the intervention, the upper con-
fidence limits included the possibility of meaningful clinical improvements, and the direction
of results in three of the four primary endpoints in the study was consistent and positive. Also,
Table 5. Effect on cardiovascular disease risk and risk factors; all four cohorts pooled.
Risk/Risk Factor Measurement at Follow-Up Change between Baseline and Follow-Up
















































N/A N/A Risk ratio 1.024 (0.96 to
1.09)
0.464 0.024







































HbA1c (percent) 9.1 (2.6), n = 285 9.5 (2.6),
n = 333












167/574 (29%) 194/668 (29%) N/A N/A Risk ratio 1.01 (0.71 to
1.42)
0.971 0.049
Number of units smoked
per day











Readiness to quit smoking Odds ratio 1.73 (1.17 to
2.57)
0.006 0.104
• Thinking of quitting in
next 30 d
73/480 (15%) 66/577 (11%) N/A N/A
• Thinking of quitting in
next 6 mo
318/480 (66%) 337/577 (58%) N/A N/A
• Not thinking of quitting 89/480 (19%) 174/577 (30%) N/A N/A
1Mean (standard deviation) or n/N (percent).
2Ten-year risk of cardiovascular disease death (sudden cardiac or stroke death). Score calculated for patients with no known cardiovascular disease.
3Uncontrolled BP defined as130/80 mm Hg for patients with diabetes or a history of cardiovascular disease, and140/90 mm Hg for all other patients.
4Adjusted for uncontrolled BP at baseline, age, and sex.
5Adjusted for insulin at baseline, uncontrolled BP at baseline, BMI, sex, hypertension, and history of cardiovascular disease.
BMI, body mass index; BP, blood pressure; CVD, cardiovascular disease; Diff, difference; DBP, diastolic blood pressure; ICC, intraclass correlation
coefficient; N/A, not applicable; SBP, systolic blood pressure.
doi:10.1371/journal.pmed.1002178.t005
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the pre-specified secondary analysis of patients with diabetes and uncontrolled HbA1c mea-
surements at baseline demonstrated a positive effect. After disaggregation of the disease
groups, other significant findings were higher rates of aspirin initiation among patients with
hypertension and diabetes, higher use of ACE inhibitors in patients with known cardiovascular
disease, and more prescriptions of sulphonylureas in patients with diabetes and a high BMI
(Table E in S1 Appendix).
The non-significant findings for the primary outcomes contrast with positive findings in
our three previous pragmatic randomised controlled trials using a similar integrated manage-
ment tool and the same training approach, focused on a narrower range of mainly communi-
cable conditions [9–15,30,42,59]. These trials showed modest, but consistent, improvements
across a range of process indicators and health and healthcare utilisation outcomes.
There are several potential reasons for the non-significant findings on the primary out-
comes of our study. One is the level of uptake of PC101 into daily clinical practice. Owing to
limited research funding, a complete and suitably detailed process evaluation of the uptake of
PC101 into clinical practice was not possible. However, limited focus group discussions and
Table 6. Effect on quality of life, depression, and mortality.
Outcome Measurement at Follow-Up Change between Baseline and Follow-Up

























































Mortality 64/2,166 (3%) 64/2,227 (3%) N/A N/A Risk ratio 1.11 (0.79 to
1.56)
0.564 0.003
1Mean (standard deviation) or n/N (percent).
2The EuroQol-5D index score is a weighted total between 0 and 1, where 0 = death and 1 = perfect health.
3The EuroQol-5D visual analogue scale is a score between 0 and 100 where 0 = worst imaginable state of health and 100 = best imaginable state of health.
4The 10-item Center for Epidemiologic Studies Depression Scale is scored from 0 to 30, with higher scores representing greater degrees of depressed
mood.
5The World Health Organization Disability Assessment Schedule 2.0 is scored from 12 to 60, with higher scores representing greater degrees of disability.
Diff, difference; ICC, intraclass correlation coefficient; N/A, not applicable.
doi:10.1371/journal.pmed.1002178.t006









Number of hospital admissions in 3 mo before follow-up
interview
0.1 (0.4), n = 1,927 0.1 (0.3), n = 2,050 IRR 1.25 (0.91 to 1.71) 0.162 0.004
Number of inpatient days in 3 mo before follow-up interview 0.4 (2.8), n = 1,927 0.3 (2.4), n = 2,050 IRR 1.43 (0.83 to 2.48) 0.201 0.003
Number of clinic visits in 3 mo before follow-up interview 2.5 (1.7), n = 1,456 2.5 (1.4), n = 1,665 IRR 1.02 (0.93 to 1.13) 0.678 0.070
ICC, intraclass correlation coefficient; IRR, incidence rate ratio.
doi:10.1371/journal.pmed.1002178.t007
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observations in clinics by members of the research team confirmed heterogeneous uptake of
PC101 within and between clinics, as might be expected in a pragmatic trial intervention.
Overall low levels of uptake would seem unlikely, given the enthusiastic response and high
uptake of the method by clinic staff reported in our previous implementation studies with the
PALSA PLUS management tool [12,42]. Other factors should be considered, such as training.
The addition of NCD care to the training programme may have proved a step too far—the
content of the PC101 management tool was twice as substantial as that of the PALSA PLUS
tool—and potentially overwhelming for nurses who were still learning to implement nurse-ini-
tiated and -managed antiretroviral treatment when the trial started. Furthermore, NCDs have
long been managed by nurses in primary care clinics throughout South Africa, albeit with min-
imal training or intervention. As seen in the baseline characteristics, poor NCD care may have
become entrenched, and markers of poor disease control routinely ignored [60]. The challenge
of “undoing” these clinical habits and effecting a change in clinical behaviour is well described
and may take repeated training sessions to achieve. Although training was provided through-
out the trial, the comprehensive nature of PC101 made it difficult to cover the curriculum for
NCDs sufficiently within the time frame of the study. Owing to limited research funding, but
consistent with a pragmatic trial design, formal assessments of adequacy of training and uptake
(use) of PC101 were not performed.
A further potential reason for the failure to show differences between groups was the effect
of a co-intervention, the concurrent Chronic Disease Season campaign, instituted by the clinic
managers in both control and intervention clinics. The impact of this unforeseen development
is seen in the higher rates of treatment intensification for hypertension and diabetes (the focus
of the campaign) than for chronic respiratory disease or depressive symptoms in both the
intervention and control clinics. Whereas only 13% of patients with chronic respiratory disease
and 3% of those with depression had medication intensified at follow-up, nearly half of those
with hypertension and diabetes had intensified treatment (42% and 53%, respectively). These
rates of intensification of antihypertensive and diabetic medications are similar to or slightly
higher than those reported in high-income country settings [50,58].
Another consideration concerns methodology. We recruited all patients with the diseases
of interest rather than only those requiring treatment intensification, and failed to assess
adherence and exclude patients who did not adhere to previously prescribed medications and
who might therefore have been less likely to have been prescribed additional treatment. How-
ever, the eligibility criteria were adopted on the assumption that decision-makers wanted evi-
dence of effectiveness of the intervention across broad groups of patients, rather than for
subgroups, and that, as lack of disease control was highly prevalent at baseline, the majority of
patients would qualify for treatment intensification.
Other limitations of the study design include dependence on self-reported diagnoses for
inclusion in the patient cohorts, reliance on process outcomes, and insufficient resources to
measure important health outcomes, such as HbA1c, at follow-up. Also, the duration and tim-
ing of the follow-up data collection might not have been optimal for a study of chronic dis-
eases, where follow-up visits being only every 3–6 mo limited opportunities for treatment
intensification. This is illustrated by the low number of clinic visits during the follow-up
period, a mean of around 2.5 per patient over a period of 14 mo (Table 7).
The main strength of the study was that it was a pragmatic trial, implemented under routine
circumstances in a real-world setting with the intervention delivered by usual health depart-
ment trainers, with minimal research-related distortions of care delivery. Observing this real-
world implementation appears to have given relevant policy-makers sufficient confidence to
make a decision on the suitability of the intervention for their health systems. Other strengths
of the study include the cluster randomised design (appropriate to reduce the risk of
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contamination in an intervention directed at groups of nurses working in clinics), high follow-
up rates for both patient interviews and prescription data, the inclusion of four different
chronic diseases in a context characterised by high rates of multimorbidity, and identification
and follow-up of patient participants by fieldworkers independent of clinical care.
So what are the implications of the trial for decision-makers in South Africa and other
LMICs who are faced with overstretched health services and the need to address NCDs and
mental health? In October 2013, even before the trial results were finalised, decision-makers
were increasingly enthusiastic about the PC101 intervention, and both the Western Cape
Department of Health and the National Department of Health in South Africa elected to com-
mence implementation. Later dissemination of the trial findings on the effectiveness of this
intervention to these local and national policy-makers did not change this decision. The deci-
sion, we were told, was much more influenced by demand from frontline clinicians and man-
agers for what was perceived to be a highly feasible and acceptable approach to expanding
skills for NCDs. Further factors that may have influenced decision-makers were the benefits of
the new mode of clinician training reported in our prior studies [9,13,15], an independent
report supporting the integrated Chronic Care Model as a feasible component of health system
reform in South Africa [61], and the findings of a non-randomised evaluation of PC101 per-
formed in 42 primary care clinics in three additional health districts [62]. The PC101 manage-
ment tool is correctly seen as a means of overcoming the “silo” approach to individual disease
management in which recommendations for different conditions may vary and even conflict
and, more importantly, ensures that NCDs and mental health are not overlooked because of
prioritisation of communicable diseases. For us, as researchers who look to rigorous research
methods to guide health system development, this has been a powerful lesson in understanding
that evidence of effectiveness is only one element under consideration by decision-makers
[63]. Given clinicians’ strong attraction to the ease of integrating PC101 into clinic practice
and the positive system effects of our intervention mentioned above, it might have been more
useful to focus our primary analysis on lack of harm. For example, the study was not powered
to test for differences in healthcare utilisation and reasons for referrals and hospitalisations.
Thus, it is not possible to evaluate the significance of the small imbalance in numbers of hospi-
tal admissions between the intervention group and the control group, since an increase in hos-
pitalisations reflecting more appropriate referrals from primary care may be interpreted as
favourable rather than as a treatment failure. Specifically designed trials are required.
We now consider that it is our responsibility as health system researchers to invest in
improving the effectiveness of this intervention. There are patterns in the data from the trial
that provide reassurance that the intervention is not harmful and that, with further optimisa-
tion, might demonstrate improvements in effectiveness. Several adjustments have been made
to the programme that is being scaled up with the aim of increasing its impact on skills, clini-
cian confidence, and quality of care. The PC101 content has been broken down into four train-
ing modules (communicable diseases, NCDs, mental health, and women’s health) to allow
staff to become familiar with one area at a time and embed changes into their clinical practice
before moving to the next. We now also explicitly aim PC101 training at doctors, through ded-
icated workshops for professionals who would otherwise miss regular onsite training due to
the sessional nature of their work. Implementation workshops, with an extra day aimed at
meeting the needs of facility and middle managers, are included in the training of nurse train-
ers, and appointment of clinical governance teams within sub-districts allows local trouble-
shooting of barriers to implementation and inclusion of non-clinicians in the day-to-day
running of the programme. A further cluster randomised trial in the North West province of
South Africa (ClinicalTrials.gov NCT02407691) is currently evaluating the effect of the mental
health module when combined with the provision of manualised depression counselling by lay
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health workers delivered to ART patients with co-morbid depression. A second study is evalu-
ating this mental health module in patients with hypertension and co-morbid depression [64].
This expansion of human resources to include lay health workers is based on our experience
from the PC101 trial that nurse training alone is insufficient to close the gap in depression care
when there is limited access to treatment in the form of counselling services or antidepressant
prescriptions (prescribing currently restricted to doctors).
Although it will not be possible to conduct another randomised controlled trial of the
adapted PC101 implementation as it is scaled up, we plan to conduct such trials for future
national and international adaptations of this programme [17]. Ease of implementability
appears to be a major feature for policy-makers, and we will include proxies, such as accept-
ability to frontline clinicians, as outcome measures in future trials.
In conclusion, this pragmatic cluster randomised trial of the effects of an integrated man-
agement tool implemented using educational outreach to nurses showed no effect on treat-
ment intensification in patients with NCDs or on case detection of depression. But neither was
there evidence of harm. Despite this lack of positive clinical outcomes, decision-makers were
disposed to view PC101 as a coherent, feasible, and acceptable extension of a programme of
integrated care previously shown to be effective in the South African health system, and health
authorities have committed to a national rollout of an improved version of the PC101 pro-
gramme. The disjuncture between the clinical outcomes of our study and the policy choice
exposes the different responsibilities of researchers and decision-makers in a health system.
For us, as intervention developers, this focuses our attention on longer term improvements to
strengthen components of the programme in order to achieve clinical impact on care for
NCDs, while, as evaluators, we see the need for ongoing audit and further randomised prag-
matic controlled trials to evaluate the effectiveness of these improvements.
Health systems research and development is an interactive and deliberative process. Per-
haps the greatest contribution of this study lies in the relationships developed between our
team and health system decision-makers, during a series of five large randomised evaluations
of health systems interventions that responded to decision-maker-defined health systems
needs over 16 years [17]. To this process we have each brought our different skills and perspec-
tives, and together have developed, and are scaling up, an iteratively improved, evidence-
informed approach to nurse-led primary care that strengthens human resources and health
systems, and brings better care to South Africans, as well as models that can be applied in
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S1 Appendix for Paper 4 
 
Table A Characteristics of clinics allocated to an educational outreach programme (Primary Care 
101) or no new training (control group). Values are numbers (percentages) unless stated otherwise. 
Clinics Intervention Control 
Number of clinics 19 19 
Headcount1: median (IQR) 19304 (16341-28064) 30882 (20091-41053) 
Setting:   
    Urban (%) 11 (58) 11 (58) 
    Peri-urban (%) 4 (21) 3 (16) 
    Rural (%) 4 (21) 5 (26) 
Number of nurses per clinic: median (IQR) 4 (3-5) 6 (3-7) 
Patient to nurse ratio (headcount/number of nurses): median 
(IQR) 
1:5552 (4329-9329) 1:5835 (4412-8009) 
Psychiatric qualified nurse available:   
    Weekly (%) 6 (32) 7 (37) 
    Monthly (%) 10 (53) 12 (63) 
    None (%) 3 (16) 0 (0) 
Doctor support:   
    Daily (%) 8 (42) 7 (37) 
    Sessional (%)  11 (58) 12 (63) 
Pharmacy on-site (%) 6 (32) 10 (53) 


















Table B: Primary Care 101 Training Cases 
Scenario Patient name Symptoms/ chronic 
diseases covered 
Core learning 
1 Godfrey Weight loss – 
diabetes screen 
 Expansion of familiar page 
 Link with chronic condition screen 
2 Patricia Headache – stress  Expansion of familiar page 
 Approach to stress 
3 Auntie Gertie Asthma: routine care  Introduce routine care approach of ‘Assess, 
Advise, Treat’ 
4 Godfrey Tuberculosis (TB): 
routine care 
 Approach to routine care for complicated 
chronic condition 
 Becoming familiar with new pages for TB 
5 Stanley Body pain – HIV  Becoming familiar with new symptom page 
 Approach to routine care for complicated 
chronic condition 
 Becoming familiar with new pages for HIV 
6 Thobeka Back pain – 
cardiovascular 
disease (CVD) risk 
 Using common symptom as trigger to 
screen for important chronic condition 
 Approach to assessing and managing CVD 
risk 
7 Xolani Face problems – 
stroke 
 Diagnosing stroke 
 Approach to routine stroke care 
8 Sipho Chest pain – 
ischaemic heart 
disease (IHD) 
 Managing the client needing urgent 
attention 
 Approach to routine IHD care 
9 Jane Fatigue – depression  Identifying the client with depression 
 Diagnosing depression 
 Approach to routine depression care 
10 Adelaide Abdominal pain – 
substance abuse 
 Identifying the client with substance abuse 
 Diagnosing substance abuse 
 Approach to routine substance abuse care 
11 Faizel Fits - epilepsy  Managing the client needing urgent 
attention 
 Approach to routine epilepsy care 
12 Melissa HIV - pregnancy  Look for other chronic condition in client 
with known chronic condition 
 Play with alternate scenarios for routine 
HIV care 
13 Caroline Diabetes - 
hypertension 
 Using routine care approach with new 
chronic condition 
 Approach to routine diabetes care 
 Diagnosing hypertension in diabetes 
14 Boeta Joint symptom – 
gout, CVD risk, 
substance abuse 
 Identifying the client with gout 
 Diagnosing gout 
 Approach to routine gout care 
 Identifying other chronic conditions in the 
client with 1 chronic condition and 
approach to routine care of client with 




Table C: Expanded treatment patterns 
Indication Available for Practice Nurse 
(PN) prescription prior to 
Primary Care 101 (PC101) 
training 
Available for PN prescription post PC101 
training 
Hypertension Hydrochlorothiazide (HCTZ) HCTZ and 
Enalapril (maximum dose 10mg daily) or 
Amlodipine (maximum dose 5mg daily) 
Diabetes Metformin Metformin and 
Glibenclamide (2.5mg daily to maximum 5mg 
twice daily (bd)) or 
Gliclazide (40mg daily to maximum 80mg bd 
and 
Simvastatin (maximum dose 10mg daily) and 






Aspirin Simvastatin (maximum dose 10mg daily) 
 
Asthma Salbutamol inhaler 
Budesonide for Clinical 
Nurse Practitioners (CNPs) 
Salbutamol inhaler and 
Budesonide (maximum dose 200mcg bd) and 
Prednisone 40mg daily for 7 days (maximum 
2 courses per year) for acute exacerbations 
COPD Salbutamol inhaler Salbutamol inhaler and 
Prednisone 40mg daily for 7 days (maximum 
















Table D: Analysis of primary outcomes: risk ratios of the associations of arm and patient level 
characteristics 
Table D Hypertension (N=3227) 
Factor n/N (%) Risk ratio (95% CI) P value 
Arm of trial    
    Control 673/1672 (40) 1 [reference]  
    Intervention 685/1555 (44) 1.10 (0.96 to 1.27) 0.165 
Stratum    
1: Bitou and Knysna  359/903 (40) 1 [reference]  
2: Hessequa and Kannaland 190/452 (42) 1.02 (0.77 to 1.35) 0.888 
3: Eden DMA and 
Oudtshoorn 
223/615 (36) 0.90 (0.67 to 1.21) 0.485 
4: George 222/440 (51) 1.19 (0.93 to 1.51) 0.165 
5: Mossel Bay 206/395 (52) 1.27 (1.05 to 1.53) 0.012 
6: Overberg 158/422 (37) 0.90 (0.72 to 1.13) 0.371 
Patient characteristics    
Age at enrolment1  1.00 (1.00 to 1.01) 0.012 
    ≤ 40 years 135/379 (36)   
    41-50 years 320/780 (41)   
    51-60 years 458/1041 (44)   
     61 years 445/1027 (43)   
Sex     
    Female 1030/2425 (43) 1 [reference]  
    Male  328/802 (41) 0.97 (0.87 to 1.08) 0.595 
BMI2    
    <=30 kg/m2 556/1438 (39) 1 [reference]  
    >30 kg/m2 735/1628 (45) 1.15 (1.05 to 1.25 0.001 
Smoking status    
    Never 660/1519 (44) 1 [reference]  
    Ex 313/790 (40) 0.95 (0.82 to 1.11) 0.512 
    Current 374/885 (42) 1.07 (0.97 to 1.17) 0.160 
Diabetes    
    Not in diabetic cohort 631/1687 (37) 1 [reference]  
    In diabetic cohort 727/1540 (47) 1.16 (1.06 to 1.27) 0.001 
Chronic respiratory disease 
(CRD) 
   
    Not in CRD cohort 1061/2491 (43) 1 [reference]  
    In CRD cohort 297/736 (40) 0.97 (0.88 to 1.07) 0.525 
BP control2    
    Controlled  267/825 (32) 1 [reference]  
    Not controlled 1091/2395 (46) 1.40 (1.20 to 1.63) 0.000 
MMT at baseline3    
    Not on MMT3 1167/2721 (43) 1 [reference]  
    On MMT3 191/482 (40) 0.87 (0.76 to 0.99) 0.031 
History of CVD2    
    No history of CVD2 1008/2378 (42) 1 [reference]  
    History of CVD2 350/849 (41) 0.96 (0.87 to 1.06) 0.448 
1Age at enrolment: presented as a categorical variable for descriptive purposes only 
2BMI=body mass index; BP=blood pressure; CVD=cardiovascular disease 







Table D Diabetes n=1842 
Factor n/N (%) Risk ratio (95% CI) P value 
Arm of trial: conditional on 
BMI1 
   
BMI ≤ 301    
    Control  202/404 (50) 1 [reference]  
    Intervention 158/327 (48) 0.97 (0.81 to 1.15) 0.717 
BMI >301    
    Control 273/532 (51) 1 [reference]  
    Intervention 297/479 (62) 1.20 (1.05 to 1.37) 0.009 
Stratum    
1: Bitou and Knysna  260/504 (52) 1 [reference]  
2: Hessequa and Kannaland 139/272 (51) 0.99 (0.78 to 1.26) 0.960 
3: Eden DMA and Oudtshoorn 137/327 (42) 0.84 (0.59 to 1.18) 0.308 
4: George 186/295 (63) 1.21 (0.96 to 1.53) 0.115 
5: Mossel Bay 127/199 (64) 1.36 (1.09 to 1.71) 0.006 
6: Overberg 130/245 (53) 1.07 (0.86 to 1.32) 0.549 
Patient characteristics    
Sex     
    Female 755/1382 (55) 1 [reference]  
    Male  224/460 (49) 0.93 (0.82 to 1.04) 0.200 
Smoking status    
    Never 526/939 (56) 1 [reference]  
    Ex 240/473 (51) 0.94 (0.84 to 1.04) 0.226 
    Current 208/415 (50) 0.95 (0.83 to 1.09) 0.490 
History of CVD1    
    No history of CVD1 777/1419 (55) 1 [reference]  
    History of CVD1 202/423 (48) 0.88 (0.80 to 0.98) 0.019 
Hypertension (HPT)    
    Not in HPT cohort 149/302 (49) 1 [reference]  
    In HPT cohort 830/1540 (54) 1.08 (0.95 to 1.23) 0.219 













Table D Chronic Respiratory Disease (CRD) N=1157 
Factor n/N (%) Risk ratio (95% CI) P value 
Arm of trial    
    Control 68/571 (12) 1 [reference]  
    Intervention 81/586 (14) 1.22 (0.88 to 1.68) 0.228 
Stratum    
1: Bitou and Knysna  31/303 (10) 1 [reference]  
2: Hessequa and Kannaland 22/166 (13) 0.97 (0.50 to 1.89) 0.930 
3: Eden DMA and Oudtshoorn 22/233 (9) 0.81 (0.45 to 1.46) 0.488 
4: George 33/155 (21) 1.21 (0.79 to 1.87) 0.379 
5: Mossel Bay 23/142 (16) 1.20 (0.70 to 2.05) 0.499 
6: Overberg 18/158 (11) 0.84 (0.50 to 1.42) 0.517 
Patient characteristics    
Age     
    <=40 16/213 (8) 1 [reference]  
    41-60 96/692 (14) 1.11 (0.75 to 1.64) 0.618 
    61-80 36/242 (15) 1.11 (0.72 to 1.71) 0.652 
    81+ 1/10 (10) 0.80 (0.10 to 6.34) 0.833 
Smoking status    
    Never 39/394 (10) 1 [reference]  
    Ex 54/290 (19) 1.49 (0.98 to 2.28) 0.062 
    Current 55/454 (12) 1.12 (0.74 to 1.69) 0.601 
Diabetes    
    Not in diabetic cohort 110/837 (13) 1 [reference]  
    In diabetic cohort 39/320 (12) 0.80 (0.59 to 1.09) 0.161 
History of tuberculosis    
    No history of tuberculosis at 
baseline 
117/943 (12) 1 [reference]  
    History of tuberculosis at 
baseline 
31/211 (15) 1.00 (0.67 to 1.49) 0.994 
Chronic Respiratory Disease 
(CRD) medication 
   
    Not on CRD drugs at baseline 27/567 (5) 1 [reference]  
    On CRD drugs but not MMT1 81/231 (35) 6.75 (4.11 to 11.09) 0.000 
    On CRD drugs at baseline and 
MMT1 
41/346 (12) 2.38 (1.34 to 4.24) 0.003 
1MMT=maximal medical therapy: defined for chronic respiratory disease as being on inhaled 










Table D Depression N=2439 (2466 in depression cohort but 27 patients excluded from depression 
primary analysis) 
Factor n/N (%) Risk ratio (95% CI) P value 
Arm of trial    
    Control 283/1186 (24) 1 [reference]  
    Intervention 224/1253 (18) 0.80 (0.57 to 1.10) 0.167 
Stratum    
1: Bitou and Knysna  120/739 (16) 1 [reference]  
2: Hessequa and Kannaland 51/341 (15) 0.82 (0.45 to 1.52) 0.533 
3: Eden DMA and Oudtshoorn 108/458 (24) 1.27 (0.62 to 2.59) 0.507 
4: George 83/328 (25) 1.13 (0.67 to 1.92) 0.651 
5: Mossel Bay 69/273 (25) 1.14 (0.65 to 2.03) 0.644 
6: Overberg 76/300 (25) 1.23 (0.70 to 2.16) 0.464 
Patient characteristics    
Sex     
    Female 413/1859 (22) 1 [reference]  
    Male  94/580 (16) 0.76 (0.62 to 0.94) 0.011 
Smoking status    
    Never 200/1011 (20) 1 [reference]  
    Ex 107/544 (20) 0.96 (0.73 to 1.26) 0.772 
    Current 193/848 (23) 0.97 (0.78 to 1.20) 0.764 
Hypertension (HPT)    
    Not in HPT cohort 218/854 (26) 1 [reference]  
    In HPT cohort 289/1585 (18) 0.72 (0.60 to 0.86) 0.000 
History of depression    
    No history of depression 233/1577 (15) 1 [reference]  
    History of depression 274/858 (32) 1.73 (1.48 to 2.02) 0.000 
CESD-10 score at baseline1,2  1.01 (0.99 to 1.04) 0.197 
    10-15 257/1459 (18)   
    16-20 145/672 (22)   
    21-25 84/272 (31)   
    26-30 21/63 (33)   
Antidepressants at baseline at a 
therapeutic dose 
   
    Not receiving antidepressants 384/2133 (18) 1 [reference]  
    Receiving antidepressants 119/292 (40) 1.46 (1.12 to 1.89) 0.004 
1CESD-10= 10-item Centre for Epidemiologic Studies Scale 











Table E: Primary outcomes disaggregated by components  
Table E Hypertension Cohort 
Outcome Interventi
on 




n/N (%) n/N (%) Type Estimate 
(95% CI) 










RR 1.07 (0.92 
to 1.24) 
0.375 Binomial MMT, BP control, 







RR 1.44 (1.02 
to 2.03) 
0.037 Binomial MMT, BP control, 
sex, diabetes, CVD1,2 
Addition or 
increase in the 






RR 1.27 (0.87 
to 1.86) 
0.218 Binomial MMT, BP control, 
sex, diabetes, CVD1,2 
1MMT=maximal medical therapy: defined for hypertension as being on  3 antihypertensive drugs at optimal 
dosage 




















Table E Diabetes Cohort 
Outcome Intervention Control Effect estimate P Regressio
n model 
Adjusted for 
n/N (%) n/N (%) Type Estimate 
(95% CI) 
Disaggregation of primary outcome 
Addition or 
increase in the 










0.472 Binomial  
Addition or 








RR 1.30 (0.98 
to 1.73) 
0.074 Binomial  
Addition or 
increase in the 
dose of 
sulphonylurea if 
BMI ≤ 30 
 
32/327 (10) 47/404 
(12) 
RR 0.87 (0.52 
to 1.47) 
0.613 Binomial MMT, age, 
interaction 
between arm 
and BMI, sex, 
HPT, history of 
CVD1,2 
Addition or 




85/479 (18) 55/532 
(10) 
RR 1.68 (1.23 
to 2.30) 
0.001 Binomial MMT, age, 
interaction 
between arm 
and BMI, sex, 
HPT, history of 
CVD1,2 
Insulin 189/851 (22) 179/991 
(18) 
RR 1.18 (0.92 
to 1.51) 
0.194 Binomial  
Addition or 
increase in the 






RR 1.23 (0.88 
to 1.72) 
0.223 Binomial  
Addition or 
increase in the 
dose of an ACE 
inhibitor if no 
history of CVD 
78/645 (12) 81/774 
(11) 
RR 1.13 (0.76 
to 1.66) 




and history of 
CVD1,2 
Addition or 
increase in the 
dose of an ACE 
inhibitor if history 
of CVD 
18/206 (9) 10/217 
(5) 
RR 2.76 (1.17 
to 6.49) 




and history of 
CVD1,2 




RR 1.73 (1.13 
to 2.63) 
0.011 Binomial  
1.70 (1.08 
to 2.66) 
0.021 MMT, BMI, age, 
sex, HPT, CVD1,2 
Addition or 
increase in the 







RR 1.19 (0.80 
to 1.78) 
0.395 Binomial  
1.15 (0.76 
to 1.75) 
0.505 MMT, age, BMI, 
sex, HPT, history 
of CVD1,2 
1MMT=maximal medical therapy: defined for diabetes as being on insulin 






Table E Chronic Respiratory Disease Cohort 
Outcome Interventi
on 
Control Effect estimate P Regressio
n model 
Adjusted for 
n/N (%) n/N (%) Type Estimate 
(95% CI) 




















RR 1.05 (0.65 
to 1.67) 
0.854  MMT, CRD drugs, 
SGRQACT, age, 








RR 0.90 (0.51 
to 1.56) 
0.697 Binomial  
Addition of 
beta agonist 
RR 0.78 (0.39 
to 1.56) 
0.482 Binomial MMT, CRD drugs, 
SGRQACT, age, 









RR 1.22 (0.66 
to 2.23) 




RR 1.27 (0.66 
to 2.44) 
0.479 Binomial MMT, CRD drugs, 
SGRQACT, age, 








RR 0.97 (0.48 
to 1.99) 




RR 1.21 (0.68 
to 2.15) 
0.517 Binomial MMT, CRD drugs, 
SGRQACT, age, 
smoking, sex, HPT 
cohort1,2 
1MMT=maximal medical therapy: defined for chronic respiratory disease as being on inhaled 
corticosteroid at a dose of  800mcg daily 














Table E Depression Cohort 
Outcome Interventi
on 
Control Effect estimate P Regressio
n model 
Adjusted for 
n/N (%) n/N (%) Type Estimate 
(95% CI) 



















0.500 Psychiatric sister, 







































0.015 Psychiatric referral 





Chapter 4: Discussion 
 
4.1 Summary of findings 
This thesis provides recent and novel evidence for high levels of multimorbidity, poor 
control and unmet treatment needs for NCDs in the South African primary care public 
sector. It confirms and provides original evidence for associations between socioeconomic 
position and blood pressure control and treatment intensification, and between 
socioeconomic position and depression symptoms and treatment. It provides new evidence 
in South Africa for a bidirectional link between socioeconomic position and depression 
symptoms, suggesting that socioeconomic position is both a cause and consequence of 
depression. Further, it provides original evidence for associations between patient and clinic 
characteristics, and the management of hypertension and depression in primary care. 
Finally, it reports on evidence of the effectiveness of the PC101 programme aimed at 
expanding nurses’ role in NCD care. Although differences in the primary endpoints of the 
RCT did not reach statistical significance, the programme was safe and feasible and has been 
adopted across South Africa. 
 
4.2 Multimorbidity, control and treatment of NCDs 
Multimorbidity is increasingly common (Mercer et al. 2012) (Barnett et al. 2012) and 
presents multiple challenges for primary health care providers (Moffat and Mercer 2015).  
 
In general, there is a paucity of current data on NCDs and their management in South Africa 
during a period of South African history dominated by HIV/AIDS, and the delayed response 
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to scaling up effective treatments for it. This has contributed to poor appreciation of the 
burden and impact of NCDs, and limited provision for their management. PC101 is an 
innovation that aims to improve this situation, but without situational analyses and 
evidence, such as provided in this thesis (Papers 1, 2 and 3), the need for and impact of 
innovations will be difficult to appreciate and assess.  
 
Paper 1 confirms high levels of multimorbidity, and demonstrates higher levels of 
comorbidity between hypertension and diabetes than previous studies in South Africa (Peer 
et al. 2013) (Steyn et al. 2008) (Lalkhen and Mash 2015). Our findings are consistent with a 
study of urban South African women that demonstrated high rates of comorbid 
psychological distress with physical disease (Mendenhall et al. 2013). As many as 65% of 
participants with chronic respiratory disease (CRD), and half of participants with 
hypertension, diabetes or CRD screened positive for depression symptoms.  
 
Paper 3 demonstrates depression symptoms at baseline being positively associated with 
chronic respiratory disease (CRD), but not with hypertension or diabetes. This might be due 
to CRD generally being more symptomatic and disabling than hypertension or diabetes. The 
association between depression symptoms and CRD is consistent with previous reports of 
up to 25% of people with COPD and 13–14% of people with asthma also having depression 
(Morrison et al. 2016). Further, paper 3 reports that baseline depression symptoms were 
not associated with a ten year risk of cardiovascular disease death score. However, a recent 
study (Kyrou et al. 2016), with a follow-up period of 10 years, showed that reported 
depression was positively and independently associated with 10-year CVD incidence, with 
depression increasing CVD risk approximately fourfold. In a meta-analysis, Pan et al found 
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depression to be associated with a significantly increased risk of stroke morbidity and 
mortality (Pan et al. 2011), and in a more recent meta-analysis, Barlinn et al found that 
depression increases the risk of first-ever stroke by 40% in the general population (Barlinn et 
al. 2014).  
 
Papers 1 and 2 report low levels of control and treatment for NCDs. Fifty-nine percent of 
participants with hypertension had a blood pressure ≥140/90 mmHg. Among participants 
with diabetes, the mean HbA1c value was 9%, 2% above target. Only 12% of participants 
with symptoms of depression had been prescribed an antidepressant at a therapeutic dose. 
Fewer than a half of participants with CRD had received a beta2-agonist and only 34% an 
inhaled corticosteroid. These findings are consistent with previous reports in South Africa of 
poor control and treatment for NCDs, and demonstrate little improvement in NCD control 
since these earlier studies were conducted (Steyn et al. 2008) (Maepe and Outhoff 2012) 
(Williams et al. 2008). 
 
4.3 Socioeconomic inequalities and the role of primary care 
This thesis reports on socioeconomic and modifiable predictors of control of hypertension 
(Paper 2) and depression (Paper 3), two of the most common chronic conditions, and causes 
of morbidity, globally and in South Africa.  
 
Lower levels of education predicted both uncontrolled blood pressure at baseline, and 
depression symptoms at baseline and follow-up. Lower levels of education were also found 
to be associated with lower probability of treatment intensification for hypertension at 
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follow-up, and treatment for depression with antidepressant medication at baseline. Lower 
income was associated with depression symptoms at baseline, and a lower probability of 
antidepressant medication at baseline and follow-up.  
 
Our finding of a positive association between level of education and blood pressure control 
is consistent with a South African study which found higher education to predict lower 
blood pressure in women (Cois and Ehrlich 2014). The associations reported in Paper 3 
between socioeconomic indicators (less education and lower income) and depression 
symptoms are consistent with previous studies, the majority of which have been 
community-based (Lund et al. 2010) (Patel and Kleinman 2003) (Araya et al. 2003) (Patel et 
al. 1999). However, our finding that depressed patients were less likely to receive treatment 
with antidepressant medications if they had less education or lower income, differs from 
the South African Stress and Health (SASH) study which found no significant associations 
between receiving treatment for mental disorders and level of education or income (Seedat 
et al. 2008).  
 
Of particular importance is the association found between clinic characteristics and control 
of hypertension and depression, as these factors are potentially modifiable. Clinic factors 
were found to be associated with both probability of treatment intensification for 
hypertension (clinics with community-based medication supply, with a doctor every day or 
more nurses) and antidepressant medication for depressed patients at follow-up (clinics 
with better access to pharmacists or community-based medication supply). Few studies 
have addressed modifiable predictors of hypertension and depression care in South Africa 
and these original findings emphasise the importance of addressing resources for primary 
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care facilities, in particular improving staffing and medication delivery services. A study in 
the Free State province of South Africa similarly showed associations between better staffed 
clinics and improved HIV outcomes; patients attending better staffed clinics were more 
likely to start ART and had lower mortality while awaiting initiation of ART (Ingle et al. 2010). 
 
To explore the findings described in Paper 3, further analyses were conducted using 
structural equation and mediation models to examine the complex causal pathways linking 
socioeconomic factors and depression (Elwell-Sutton et al. unpublished). The results support 
the findings reported in Paper 3 of a bidirectional link between depression symptoms and 
socioeconomic adversity, and also suggest a number of direct and indirect pathways linking 
the two with mediating factors including education, income and employment.  
 
Of interest, 73 percent of participants were women. Studies have demonstrated that 
women seek healthcare to a greater extent than men for both physical and 
mental health concerns (Thompson et al. 2016) (Galdas, Cheater, and Marshall 2005). It is 
therefore expected for more women to be recruited in the study. One might expect that the 
inclusion criterion to be planning to reside in the area for the study period excluded migrant 
men but, in fact, only 41 patients out of 4904 screened were excluded on the basis of this 
requirement. 
 
4.4 Addressing NCDs: The PC101 programme 
The increasing burden of NCDs and multimorbidity described in this thesis necessitates a 
comprehensive and integrated approach to chronic disease care, including equipping 
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primary health care providers to manage NCDs, communicable diseases, mental illness and 
the complexities of multimorbidity. 
 
The PC101 programme was aimed at addressing the burden of multimorbidity, and the low 
levels of control and treatment for NCDs in particular. It does this by providing on-site 
training in the use of a clinical management tool that provides an integrated approach to 
the primary care management of adults and allows enhanced prescribing provisions for first-
line NCD treatments for nurses trained in the use of the tool. It builds on predecessor 
programmes which had focused largely on communicable diseases, demonstrating 
consistent, wide-ranging and reproducible outcomes (Fairall et al. 2005) (Zwarenstein et al. 
2011) (Fairall et al. 2012). 
 
The RCT evaluating the PC101 programme and reported in Paper 4, saw treatment 
intensification in both control and intervention arms, particularly for the hypertension and 
diabetes cohorts, but no statistically significant differences in the primary outcome 
measures between arms. This is in contrast to the RCTs which have evaluated the PC101 
programme’s predecessors, PALSA , PALSA PLUS, and the introduction of NIMART, which did 
show statistically significantly greater improvements in care and in health outcomes in the 
intervention arms, as summarised in Table 2 (Fairall et al. 2005) (Zwarenstein et al. 2011) 
(Fairall et al. 2012) (Bachmann et al. 2010). 
 
There are a number of possible reasons why the PC101 programme might not have shown 
significant results for the primary outcome measures, whereas these previous studies did. 
Firstly, the PALSA and PALSA PLUS programmes focussed on a limited number of diseases, 
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predominantly respiratory disease (PALSA) and HIV (PALSA PLUS). Expanding the PALSA 
PLUS clinical management tool to encompass the most common symptoms and chronic 
diseases presenting in primary care may have been overwhelming for nurses. In addition, it 
takes time to change clinician behaviour, perhaps more so for NCDs where ineffective 
practices can become entrenched and ritualised, and frequency of contact with health 
services, and thus opportunity to improve care, is much reduced compared with HIV, and 
perhaps we would have seen more impressive results with a longer follow-up period.  
 
Secondly, a ‘Chronic Disease Season’ was introduced in the Eden district during the study 
period, which focused on the management of hypertension and diabetes. This was in part 
triggered by the PC101 trial itself, which sparked a renewed interest in NCDs, hypertension 
and diabetes in particular, in the district. This acted as a co-intervention and was rolled out 
across 17 intervention and 16 control clinics during the follow-up period. Resulting from 
this, a dilution effect for our trial is suggested by the high rates of treatment intensification 
in our control as well as intervention arms, particularly for hypertension and diabetes. 
Further, this was higher compared to previous studies that selected treatment 
intensification as a primary outcome - about 30% compared to our 40-50% treatment 
intensification for hypertension and diabetes (Selby et al. 2012) (Billue et al. 2012).  
 
Thirdly, it might be that treatment intensification was too broad an outcome measure. 
Treatment intensification was not associated with better disease control at follow-up for 
hypertension and diabetes, as would have been expected. This might be due to patients 
having their treatment intensified, but not adhering to their treatment regimens. We are 
unable to investigate this as adherence assessments are complex and were beyond the 
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scope of this study. Further, in keeping with the pragmatic orientation of the trial, inclusion 
criteria were broad. This meant that all patients with the conditions of interest were 
enrolled, including those not adherent to their treatment regimens, for whom adherence 
counselling rather than treatment intensification may have been more appropriate.  
 
Finally, we cannot exclude that there may have been low levels of uptake of PC101 by 
clinic staff. Due to financial constraints, we were unable to conduct a detailed process 
evaluation alongside the trial to explore this. However, limited focus group discussions 
confirmed a range of uptake of the programme within and between clinics, and 
increasing uptake over time.  
 
4.5 Policy uptake  
In 2013 the local Western Cape and National Departments of Health in South Africa elected 
to commence national implementation of the PC101 programme. This decision was not 
reversed when the results of the trial were known, in large part because the PC101 
programme is perceived to be a highly feasible and acceptable approach to expansion of 
skills necessary to address rises in multimorbidity. It was instead influenced by high demand 
expressed by frontline clinicians and managers in the Western Cape province. The National 
Department were also likely to have been influenced by the generally positive (unpublished) 
findings of a non-randomised evaluation of PC101 performed in 42 primary care clinics in 
three other health districts, by an independent researcher commissioned by the National 




PC101 is now called Adult Primary Care (APC) nationally, and Practical Approach to Care Kit 
(PACK) in the Western Cape province. It is a key element of the Integrated Clinical Services 
Management (ICSM) programme and is included in the checklist of audit criteria for the 
Ideal Clinic and ICSM compliant package of clinical guidelines (Department of Health 2016). 
 
The Knowledge Translation Unit has, nevertheless, introduced several measures to improve 
effectiveness of the programme. The PC101 content has been broken down into four 
training modules (communicable diseases, NCDs, mental health and women’s health) to 
allow staff to become familiar with one area at a time and embed changes into their clinical 
practice before moving to the next. PC101 workshops are also now provided for doctors, 
District Implementation Workshops are provided for facility and middle managers, and 
appointment of clinical governance teams within sub-districts has been implemented, 
allowing local trouble-shooting of barriers to implementation, and inclusion of non-clinicians 
in the day-to-day running of the programme.   
 
A community health worker module has been introduced, focusing on condition and 
medication literacy, and pamphlets are available in local languages. However, there may 
need to be more emphasis on providing counselling for lifestyle and pharmacological 
management of NCDs. Although the programme aims to provide an integrated approach to 
primary care, with limited time and resources in the public sector primary care setting, it 
might be necessary to prioritise care, adopting risk stratification approaches. The high 
proportion (10%) of hypertensive participants in the PC101 trial with a blood pressure 
greater than or equal to 180/110 mmHg, putting them at markedly increased and 
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immediate risk of complications such as heart attack and stroke, suggests this group of 
patients warrants particular attention.  
 
The results of the PC101 trial suggest that training in depression diagnosis and management 
alone is insufficient in improving the care of this condition in primary care. There is a paucity 
of counselling and mental health referral services in the public sector and antidepressant 
prescribing is, at present, restricted to doctors. In collaboration with the PRogramme for 
Improving Mental health carE (PRIME) in South Africa, an intervention has been developed 
building on PC101 and supplementing it with the introduction of lay counsellors to provide 
individual and group on-site depression counselling (Petersen et al. 2016). We are currently 
conducting a pair of randomised controlled trials in the North West province, evaluating this 
PC101 programme with enhanced mental health provisions. The first trial is evaluating the 
effect on depressed adults receiving ART (ClinicalTrials.gov NCT02407691); the second trial 
the effect on depressed patients on antihypertensive medication (ClinicalTrials.gov  
NCT02425124). To date, 2747 patients across the two trials have been enrolled and are 
being followed-up. Results are expected in mid-2018. 
 
4.6 Further developments arising from this work 
PC101 has been further developed into the Practical Approach to Care Kit (PACK) 
(pack.bmj.com) as one of a suite of integrated, coherent clinical management tools 





In 2015, a partnership was established with the British Medical Journal (BMJ) Publishing 
Group to enable the development of a global template of the ‘PACK Adult’ programme. This 
template is now complete and includes a mentorship programme for countries interested in 
localising the programme for their local contexts as well as yearly updates. It also includes a 
database, linking each of the 2372 recommendations in the guide to the BMJ’s equivalent 
evidence product, Best Practice (http://bestpractice.bmj.com/best-
practice/marketing/about-best-practice.html?button=site-nav), and other sources such as 
World Health Organization recommendations.   
 
Localisations of PACK Adult for Brazil and Nigeria have been completed, with a randomised 
controlled trial underway to evaluate its effectiveness on respiratory and cardiovascular 
endpoints in the city of Florianópolis, Brazil (ClinicalTrials.gov NCT02786030). Discussions 
are underway for localisation of the programme in a number of other countries.  
 
PACK Child, a clinical management tool similar in layout to PACK Adult, aimed at equipping 
nurses and doctors to manage common childhood conditions from ages 0 to 13 years at 
primary care level, is in the final stages of development, and a randomised controlled trial to 
evaluate it is in the planning stages. A tool for the primary care management of adolescents, 
‘PACK Adolescent’, is also scheduled to be developed, starting in April 2017.  
 
The Knowledge Translation Unit has also been involved in the adaptation of the PC101 and 
PACK programmes for undergraduate medical students at the Universities of Stellenbosch 




4.7 Limitations and strengths 
Limitations and strengths are outlined in detail in each of the four papers. Key limitations 
and strengths of the thesis are summarised below. 
 
Case definition: We relied on self-report of disease for inclusion in the four cohorts, which 
may have resulted in potential misclassification in that some participants reported 
conditions that were not confirmed, while others were found to be receiving medications 
for a disease that they had not reported. For example, 5% of participants in the 
hypertension cohort, and 7% of participants in the diabetes cohort had no evidence of 
being on medication for hypertension and diabetes respectively. Including patients who 
reported a disease, but were not being treated for it, may have contributed to dilution of 
treatment effects.  
 
Pragmatic study design: While a pragmatic study design is useful for policy makers, it is 
subject to weaknesses that influence the outcomes, chief of which is unforeseen co-
interventions; in our study the ‘Chronic Disease Season’, introduced by the health authority, 
was intended to improve NCD care in all clinics and appeared to contribute to higher than 
expected treatment intensification rates in both the intervention and control groups, 
particularly for hypertension and diabetes.  
 
Limited health process evaluation: Due to limited funds, a systematic evaluation of  
uptake of PC101 by intended users, including barriers to and facilitators of uptake, was 




Evaluation of risk factors: Although the randomised controlled trial provides rigorous 
evidence of causation, observational evidence is not as strong and does not prove that 
associations are causal. This said, the longitudinal design strengthened the observational 
analyses, allowing inference of direction of causation which is ambiguous with cross-
sectional studies. 
 
The methods of the reported studies have a number of strengths. First, the pragmatic 
orientation of the trial, observing ‘real-world’ implementation of the PC101 programme, 
appears to have given relevant policy makers sufficient confidence to make a decision on 
the suitability of the intervention for their health system. The work provides both 
experimental evidence from a rigorously conducted randomised controlled trial and findings 
from observational studies conducted alongside the RCT in the primary care setting. The 
sample size was large: a total of 4393 participants across 38 clinics in the RCT, with 
exceptionally high follow-up rates and data of assured quality. The longitudinal study design 
enabled analysis of change in control and treatment, and allowed conclusions on the 
direction of causation, for example, the bidirectional link between socioeconomic factors 
and depression. A range of socioeconomic and modifiable predictors of hypertension and 
depression care were investigated. Further, health outcomes as well as process outcomes 
were included, such as blood pressure, HbA1c levels in blood, and validated health 







This thesis provides new and original evidence for high levels of multimorbidity and unmet 
treatment needs for NCDs in the South African public primary care sector. It confirms 
associations between socioeconomic and clinic characteristics, and hypertension control 
and treatment, and depression symptoms and treatment. It identifies potentially modifiable 
clinic-level factors that could improve care for these diseases. It provides new evidence from 
South Africa in support of the bidirectional relationship between poverty and depression. 
Finally, it reports evidence of the effectiveness of a novel programme aimed at improving 
NCD management by supporting and expanding nurses’ role in NCD care. 
 
The work points to the need for improved strategies for diagnosing and managing NCDs and 
for better integrated NCD care, including equipping primary health care providers to 
manage NCDs and the complexities of multimorbidity.  
 
Health services need to be sensitive to the impact of socioeconomic factors, in particular 
lower levels of education. Clinic factors that may be addressed to improve NCD care include 
adequate staffing of clinics, having pharmacists on site, and provision for community-based 
collection of chronic medications. The latter is likely to be relevant to the care of all chronic 
diseases, and points to the need for expansion of convenient medication delivery services in 
South Africa. Together, these measures should be viewed as achievable opportunities for 
improving the management of NCDs in primary care in South Africa. 
 
PC101 offers a practical and acceptable tool to help expand the scope of practice of  
non-physician clinicians to include NCD care. The programme, with several subsequent 
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adjustments aimed at increasing its impact, has been rolled out nationally in South Africa 
and is included in the National Department of Health’s checklist criteria for the Ideal  
Clinic and Integrated Clinical Services Management (ICSM) compliant package of  
clinical guidelines.   
 
PC101 forms the basis for the Practical Approach to Care Kit (PACK) (pack.bmj.com) which 
now extends to children, adolescents and community health workers. In partnership with 
the British Medical Journal (BMJ), global templates of the ‘PACK Adult’ programme have 
been developed. Localisations of PACK Adult for Brazil and Nigeria have been completed, 
and a randomised controlled trial is underway to evaluate the programme in the city of 
Florianópolis, Brazil. Ongoing development and evaluation of these programmes is required 
to ensure continued improvements in the management of NCDs in primary care. 
 
In summary, this thesis, including the four publications, addresses the public health 
challenge of providing integrated chronic disease management in South African primary 
care. It identifies needs and potential solutions to the needs of patients with NCDs in the 
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